<!DOCTYPE html>
<html lang="en" class="grade-c">
<head>
    <title>Repression of microRNA-768-3p by MEK/ERK signalling contributes to enhanced mRNA translation in human melanoma | Oncogene</title>
    
        
    


<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="applicable-device" content="pc,mobile">
<meta name="viewport" content="width=device-width,initial-scale=1.0,maximum-scale=5,user-scalable=yes">

<script data-test="dataLayer">
    window.dataLayer = [{"content":{"category":{"contentType":"original article","legacy":{"webtrendsPrimaryArticleType":"research","webtrendsSubjectTerms":"cell-signalling;melanoma;mirnas;translation","webtrendsContentCategory":null,"webtrendsContentCollection":null,"webtrendsContentGroup":"Oncogene","webtrendsContentGroupType":null,"webtrendsContentSubGroup":"Original Article"}},"article":{"doi":"10.1038/onc.2013.237"},"attributes":{"cms":null,"deliveryPlatform":"oscar","copyright":{"open":false,"legacy":{"webtrendsLicenceType":null}}},"contentInfo":{"authors":["C C Jiang","A Croft","H-Y Tseng","S T Guo","L Jin","P Hersey","X D Zhang"],"publishedAt":1371427200,"publishedAtString":"2013-06-17","title":"Repression of microRNA-768-3p by MEK/ERK signalling contributes to enhanced mRNA translation in human melanoma","legacy":null,"publishedAtTime":null,"documentType":"aplusplus"},"journal":{"pcode":"onc","title":"oncogene","volume":"33","issue":"20"},"authorization":{"status":true},"features":[{"name":"furtherReadingSection","present":true}],"collection":null},"page":{"category":{"pageType":"article"},"attributes":{"template":"mosaic","featureFlags":[{"name":"ab_test_highlight_supp_info","active":false},{"name":"nature-oa-paywall","active":true},{"name":"nature-onwards-journey","active":false}],"testGroup":null},"search":null},"privacy":{},"version":"1.0.0","product":null,"session":null,"user":null,"backHalfContent":true,"country":"US","hasBody":true,"uneditedManuscript":false,"twitterId":["o3xnx","o43y9","o3ef7"]}];
    window.dataLayer.push({
        ga4MeasurementId: 'G-ERRNTNZ807',
        ga360TrackingId: 'UA-71668177-1',
        twitterId: ['3xnx', 'o43y9', 'o3ef7'],
        ga4ServerUrl: 'https://collect.nature.com',
        imprint: 'nature'
    });
</script>


    <script>
        window.dataLayer.push({
            cmpAndNewGtmFeatureFlag: true
        });
    </script>



    <script>
        (function(w, d) {
            w.config = w.config || {};
            w.config.mustardcut = false;

            
            if (w.matchMedia && w.matchMedia('only screen and (-webkit-min-device-pixel-ratio:0) and (min-color-index:0), (-ms-high-contrast: none), only all and (min--moz-device-pixel-ratio:0) and (min-resolution: 3e1dpcm)').matches) {
                w.config.mustardcut = true;
                d.classList.add('js');
                d.classList.remove('grade-c');
            }
        })(window, document.documentElement);
    </script>


 



    
         
            
    <style>@media only screen and (-webkit-min-device-pixel-ratio: 0) and (min-color-index: 0), (-ms-high-contrast: none), only all and (min--moz-device-pixel-ratio: 0) and (min-resolution: 3 e1dpcm) { html{text-size-adjust:100%;box-sizing:border-box;font-family:sans-serif;font-size:100%;height:100%;line-height:1.15;overflow-y:scroll}body{background:#eee;color:#222;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;line-height:1.76;min-height:100%}article,aside,header,main,nav,section{display:block}h1{font-size:2em}a,sup{vertical-align:baseline}a{background-color:transparent;color:#069;overflow-wrap:break-word;text-decoration:underline;word-break:break-word}b{font-weight:bolder}sup{font-size:75%;line-height:0;position:relative;top:-.5em}img{border:0;height:auto;max-width:100%;vertical-align:middle}svg:not(:root){overflow:hidden}button,input,select{font-family:sans-serif;font-size:100%;line-height:1.15}select{margin:0}button,input{overflow:visible}button,select{text-transform:none}[type=submit],button{-webkit-appearance:button}[hidden]{display:none}button{border-radius:0;cursor:pointer}button,h1{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}h1{font-size:2rem;font-weight:700;letter-spacing:-.03906rem;line-height:2.25rem}.c-card--major .c-card__title,.u-h2,h2{font-size:1.5rem;line-height:1.6rem}.c-card--major .c-card__title,.u-h2{letter-spacing:-.01172rem;margin-bottom:8px}h2,h3{letter-spacing:-.01172rem}.c-card--major .c-card__title,.c-card__title,.c-reading-companion__figure-title,.u-h2,.u-h3,.u-h4,h2,h3,h4,h5,h6{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-weight:700}.c-card__title,.c-reading-companion__figure-title,.u-h3,.u-h4,h3,h4,h5,h6{line-height:1.4rem}.c-card__title,h3{font-size:1.25rem}.c-reading-companion__figure-title,.u-h3,.u-h4{letter-spacing:-.01172rem}.u-h3{font-size:1.25rem;margin-bottom:8px}.c-reading-companion__figure-title,.u-h4{font-size:1.125rem}.u-h4{margin-bottom:8px}body,button,div,form,h1,h2,h3,input{margin:0;padding:0}p{padding:0}nav ol,nav ul{list-style:none none}body{font-size:1.125rem}p{margin:0 0 28px}ol,ul{margin-bottom:28px;margin-top:0}p:empty{display:none}.sans-serif{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}.article-page{background:#fff}.c-article-header{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;margin-bottom:40px}.c-article-identifiers{color:#6f6f6f;display:flex;flex-wrap:wrap;font-size:1rem;line-height:1.3;list-style:none;margin:0 0 8px;padding:0}.c-article-identifiers__item{border-right:1px solid #6f6f6f;list-style:none;margin-right:8px;padding-right:8px}.c-article-identifiers__item:last-child{border-right:0;margin-right:0;padding-right:0}.c-article-identifiers__open{color:#b74616}.c-article-title{font-size:1.5rem;line-height:1.25;margin-bottom:16px}@media only screen and (min-width:768px){.c-article-title{font-size:1.875rem;line-height:1.2}}.c-article-author-list{display:inline;font-size:1rem;list-style:none;margin:0 8px 0 0;padding:0;width:100%}.c-article-author-list__item{margin-left:0}.c-article-author-list li,.c-article-author-list__item{display:inline;padding-right:0}.c-article-author-list__show-more{margin-right:4px}@media only screen and (max-width:539px){html.js .js-small-screen-show-inline{display:inline!important;visibility:visible!important}.js .js-smaller-author-etal{display:none;visibility:hidden}}.c-article-info-details{font-size:1rem;margin-bottom:8px;margin-top:16px}.c-article-info-details__cite-as{border-left:1px solid #6f6f6f;margin-left:8px;padding-left:8px}.c-button-author-list{background:#ebf1f5;border:4px solid #ebf1f5;border-radius:20px;color:#666;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:.875rem;line-height:1.4;padding:2px 11px 2px 8px;text-decoration:none}.c-button-author-list svg{margin:1px 4px 0 0}.c-article-metrics-bar{display:flex;flex-wrap:wrap;font-size:1rem;line-height:1.3}.c-article-metrics-bar__wrapper{margin:0 0 16px}.c-article-metrics-bar__item{-webkit-box-align:baseline;align-items:baseline;border-right:1px solid #6f6f6f;margin-right:8px}.c-article-metrics-bar__item:last-child{border-right:0}.c-article-metrics-bar__count{font-weight:700;margin:0}.c-article-metrics-bar__label{color:#626262;font-style:normal;font-weight:400;margin:0 10px 0 5px}.c-article-metrics-bar__details{margin:0}.c-article-main-column{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;margin-right:8.6%;width:60.2%}@media only screen and (max-width:1023px){.c-article-main-column{margin-right:0;width:100%}}.c-article-associated-content__container .c-article-associated-content__title,.c-article-section__title{border-bottom:2px solid #d5d5d5;font-size:1.25rem;line-height:1.3;padding-bottom:8px}@media only screen and (min-width:768px){.c-article-associated-content__container .c-article-associated-content__title,.c-article-section__title{font-size:1.5rem;line-height:1.24}}.c-article-section{clear:both}.c-article-section__content{margin-bottom:40px;padding-top:8px}@media only screen and (max-width:1023px){.c-article-section__content{padding-left:0}}.c-reading-companion__figure-full-link svg{margin-left:4px}.c-article-authors-search{margin-bottom:24px;margin-top:0}.c-article-authors-search__item,.c-article-authors-search__title{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}.c-article-authors-search__title{color:#626262;font-size:1.05rem;font-weight:700;margin:0;padding:0}.c-article-authors-search__item{font-size:1rem}.c-article-authors-search__text{margin:0}.c-article-share-box__no-sharelink-info{font-size:.813rem;font-weight:700;margin-bottom:24px;padding-top:4px}.c-article-share-box__only-read-input{border:1px solid #d5d5d5;display:inline-block;font-size:.875rem;font-weight:700;margin-bottom:8px;padding:8px 10px}.c-article-share-box__button--link-like{background-color:transparent;border:0;color:#069;cursor:pointer;font-size:.875rem;margin-bottom:8px;margin-left:10px}.c-article-editorial-summary__container{border-bottom:1px solid #d5d5d5}.c-article-editorial-summary__container .c-article-editorial-summary__article-title{font-size:.875rem;line-height:1.4}.c-article-editorial-summary__container .c-article-editorial-summary__content{font-size:.875rem}.c-article-editorial-summary__container .c-article-editorial-summary__content p:last-child{margin-bottom:0}.c-article-editorial-summary__container .c-article-editorial-summary__content--less{max-height:9.5rem;overflow:hidden}.c-article-editorial-summary__container .c-article-editorial-summary__button{background-color:#fff;border:0;color:#069;font-size:.875rem;margin-bottom:16px;text-decoration:none}.c-article-editorial-summary__container .c-article-editorial-summary__button.active,.c-article-editorial-summary__container .c-article-editorial-summary__button.hover,.c-article-editorial-summary__container .c-article-editorial-summary__button:active,.c-article-editorial-summary__container .c-article-editorial-summary__button:hover{text-decoration:underline;text-decoration-skip-ink:auto}.c-article-editorial-summary__container .c-article-editorial-summary__button:focus{outline:3px solid #fece3e;will-change:transform}.c-article-associated-content__container .c-article-associated-content__collection-label{font-size:.875rem;line-height:1.4}.c-article-associated-content__container .c-article-associated-content__collection-title,.c-nature-box{line-height:1.3}@media only screen and (min-width:1024px){.c-pdf-button__container{display:none}}.c-context-bar{box-shadow:0 0 10px 0 rgba(51,51,51,.2);position:relative;width:100%}.c-context-bar__title,.c-header__menu--global .c-header__item svg{display:none}.c-article-extras{float:left;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;width:31.2%}@media only screen and (max-width:1023px){.c-article-extras{display:none}}.c-reading-companion{clear:both}.c-reading-companion__sticky{max-width:389px}.c-reading-companion__scroll-pane{margin:0;min-height:200px;overflow:hidden auto}.c-reading-companion__tabs{-webkit-box-orient:horizontal;-webkit-box-direction:normal;display:flex;flex-flow:row nowrap;font-size:1rem;list-style:none;margin:0 0 8px;padding:0}.c-reading-companion__tabs>li{-webkit-box-flex:1;flex-grow:1}.c-reading-companion__tab{background-color:#eee;border:1px solid #d5d5d5;border-image:initial;border-left-width:0;color:#069;font-size:1rem;padding:8px 8px 8px 15px;text-align:left;width:100%}.c-reading-companion__tabs li:first-child .c-reading-companion__tab{border-left-width:1px}.c-reading-companion__tab--active{background-color:#fff;border-bottom:1px solid #fff;color:#222;font-weight:700}.c-reading-companion__figures-list,.c-reading-companion__references-list,.c-reading-companion__sections-list{list-style:none;padding:0}.c-reading-companion__sections-list{margin:0 0 8px;min-height:50px}.c-reading-companion__section-item{font-size:1rem;padding:0}.c-reading-companion__section-item a{display:block;line-height:1em;overflow:hidden;padding:8px 0 8px 16px;text-overflow:ellipsis;white-space:nowrap}.c-reading-companion__figure-item{border-top:1px solid #d5d5d5;font-size:1rem;padding:16px 8px 16px 0}.c-reading-companion__figure-item:first-child{border-top:none;padding-top:8px}.c-reading-companion__reference-item{border-top:1px solid #d5d5d5;font-size:1rem;padding:8px 8px 8px 16px}.c-reading-companion__reference-item:first-child{border-top:none}.c-reading-companion__reference-item a{word-break:break-word}.c-reading-companion__reference-citation{display:inline}.c-reading-companion__reference-links{font-size:.813rem;font-weight:700;list-style:none;margin:8px 0 0;padding:0;text-align:right}.c-reading-companion__reference-links>a{display:inline-block;padding-left:8px}.c-reading-companion__reference-links>a:first-child{display:inline-block;padding-left:0}.c-reading-companion__figure-title{display:block;margin:0 0 8px}.c-reading-companion__figure-links{-webkit-box-pack:justify;display:flex;justify-content:space-between;margin:8px 0 0}.c-reading-companion__figure-links>a{display:inline-block}.c-reading-companion__panel{border-top:none;display:none;margin-top:0;padding-top:0}.c-reading-companion__panel--active{display:block}.c-pdf-download{display:flex;margin-bottom:24px;max-height:48px}@media only screen and (min-width:540px){.c-pdf-download{max-height:none}}@media only screen and (min-width:1024px){.c-pdf-download{max-height:48px}}.c-pdf-download__link{-webkit-box-pack:justify;-webkit-box-flex:1;background:#069;border:1px solid #069;border-radius:2px;color:#fff;display:flex;flex:1 1 0%;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1rem;justify-content:space-between;line-height:1.3;padding:13px 24px;text-decoration:none}.c-article-metrics__heading a,.c-article-metrics__posts .c-card__title a{color:inherit}.c-article-metrics__posts .c-card__title{font-size:1.05rem}.c-article-metrics__posts .c-card__title+span{color:#6f6f6f;font-size:1rem}p{overflow-wrap:break-word;word-break:break-word}.c-ad{text-align:center}@media only screen and (min-width:320px){.c-ad{padding:8px}}.c-ad--728x90{background-color:#ccc;display:none}.c-ad--728x90 .c-ad__inner{min-height:calc(1.5em + 94px)}@media only screen and (min-width:768px){.js .c-ad--728x90{display:none}}.c-ad__label{color:#333;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:.875rem;font-weight:400;line-height:1.5;margin-bottom:4px}.c-author-list{color:#6f6f6f;font-family:inherit;font-size:1rem;line-height:inherit;list-style:none;margin:0;padding:0}.c-author-list>li,.c-breadcrumbs>li,.c-footer__list--inline>li,.js .c-author-list,.u-list-comma-separated>li,.u-list-inline>li{display:inline}.c-author-list>li:not(:first-child):not(:last-child):before{content:", "}.c-author-list>li:not(:only-child):last-child:before{content:" & "}.c-author-list--compact{font-size:.875rem;line-height:1.4}.c-author-list--truncated>li:not(:only-child):last-child:before{content:" ... "}.js .c-author-list__hide{display:none;visibility:hidden}.c-skip-link{background:#069;bottom:auto;color:#fff;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:.875rem;padding:8px;position:absolute;text-align:center;transform:translateY(-100%);z-index:9999}@media (prefers-reduced-motion:reduce){.c-skip-link{transition:top .3s ease-in-out 0s}}@media print{.c-skip-link{display:none}}.c-skip-link:link{color:#fff}.c-status-message{-webkit-box-align:center;align-items:center;box-sizing:border-box;display:flex;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1rem;position:relative;width:100%}.c-card__summary>p:last-child,.c-status-message :last-child{margin-bottom:0}.c-status-message--boxed{background-color:#fff;border:1px solid #eee;border-radius:2px;line-height:1.4;padding:16px}.c-status-message__heading{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1rem;font-weight:700}.c-status-message__icon{fill:currentcolor;-webkit-box-flex:0;display:inline-block;flex:0 0 auto;height:1.5em;margin-right:8px;transform:translate(0);vertical-align:text-top;width:1.5em}.c-status-message__icon--top{align-self:flex-start}.c-status-message--info .c-status-message__icon{color:#003f8d}.c-status-message--boxed.c-status-message--info{border-bottom:4px solid #003f8d}.c-status-message--error .c-status-message__icon{color:#c40606}.c-status-message--boxed.c-status-message--error{border-bottom:4px solid #c40606}.c-status-message--success .c-status-message__icon{color:#00b8b0}.c-status-message--boxed.c-status-message--success{border-bottom:4px solid #00b8b0}.c-status-message--warning .c-status-message__icon{color:#edbc53}.c-status-message--boxed.c-status-message--warning{border-bottom:4px solid #edbc53}.c-breadcrumbs{color:#000;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1rem;list-style:none;margin:0;padding:0}.c-breadcrumbs__link{color:#666}.c-breadcrumbs__chevron{fill:#888;margin:4px 4px 0}.c-card__body{-webkit-box-flex:1;flex:1 1 auto;padding:16px}.c-card__title{letter-spacing:-.01875rem;margin-bottom:8px;margin-top:0}.c-card--flush .c-card__body{padding:0}.c-card--dark .c-card__title{color:#fff}.c-header{background-color:#fff;border-bottom:5px solid #000;font-size:1rem;line-height:1.4;margin-bottom:16px}.c-header__row{padding:8px 0;position:relative}.c-header__row:not(:last-child){border-bottom:1px solid #eee}.c-header__row--flush{padding:0}.c-header__split{-webkit-box-align:center;-webkit-box-pack:justify;align-items:center;display:flex;justify-content:space-between}.c-header__logo-container{-webkit-box-flex:1;flex:1 1 0px;line-height:0;margin-right:24px}.c-header__logo{transform:translateZ(0)}.c-header__logo img{max-height:32px}.c-header__container{margin:0 auto;max-width:1280px;padding:0 16px}.c-header__menu{-webkit-box-align:center;-webkit-box-flex:0;align-items:center;display:flex;flex:0 1 auto;flex-wrap:wrap;font-weight:700;line-height:1.4;list-style:none;margin:0 -8px;padding:0}.c-header__menu--global{-webkit-box-pack:end;font-weight:400;justify-content:flex-end}@media only screen and (min-width:540px){.c-header__menu--global .c-header__item svg{display:block}}.c-header__menu--journal{font-size:.875rem}@media only screen and (min-width:540px){.c-header__menu--journal{flex-wrap:nowrap;font-size:1rem}}@media only screen and (max-width:1023px){.c-header__menu--tools{display:none}}.c-header__item{display:flex}@media only screen and (min-width:540px){.c-header__item:not(:first-child){margin-left:8px}}.c-header__item--pipe{border-left:2px solid #eee;padding-left:8px}@media only screen and (max-width:767px){.c-header__item--nature-research{display:none}}.c-header__row--flush .c-header__item{padding-bottom:8px;padding-top:8px}.c-header__link{-webkit-box-align:center;align-items:center;color:inherit;display:flex;padding:8px;white-space:nowrap}.c-header-expander a{color:inherit}.c-header__link>svg{margin-left:2px;transition-duration:.2s}@media only screen and (min-width:540px){.c-header__link>svg{margin-left:4px}}.c-header__show-text{display:none}@media only screen and (min-width:540px){.c-header__show-text{display:inline}.c-header__item--dropdown-menu{position:relative}.c-header__menu--journal .c-header__item--dropdown-menu:last-child .c-header-expander.has-tethered{left:auto;right:0}}@media only screen and (min-width:768px){.c-header__menu--journal .c-header__item--dropdown-menu:last-child .c-header-expander.has-tethered{left:0;right:auto}}.c-header-expander{background-color:#000;border-bottom:1px solid #2f2f2f;color:#eee;font-size:.875rem;line-height:1.2;padding:16px 0}.c-header-expander button{background-color:transparent;border:1px solid #fff;color:#fff}.c-header-expander__container{margin:0 auto;max-width:1280px;padding:0 16px}.c-header-expander__keyline{border-bottom:1px solid #555;margin-bottom:0;padding-bottom:16px}.c-header-expander__heading{display:inline-block;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1.25rem;font-weight:400;line-height:1.4}.c-header-expander__list{display:flex;flex-wrap:wrap;margin:0;padding:0}.c-header-expander__item{margin:0 16px 8px 0}.c-header-expander__link{-webkit-box-align:center;align-items:center;color:inherit;display:flex;white-space:nowrap}.c-header-expander__link>svg{margin-left:8px}.c-header-expander.has-tethered{border-bottom:0;border-radius:0 0 2px 2px;left:0;position:absolute;top:100%;transform:translateY(5px);width:100%;z-index:1}@media only screen and (min-width:540px){.c-header-expander.has-tethered{transform:translateY(8px);width:auto}}@media only screen and (min-width:768px){.c-header-expander.has-tethered{min-width:225px}}.c-header-expander.has-tethered .c-header-expander__list{display:block}.c-header-expander.has-tethered .c-header-expander__item{margin:0;padding:8px 0}.c-header-expander.has-tethered .c-header-expander__item--keyline{border-top:1px solid #fff;margin-top:8px;padding-top:16px}.c-header-expander.has-tethered .c-header-expander__item--keyline-first-item-only~.c-header-expander__item--keyline-first-item-only{border-top:none;padding-top:0}.c-header-expander--tray.has-tethered{padding:32px 0 24px;transform:none;width:100%}.c-search{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1.25rem;font-weight:400;line-height:1.3}.c-search--max-width{max-width:720px}.c-search__field{-webkit-box-orient:horizontal;-webkit-box-direction:normal;-webkit-box-align:center;align-items:center;display:flex;flex-flow:row wrap}.c-search__input-container{-webkit-box-flex:1;flex:1 0 100%;margin-bottom:8px}@media only screen and (min-width:768px){.c-search__input-container--md{-webkit-box-flex:999;flex:999 1 auto;margin-bottom:0;margin-right:16px}}.c-search__select-container{-webkit-box-flex:1;flex:1 1 auto;margin-bottom:8px}@media only screen and (min-width:540px){.c-search__select-container{-webkit-box-flex:999;flex:999 1 auto;margin-bottom:0;margin-right:16px}}@media only screen and (min-width:768px){.c-search__select-container{-webkit-box-flex:1;flex:1 0 auto}}.c-search__button-container{-webkit-box-flex:1;flex:1 0 100%}@media only screen and (min-width:540px){.c-search__button-container{-webkit-box-flex:1;flex:1 0 auto}}.c-search__input,.c-search__select{background-color:#fff;border:1px solid;border-radius:3px;box-sizing:border-box;font-size:1rem;padding:.6em 1em;width:100%}.c-search__select{-webkit-appearance:none;background-image:url("data:image/svg+xml,%3Csvg height='16' viewBox='0 0 16 16' width='16' xmlns='http://www.w3.org/2000/svg'%3E%3Cpath d='m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z' fill='%23333' fill-rule='evenodd' transform='matrix(0 1 -1 0 11 3)'/%3E%3C/svg%3E");background-position:right .7em top 50%;background-repeat:no-repeat;background-size:1em;box-shadow:0 1px 0 1px rgba(0,0,0,.04);display:block;margin:0;max-width:100%;min-width:150px}.u-button{-webkit-box-align:center;-webkit-box-pack:center;align-items:center;background-color:transparent;background-image:none;border:1px solid #069;border-radius:2px;color:#069;cursor:pointer;display:inline-flex;font-family:sans-serif;font-size:1rem;justify-content:center;line-height:1.3;margin:0;padding:8px;position:relative;text-decoration:none;transition:all .25s ease 0s,color .25s ease 0s,border-color .25s ease 0s;width:auto}.u-button--primary{background-color:#069;background-image:none;border:1px solid #069;color:#fff}.u-button--full-width{display:flex;width:100%}.u-display-none{display:none}.js .u-js-hide,.u-hide{display:none;visibility:hidden}.u-visually-hidden{clip:rect(0,0,0,0);border:0;height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}@media print{.u-hide-print{display:none}}@media only screen and (min-width:768px){.u-show-at-md{display:block;visibility:visible}}@media only screen and (min-width:1024px){.u-hide-at-lg{display:none;visibility:hidden}}.u-clearfix:after,.u-clearfix:before{content:"";display:table}.u-clearfix:after{clear:both}.u-float-left{float:left}.u-icon{fill:currentcolor;display:inline-block;height:1em;transform:translate(0);vertical-align:text-top;width:1em}.u-full-height{height:100%}.u-link-inherit{color:inherit}.u-list-reset{list-style:none;margin:0;padding:0}.u-overflow-hidden{overflow:hidden}.u-sans-serif{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}.u-text-bold{font-weight:700}.u-container{margin:0 auto;max-width:1280px;padding:0 16px}.u-display-inline-block{display:inline-block}.u-ma-0{margin:0}.u-mt-32{margin-top:32px}.u-mr-2{margin-right:2px}.u-mr-24{margin-right:24px}.u-mb-8{margin-bottom:8px}.u-mb-16{margin-bottom:16px}.u-mb-24{margin-bottom:24px}.u-mb-32{margin-bottom:32px}html *,html :after,html :before{box-sizing:inherit}.c-article-section__title,.c-article-title{font-weight:700}.c-card__title{line-height:1.4em}.c-header__link{text-decoration:inherit}.grade-c-hide{display:block}.u-lazy-ad-wrapper{background-color:#ccc;display:none;min-height:137px}@media only screen and (min-width:768px){.u-lazy-ad-wrapper{display:block}} }</style>

            
            
            
                <link data-inline-css-source="critical-css" rel="stylesheet" href="/static/css/article-6179faa582.css" media="print" onload="this.media='only screen and (-webkit-min-device-pixel-ratio:0) and (min-color-index:0), (-ms-high-contrast: none), only all and (min--moz-device-pixel-ratio:0) and (min-resolution: 3e1dpcm)';this.onload=null">
                <noscript>
                    <link rel="stylesheet" type="text/css" href="/static/css/article-6179faa582.css" media="only screen and (-webkit-min-device-pixel-ratio:0) and (min-color-index:0), (-ms-high-contrast: none), only all and (min--moz-device-pixel-ratio:0) and (min-resolution: 3e1dpcm)">
                </noscript>
            
            <link rel="stylesheet" type="text/css" href="/static/css/article-print-5caae571ed.css" media="print">
        
    




<link rel="apple-touch-icon" sizes="180x180" href=/static/images/favicons/nature/apple-touch-icon.png>
<link rel="icon" type="image/png" sizes="32x32" href=/static/images/favicons/nature/favicon-32x32.png>
<link rel="icon" type="image/png" sizes="16x16" href=/static/images/favicons/nature/favicon-16x16.png>
<link rel="manifest" href=/static/manifest.json crossorigin="use-credentials">
<link rel="mask-icon" href=/static/images/favicons/nature/safari-pinned-tab.svg color="#000000">
<link rel="shortcut icon" href=/static/images/favicons/nature/favicon.ico>
<meta name="msapplication-TileColor" content="#000000">
<meta name="msapplication-config" content=/static/browserconfig.xml>
<meta name="theme-color" content="#000000">
<meta name="application-name" content="Nature">


<script>
    (function () {
        if ( typeof window.CustomEvent === "function" ) return false;
        function CustomEvent ( event, params ) {
            params = params || { bubbles: false, cancelable: false, detail: null };
            var evt = document.createEvent( 'CustomEvent' );
            evt.initCustomEvent( event, params.bubbles, params.cancelable, params.detail );
            return evt;
        }

        CustomEvent.prototype = window.Event.prototype;

        window.CustomEvent = CustomEvent;
    })();
</script>



<!-- Google Tag Manager -->
<script data-test="gtm-head">
    window.initGTM = function() {
        if (window.config.mustardcut) {
            (function (w, d, s, l, i) {
                w[l] = w[l] || [];
                w[l].push({'gtm.start': new Date().getTime(), event: 'gtm.js'});
                var f = d.getElementsByTagName(s)[0],
                        j = d.createElement(s),
                        dl = l != 'dataLayer' ? '&l=' + l : '';
                j.async = true;
                
                    j.src = 'https://collect.nature.com/gtm.js?id=' + i + dl;
                
                f.parentNode.insertBefore(j, f);
            })(window, document, 'script', 'dataLayer', 'GTM-MRVXSHQ');
        }
    }
</script>
<!-- End Google Tag Manager -->

    <script>
    (function(w,d,t) {
        function cc() {
            var h = w.location.hostname;
            if (h.indexOf('preview-www.nature.com') > -1) return;

            var e = d.createElement(t),
                    s = d.getElementsByTagName(t)[0];

            if (h.indexOf('nature.com') > -1) {
                e.src = 'https://push-content.springernature.io/pcf_sb_5_1617714720898560639/production_live/consent-bundle-8-8.js';
                e.setAttribute('onload', "initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')");
            } else {
                e.src = '/static/js/cookie-consent-es5-bundle-444fb65518.js';
                e.setAttribute('data-consent', h);
            }
            s.insertAdjacentElement('afterend', e);
        }

        cc();
    })(window,document,'script');
</script>


    <script id="js-position0">
        (function(w, d) {
            w.idpVerifyPrefix = 'https://verify.nature.com';
            w.ra21Host = 'https://wayf.springernature.com';
            var moduleSupport = (function() {
                return 'noModule' in d.createElement('script');
            })();

            var polyfillsUrl = function() {
                var features = {
                    'IntersectionObserver': window.IntersectionObserver,
                    'Promise': window.Promise,
                    'URLSearchParams': window.URLSearchParams,
                    'Symbol.iterator': window.Symbol && Symbol.iterator,
                    'Array.from': Array.from,
                    'Array.prototype.includes': Array.prototype.includes,
                    'Array.prototype.find': Array.prototype.find,
                    'Array.prototype.forEach': Array.prototype.forEach,
                    'NodeList.prototype.forEach': NodeList.prototype.forEach,
                    'Element.prototype.closest': Element.prototype.closest,
                    'Element.prototype.prepend': Element.prototype.prepend,
                    'Element.prototype.remove': Element.prototype.remove,
                    'Object.assign': Object.assign
                };
                var req = [];
                for (var feature in features) {
                    if (Object.prototype.hasOwnProperty.call(features, feature) && !features[feature]) {
                        req.push(feature);
                    }
                }
                if (req.length) {
                    return 'https://polyfill.io/v3/polyfill.min.js?features=' + req.join('%2C') + '&flags=always';
                }
                return null;
            };

            if (w.config.mustardcut === true) {
                w.loader = {
                    index: 0,
                    registered: [],
                    scripts: [
                        {src: polyfillsUrl(), test: 'polyfills-js', noinit: true},
                        
                            {src: '/static/js/global-article-es6-bundle-72b56b511b.js', test: 'global-article-js', module: true},
                            {src: '/static/js/global-article-es5-bundle-4afb8cefba.js', test: 'global-article-js', nomodule: true},
                            {src: '/static/js/shared-es6-bundle-52043d4c0f.js', test: 'shared-js', module: true},
                            {src: '/static/js/shared-es5-bundle-19fd0d3511.js', test: 'shared-js', nomodule: true},
                            {src: '/static/js/header-150-es6-bundle-5bb959eaa1.js', test: 'header-150-js', module: true},
                            {src: '/static/js/header-150-es5-bundle-88bc691ce2.js', test: 'header-150-js', nomodule: true}
                        
                    ].filter(function (s) {
                        if (s.src === null) return false;
                        if (moduleSupport && s.nomodule) return false;
                        return !(!moduleSupport && s.module);
                    }),

                    register: function (value) {
                        this.registered.push(value);
                    },

                    ready: function () {
                        if (this.registered.length === this.scripts.length) {
                            this.registered.forEach(function (fn) {
                                if (typeof fn === 'function') {
                                    setTimeout(fn, 0); 
                                }
                            });
                            this.ready = function () {};
                        }
                    },

                    insert: function (s) {
                        var t = d.getElementById('js-position' + this.index);
                        if (t && t.insertAdjacentElement) {
                            t.insertAdjacentElement('afterend', s);
                        } else {
                            d.head.appendChild(s);
                        }
                        ++this.index;
                    },

                    createScript: function (script, beforeLoad) {
                        var s = d.createElement('script');
                        s.id = 'js-position' + (this.index + 1);
                        s.setAttribute('data-test', script.test);
                        if (beforeLoad) {
                            s.defer = 'defer';
                            s.onload = function () {
                                if (script.noinit) {
                                    loader.register(true);
                                }
                                if (d.readyState === 'interactive' || d.readyState === 'complete') {
                                    loader.ready();
                                }
                            };
                        } else {
                            s.async = 'async';
                        }
                        s.src = script.src;
                        return s;
                    },

                    init: function () {
                        this.scripts.forEach(function (s) {
                            loader.insert(loader.createScript(s, true));
                        });

                        d.addEventListener('DOMContentLoaded', function () {
                            loader.ready();
                            
                                var conditionalScripts = [
                                    {match: 'div[data-pan-container]', src: '/static/js/pan-zoom-es6-bundle-885b4d4cd7.js', test: 'pan-zoom-js',  module: true },
                                    {match: 'div[data-pan-container]', src: '/static/js/pan-zoom-es5-bundle-d50736306e.js', test: 'pan-zoom-js',  nomodule: true },
                                    {match: 'math,span.mathjax-tex', src: '/static/js/math-21da043fb2.js', test: 'math-js'}
                                ];
                            

                            if (conditionalScripts) {
                                conditionalScripts.filter(function (script) {
                                    return !!document.querySelector(script.match) && !((moduleSupport && script.nomodule) || (!moduleSupport && script.module));
                                }).forEach(function (script) {
                                    loader.insert(loader.createScript(script));
                                });
                            }
                        }, false);
                    }
                };
                loader.init();
            }
        })(window, document);
    </script>




<meta name="robots" content="noarchive">
<meta name="access" content="Yes">


<link rel="search" href="http://www.nature.com/search">
<link rel="search" href="http://www.nature.com/opensearch/opensearch.xml" type="application/opensearchdescription+xml" title="nature.com">
<link rel="search" href="http://www.nature.com/opensearch/request" type="application/sru+xml" title="nature.com">



    
    <script type="application/ld+json">{"mainEntity":{"headline":"Repression of microRNA-768-3p by MEK/ERK signalling contributes to enhanced mRNA translation in human melanoma","description":"Increased global protein synthesis and selective translation of mRNAs encoding proteins contributing to malignancy is common in cancer cells. This is often associated with elevated expression of eukaryotic translation initiation factor 4 (eIF4E), the rate-limiting factor of cap-dependent translation initiation. We report here that in human melanoma downregulation of miR-768-3p as a result of activation of the mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK) pathway has an important role in the upregulation of eIF4E and enhancement in protein synthesis. Melanoma cells displayed increased nascent protein production and elevated eIF4E expression, which was associated with the downregulation of miR-768-3p that was predicted to target the 3′-untranslated region of the eIF4E mRNA. Overexpression of miR-768-3p led to the downregulation of the endogenous eIF4E protein, reduction in nascent protein synthesis and inhibition of cell survival and proliferation. These effects were efficiently reversed when eIF4E was co-overexpressed in melanoma cells. On the other hand, introduction of anti-miR-768-3p into melanocytes upregulated endogenous eIF4E protein expression and increased global protein synthesis. Downregulation of miR-768-3p appeared to be mediated by activation of the MEK/ERK pathway, in that treatment of BRAFV600E melanoma cells with the mutant BRAF inhibitor PLX4720 or exposure of either BRAFV600E or wild-type BRAF melanoma cells to the MEK inhibitor U0126 resulted in the upregulation of miR-768-3p and inhibition of nascent protein synthesis. This inhibition was partially blocked in cells cointroduced with anti-miR-768-3p. Significantly, miR-768-3p was similarly downregulated, which was inversely associated with the expression levels of eIF4E in fresh melanoma isolates. Taken together, these results identify downregulation of miR-768-3p and subsequent upregulation of eIF4E as an important mechanism in addition to phosphorylation of eIF4E responsible for MEK/ERK-mediated enhancement of protein synthesis in melanoma.","datePublished":"2013-06-17","dateModified":"2013-06-17","pageStart":"2577","pageEnd":"2588","sameAs":"https://doi.org/10.1038/onc.2013.237","keywords":"Cell signalling,Melanoma,miRNAs,Translation,Medicine/Public Health,general,Internal Medicine,Cell Biology,Human Genetics,Oncology,Apoptosis","image":"https://static-content.springer.com/image/art%3A10.1038%2Fonc.2013.237/MediaObjects/41388_2014_Article_BFonc2013237_Fig1_HTML.jpg","isPartOf":{"name":"Oncogene","issn":["1476-5594","0950-9232"],"volumeNumber":"33","@type":["Periodical","PublicationVolume"]},"publisher":{"name":"Nature Publishing Group UK","logo":{"url":"https://www.springernature.com/app-sn/public/images/logo-springernature.png","@type":"ImageObject"},"@type":"Organization"},"author":[{"name":"Jiang, C C","affiliation":[{"name":"Priority Research Centre for Cancer Research, University of Newcastle","address":{"name":"Priority Research Centre for Cancer Research, University of Newcastle, Callaghan, Australia","@type":"PostalAddress"},"@type":"Organization"},{"name":"School of Medicine and Public Health, University of Newcastle","address":{"name":"School of Medicine and Public Health, University of Newcastle, Callaghan, Australia","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Croft, A","affiliation":[{"name":"Priority Research Centre for Cancer Research, University of Newcastle","address":{"name":"Priority Research Centre for Cancer Research, University of Newcastle, Callaghan, Australia","@type":"PostalAddress"},"@type":"Organization"},{"name":"Oncology and Immunology Unit, Calvary Mater Newcastle Hospital","address":{"name":"Oncology and Immunology Unit, Calvary Mater Newcastle Hospital, Waratah, Australia","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Tseng, H-Y","affiliation":[{"name":"Priority Research Centre for Cancer Research, University of Newcastle","address":{"name":"Priority Research Centre for Cancer Research, University of Newcastle, Callaghan, Australia","@type":"PostalAddress"},"@type":"Organization"},{"name":"School of Medicine and Public Health, University of Newcastle","address":{"name":"School of Medicine and Public Health, University of Newcastle, Callaghan, Australia","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Guo, S T","affiliation":[{"name":"Shanxi Cancer Hospital and Institute","address":{"name":"Department of Molecular Biology, Shanxi Cancer Hospital and Institute, Taiyuan, People’s Republic of China","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Jin, L","affiliation":[{"name":"Kolling Institute for Medical Research, University of Sydney","address":{"name":"Kolling Institute for Medical Research, University of Sydney, St Leonards, Australia","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Hersey, P","affiliation":[{"name":"Kolling Institute for Medical Research, University of Sydney","address":{"name":"Kolling Institute for Medical Research, University of Sydney, St Leonards, Australia","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Zhang, X D","affiliation":[{"name":"Priority Research Centre for Cancer Research, University of Newcastle","address":{"name":"Priority Research Centre for Cancer Research, University of Newcastle, Callaghan, Australia","@type":"PostalAddress"},"@type":"Organization"},{"name":"School of Medicine and Public Health, University of Newcastle","address":{"name":"School of Medicine and Public Health, University of Newcastle, Callaghan, Australia","@type":"PostalAddress"},"@type":"Organization"},{"name":"Shanxi Cancer Hospital and Institute","address":{"name":"Department of Molecular Biology, Shanxi Cancer Hospital and Institute, Taiyuan, People’s Republic of China","@type":"PostalAddress"},"@type":"Organization"}],"email":"Xu.Zhang@newcastle.edu.au","@type":"Person"}],"@type":"ScholarlyArticle"},"@context":"https://schema.org","@type":"WebPage"}</script>



    
    <link rel="canonical" href="https://www.nature.com/articles/onc2013237">
    

    <meta name="journal_id" content="41388">

    <meta name="dc.title" content="Repression of microRNA-768-3p by MEK/ERK signalling contributes to enhanced mRNA translation in human melanoma">

    <meta name="dc.source" content="Oncogene 2014 33:20">

    <meta name="dc.format" content="text/html">

    <meta name="dc.publisher" content="Nature Publishing Group">

    <meta name="dc.date" content="2013-06-17">

    <meta name="dc.type" content="OriginalPaper">

    <meta name="dc.language" content="En">

    <meta name="dc.copyright" content="2014 Macmillan Publishers Limited">

    <meta name="dc.rights" content="2014 Macmillan Publishers Limited">

    <meta name="dc.rightsAgent" content="journalpermissions@springernature.com">

    <meta name="dc.description" content="Increased global protein synthesis and selective translation of mRNAs encoding proteins contributing to malignancy is common in cancer cells. This is often associated with elevated expression of eukaryotic translation initiation factor 4 (eIF4E), the rate-limiting factor of cap-dependent translation initiation. We report here that in human melanoma downregulation of miR-768-3p as a result of activation of the mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK) pathway has an important role in the upregulation of eIF4E and enhancement in protein synthesis. Melanoma cells displayed increased nascent protein production and elevated eIF4E expression, which was associated with the downregulation of miR-768-3p that was predicted to target the 3&#8242;-untranslated region of the eIF4E mRNA. Overexpression of miR-768-3p led to the downregulation of the endogenous eIF4E protein, reduction in nascent protein synthesis and inhibition of cell survival and proliferation. These effects were efficiently reversed when eIF4E was co-overexpressed in melanoma cells. On the other hand, introduction of anti-miR-768-3p into melanocytes upregulated endogenous eIF4E protein expression and increased global protein synthesis. Downregulation of miR-768-3p appeared to be mediated by activation of the MEK/ERK pathway, in that treatment of BRAFV600E melanoma cells with the mutant BRAF inhibitor PLX4720 or exposure of either BRAFV600E or wild-type BRAF melanoma cells to the MEK inhibitor U0126 resulted in the upregulation of miR-768-3p and inhibition of nascent protein synthesis. This inhibition was partially blocked in cells cointroduced with anti-miR-768-3p. Significantly, miR-768-3p was similarly downregulated, which was inversely associated with the expression levels of eIF4E in fresh melanoma isolates. Taken together, these results identify downregulation of miR-768-3p and subsequent upregulation of eIF4E as an important mechanism in addition to phosphorylation of eIF4E responsible for MEK/ERK-mediated enhancement of protein synthesis in melanoma.">

    <meta name="prism.issn" content="1476-5594">

    <meta name="prism.publicationName" content="Oncogene">

    <meta name="prism.publicationDate" content="2013-06-17">

    <meta name="prism.volume" content="33">

    <meta name="prism.number" content="20">

    <meta name="prism.section" content="OriginalPaper">

    <meta name="prism.startingPage" content="2577">

    <meta name="prism.endingPage" content="2588">

    <meta name="prism.copyright" content="2014 Macmillan Publishers Limited">

    <meta name="prism.rightsAgent" content="journalpermissions@springernature.com">

    <meta name="prism.url" content="https://www.nature.com/articles/onc2013237">

    <meta name="prism.doi" content="doi:10.1038/onc.2013.237">

    <meta name="citation_pdf_url" content="https://www.nature.com/articles/onc2013237.pdf">

    <meta name="citation_fulltext_html_url" content="https://www.nature.com/articles/onc2013237">

    <meta name="citation_journal_title" content="Oncogene">

    <meta name="citation_journal_abbrev" content="Oncogene">

    <meta name="citation_publisher" content="Nature Publishing Group">

    <meta name="citation_issn" content="1476-5594">

    <meta name="citation_title" content="Repression of microRNA-768-3p by MEK/ERK signalling contributes to enhanced mRNA translation in human melanoma">

    <meta name="citation_volume" content="33">

    <meta name="citation_issue" content="20">

    <meta name="citation_publication_date" content="2014/05">

    <meta name="citation_online_date" content="2013/06/17">

    <meta name="citation_firstpage" content="2577">

    <meta name="citation_lastpage" content="2588">

    <meta name="citation_article_type" content="Article">

    <meta name="citation_fulltext_world_readable" content="">

    <meta name="citation_language" content="en">

    <meta name="dc.identifier" content="doi:10.1038/onc.2013.237">

    <meta name="DOI" content="10.1038/onc.2013.237">

    <meta name="citation_doi" content="10.1038/onc.2013.237">

    <meta name="description" content="Increased global protein synthesis and selective translation of mRNAs encoding proteins contributing to malignancy is common in cancer cells. This is often associated with elevated expression of eukaryotic translation initiation factor 4 (eIF4E), the rate-limiting factor of cap-dependent translation initiation. We report here that in human melanoma downregulation of miR-768-3p as a result of activation of the mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK) pathway has an important role in the upregulation of eIF4E and enhancement in protein synthesis. Melanoma cells displayed increased nascent protein production and elevated eIF4E expression, which was associated with the downregulation of miR-768-3p that was predicted to target the 3&#8242;-untranslated region of the eIF4E mRNA. Overexpression of miR-768-3p led to the downregulation of the endogenous eIF4E protein, reduction in nascent protein synthesis and inhibition of cell survival and proliferation. These effects were efficiently reversed when eIF4E was co-overexpressed in melanoma cells. On the other hand, introduction of anti-miR-768-3p into melanocytes upregulated endogenous eIF4E protein expression and increased global protein synthesis. Downregulation of miR-768-3p appeared to be mediated by activation of the MEK/ERK pathway, in that treatment of BRAFV600E melanoma cells with the mutant BRAF inhibitor PLX4720 or exposure of either BRAFV600E or wild-type BRAF melanoma cells to the MEK inhibitor U0126 resulted in the upregulation of miR-768-3p and inhibition of nascent protein synthesis. This inhibition was partially blocked in cells cointroduced with anti-miR-768-3p. Significantly, miR-768-3p was similarly downregulated, which was inversely associated with the expression levels of eIF4E in fresh melanoma isolates. Taken together, these results identify downregulation of miR-768-3p and subsequent upregulation of eIF4E as an important mechanism in addition to phosphorylation of eIF4E responsible for MEK/ERK-mediated enhancement of protein synthesis in melanoma.">

    <meta name="dc.creator" content="Jiang, C C">

    <meta name="dc.creator" content="Croft, A">

    <meta name="dc.creator" content="Tseng, H-Y">

    <meta name="dc.creator" content="Guo, S T">

    <meta name="dc.creator" content="Jin, L">

    <meta name="dc.creator" content="Hersey, P">

    <meta name="dc.creator" content="Zhang, X D">

    <meta name="dc.subject" content="Cell signalling">

    <meta name="dc.subject" content="Melanoma">

    <meta name="dc.subject" content="miRNAs">

    <meta name="dc.subject" content="Translation">

    <meta name="citation_reference" content="citation_journal_title=Nat Rev Cancer; citation_title=Translational control in cancer; citation_author=D Silvera, SC Formenti, RJ Schneider; citation_volume=10; citation_publication_date=2010; citation_pages=254-266; citation_doi=10.1038/nrc2824; citation_id=CR1">

    <meta name="citation_reference" content="citation_journal_title=Oncogene; citation_title=Mechanisms of translational deregulation in human tumors and therapeutic intervention strategies; citation_author=B Bilanges, D Stokoe; citation_volume=26; citation_publication_date=2007; citation_pages=5973-5990; citation_doi=10.1038/sj.onc.1210431; citation_id=CR2">

    <meta name="citation_reference" content="citation_journal_title=Cancer Res; citation_title=Translation regulation as a therapeutic target in cancer; citation_author=M Grzmil, BA Hemmings; citation_volume=72; citation_publication_date=2012; citation_pages=3891-3900; citation_doi=10.1158/0008-5472.CAN-12-0026; citation_id=CR3">

    <meta name="citation_reference" content="citation_journal_title=Cell Cycle; citation_title=Translational control of cell fate: from integration of environmental signals to breaching anticancer defense; citation_author=PB Bitterman, VA Polunovsky; citation_volume=11; citation_publication_date=2012; citation_pages=1097-1107; citation_doi=10.4161/cc.11.6.19610; citation_id=CR4">

    <meta name="citation_reference" content="citation_journal_title=Cell; citation_title=Regulation of translation initiation in eukaryotes: mechanisms and biological targets; citation_author=N Sonenberg, AG Hinnebusch; citation_volume=136; citation_publication_date=2009; citation_pages=731-745; citation_doi=10.1016/j.cell.2009.01.042; citation_id=CR5">

    <meta name="citation_reference" content="citation_journal_title=Nat Rev Mol Cell Biol; citation_title=The mechanism of eukaryotic translation initiation and principles of its regulation; citation_author=RJ Jackson, CU Hellen, TV Pestova; citation_volume=11; citation_publication_date=2010; citation_pages=113-127; citation_doi=10.1038/nrm2838; citation_id=CR6">

    <meta name="citation_reference" content="citation_journal_title=Oncogene; citation_title=MNK1 and EIF4E are downstream effectors of MEKs in the regulation of the nuclear export of HDM2 mRNA; citation_author=A Phillips, JP Blaydes; citation_volume=27; citation_publication_date=2008; citation_pages=1645-1649; citation_doi=10.1038/sj.onc.1210785; citation_id=CR7">

    <meta name="citation_reference" content="citation_journal_title=Oncotarget; citation_title=Targeting Mnks for cancer therapy; citation_author=J Hou, F Lam, C Proud, S Wang; citation_volume=3; citation_publication_date=2012; citation_pages=118-131; citation_doi=10.18632/oncotarget.453; citation_id=CR8">

    <meta name="citation_reference" content="citation_journal_title=Curr Opin Genet Dev; citation_title=The cancerous translation apparatus; citation_author=CR Stumpf, D Ruggero; citation_volume=21; citation_publication_date=2011; citation_pages=474-483; citation_doi=10.1016/j.gde.2011.03.007; citation_id=CR9">

    <meta name="citation_reference" content="citation_journal_title=Genes Dev; citation_title=Dissecting eIF4E action in tumorigenesis; citation_author=HG Wendel, RL Silva, A Malina, JR Mills, H Zhu, T Ueda; citation_volume=21; citation_publication_date=2007; citation_pages=3232-3237; citation_doi=10.1101/gad.1604407; citation_id=CR10">

    <meta name="citation_reference" content="citation_journal_title=Oncogene; citation_title=The role of translation in neoplastic transformation from a pathologist&#39;s point of view; citation_author=IB Rosenwald; citation_volume=23; citation_publication_date=2004; citation_pages=3230-3247; citation_doi=10.1038/sj.onc.1207552; citation_id=CR11">

    <meta name="citation_reference" content="citation_journal_title=Cancer Res; citation_title=Eukaryotic translation initiation factor 4E induced progression of primary human mammary epithelial cells along the cancer pathway is associated with targeted translational deregulation of oncogenic drivers and inhibitors; citation_author=O Larsson, S Li, OA Issaenko, S Avdulov, M Peterson, K Smith; citation_volume=67; citation_publication_date=2007; citation_pages=6814-6824; citation_doi=10.1158/0008-5472.CAN-07-0752; citation_id=CR12">

    <meta name="citation_reference" content="citation_journal_title=Oncol Rep; citation_title=Expression levels of eIF4E, VEGF, and cyclin D1, and correlation of eIF4E with VEGF and cyclin D1 in multi-tumor tissue microarray; citation_author=SX Yang, SM Hewitt, SM Steinberg, DJ Liewehr, SM Swain; citation_volume=17; citation_publication_date=2007; citation_pages=281-287; citation_id=CR13">

    <meta name="citation_reference" content="citation_journal_title=Br J Cancer; citation_title=Combined analysis of eIF4E and 4E-binding protein expression predicts breast cancer survival and estimates eIF4E activity; citation_author=LJ Coleman, MB Peter, TJ Teall, RA Brannan, AM Hanby, H Honarpisheh; citation_volume=100; citation_publication_date=2009; citation_pages=1393-1399; citation_doi=10.1038/sj.bjc.6605044; citation_id=CR14">

    <meta name="citation_reference" content="citation_journal_title=Oncogene; citation_title=eIF-4E expression and its role in malignancies and metastases; citation_author=A De Benedetti, JR Graff; citation_volume=23; citation_publication_date=2004; citation_pages=3189-3199; citation_doi=10.1038/sj.onc.1207545; citation_id=CR15">

    <meta name="citation_reference" content="citation_journal_title=Nat Rev Genet; citation_title=MicroRNAs: small RNAs with a big role in gene regulation; citation_author=L He, GJ Hannon; citation_volume=5; citation_publication_date=2004; citation_pages=522-531; citation_doi=10.1038/nrg1379; citation_id=CR16">

    <meta name="citation_reference" content="citation_journal_title=J Clin Oncol; citation_title=MicroRNAs in cancer: small molecules with a huge impact; citation_author=MV Iorio, CM Croce; citation_volume=27; citation_publication_date=2009; citation_pages=5848-5856; citation_doi=10.1200/JCO.2009.24.0317; citation_id=CR17">

    <meta name="citation_reference" content="citation_journal_title=Proc Natl Acad Sci USA; citation_title=MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function; citation_author=DT Humphreys, BJ Westman, DI Martin, T Preiss; citation_volume=102; citation_publication_date=2005; citation_pages=16961-16966; citation_doi=10.1073/pnas.0506482102; citation_id=CR18">

    <meta name="citation_reference" content="citation_journal_title=Science; citation_title=MicroRNA inhibition of translation initiation in vitro by targeting the cap-binding complex eIF4F; citation_author=G Mathonnet, MR Fabian, YV Svitkin, A Parsyan, L Huck, T Murata; citation_volume=317; citation_publication_date=2007; citation_pages=1764-1767; citation_doi=10.1126/science.1146067; citation_id=CR19">

    <meta name="citation_reference" content="citation_journal_title=Nature; citation_title=The microcosmos of cancer; citation_author=A Lujambio, SW Lowe; citation_volume=482; citation_publication_date=2012; citation_pages=347-355; citation_doi=10.1038/nature10888; citation_id=CR20">

    <meta name="citation_reference" content="citation_journal_title=Cancer Res; citation_title=The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms; citation_author=F Felicetti, MC Errico, L Bottero, P Segnalini, A Stoppacciaro; citation_volume=68; citation_publication_date=2008; citation_pages=2745-2754; citation_doi=10.1158/0008-5472.CAN-07-2538; citation_id=CR21">

    <meta name="citation_reference" content="citation_journal_title=Proc Natl Acad Sci USA; citation_title=MicroRNA-149*, a p53-responsive microRNA, functions as an oncogenic regulator in human melanoma; citation_author=L Jin, WL Hu, CC Jiang, JX Wang, CC Han, P Chu; citation_volume=108; citation_publication_date=2011; citation_pages=15840-15845; citation_doi=10.1073/pnas.1019312108; citation_id=CR22">

    <meta name="citation_reference" content="citation_journal_title=Melanoma Res; citation_title=MicroRNA regulation of melanoma progression; citation_author=VF Bonazzi, MS Stark, NK Hayward; citation_volume=22; citation_publication_date=2012; citation_pages=101-113; citation_doi=10.1097/CMR.0b013e32834f6fbb; citation_id=CR23">

    <meta name="citation_reference" content="citation_journal_title=Pigment Cell Melanoma Res; citation_title=The evolving concept of &#8216;melano-miRs&#8217;-microRNAs in melanomagenesis; citation_author=DW Mueller, AK Bosserhoff; citation_volume=23; citation_publication_date=2010; citation_pages=620-626; citation_doi=10.1111/j.1755-148X.2010.00734.x; citation_id=CR24">

    <meta name="citation_reference" content="citation_journal_title=Pathology; citation_title=The emerging important role of microRNAs in the pathogenesis, diagnosis and treatment of human cancers; citation_author=JS Wilmott, XD Zhang, P Hersey, RA Scolyer; citation_volume=43; citation_publication_date=2011; citation_pages=657-671; citation_doi=10.1097/PAT.0b013e32834a7358; citation_id=CR25">

    <meta name="citation_reference" content="citation_journal_title=Nat Rev Genet; citation_title=Causes and consequences of microRNA dysregulation in cancer; citation_author=CM Croce; citation_volume=10; citation_publication_date=2009; citation_pages=704-714; citation_doi=10.1038/nrg2634; citation_id=CR26">

    <meta name="citation_reference" content="citation_journal_title=Oncogene; citation_title=MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer; citation_author=ST Guo, CC Jiang, GP Wang, YP Li, CY Wang, XY Guo; citation_volume=32; citation_publication_date=2012; citation_pages=1910-1920; citation_doi=10.1038/onc.2012.214; citation_id=CR27">

    <meta name="citation_reference" content="citation_journal_title=Nature; citation_title=Mutations of the BRAF gene in human cancer; citation_author=H Davies, GR Bignell, C Cox, P Stephens, S Edkins, S Clegg; citation_volume=417; citation_publication_date=2002; citation_pages=949-954; citation_doi=10.1038/nature00766; citation_id=CR28">

    <meta name="citation_reference" content="citation_journal_title=Mol Oncol; citation_title=Human cutaneous melanoma; a review of NRAS and BRAF mutation frequencies in relation to histogenetic subclass and body site; citation_author=A Platz, S Egyhazi, U Ringborg, J Hansson; citation_volume=1; citation_publication_date=2008; citation_pages=395-405; citation_doi=10.1016/j.molonc.2007.12.003; citation_id=CR29">

    <meta name="citation_reference" content="citation_journal_title=Oncogene; citation_title=Oncogenic B-Raf signaling in melanoma cells controls a network of microRNAs with combinatorial functions; citation_author=KL Couts, EM Anderson, MM Gross, K Sullivan, NG Ahn; citation_volume=32; citation_publication_date=2012; citation_pages=1959-1970; citation_doi=10.1038/onc.2012.209; citation_id=CR30">

    <meta name="citation_reference" content="citation_journal_title=J Invest Dermatol; citation_title=MicroRNA expression profiles associated with mutational status and survival in malignant melanoma; citation_author=S Caramuta, S Egyh&#225;zi, M Rodolfo, D Witten, J Hansson, C Larsson; citation_volume=130; citation_publication_date=2010; citation_pages=2062-2070; citation_doi=10.1038/jid.2010.63; citation_id=CR31">

    <meta name="citation_reference" content="citation_journal_title=Mol Cell; citation_title=Translational homeostasis via the mRNA cap-binding protein, eIF4E; citation_author=A Yanagiya, E Suyama, H Adachi, YV Svitkin, P Aza-Blanc, H Imataka; citation_volume=46; citation_publication_date=2012; citation_pages=847-858; citation_doi=10.1016/j.molcel.2012.04.004; citation_id=CR32">

    <meta name="citation_reference" content="citation_journal_title=Cell; citation_title=Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G; citation_author=NJ Moerke, H Aktas, H Chen, S Cantel, MY Reibarkh, A Fahmy; citation_volume=128; citation_publication_date=2007; citation_pages=257-267; citation_doi=10.1016/j.cell.2006.11.046; citation_id=CR33">

    <meta name="citation_reference" content="citation_journal_title=Blood; citation_title=Small nucleolar RNA expression profiling identifies potential prognostic markers in peripheral T-cell lymphoma; citation_author=W Valleron, L Ysebaert, L Berquet, V Fataccioli, C Quelen, A Martin; citation_volume=120; citation_publication_date=2012; citation_pages=3997-4005; citation_doi=10.1182/blood-2012-06-438135; citation_id=CR34">

    <meta name="citation_reference" content="citation_journal_title=Mol Genet Genom; citation_title=Many ways to generate microRNA-like small RNAs: non-canonical pathways for microRNA production; citation_author=K Miyoshi, T Miyoshi, H Siomi; citation_volume=284; citation_publication_date=2010; citation_pages=95-103; citation_doi=10.1007/s00438-010-0556-1; citation_id=CR35">

    <meta name="citation_reference" content="citation_journal_title=Proc Natl Acad Sci USA; citation_title=Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma; citation_author=JD Arroyo, JR Chevillet, EM Kroh, IK Ruf, CC Pritchard, DF Gibson; citation_volume=108; citation_publication_date=2011; citation_pages=5003-5008; citation_doi=10.1073/pnas.1019055108; citation_id=CR36">

    <meta name="citation_reference" content="citation_journal_title=J Cell Sci; citation_title=Biogenesis of small nuclear RNPs; citation_author=T Kiss; citation_volume=117; citation_publication_date=2004; citation_pages=5949-5951; citation_doi=10.1242/jcs.01487; citation_id=CR37">

    <meta name="citation_reference" content="citation_journal_title=Proc Natl Acad Sci USA; citation_title=Increased expression of eukaryotic translation initiation factors eIF-4E and eIF-2 alpha in response to growth induction by c-myc; citation_author=IB Rosenwald, DB Rhoads, LD Callanan, KJ Isselbacher, EV Schmidt; citation_volume=90; citation_publication_date=1993; citation_pages=6175-6178; citation_doi=10.1073/pnas.90.13.6175; citation_id=CR38">

    <meta name="citation_reference" content="citation_journal_title=PLoS One; citation_title=Epigenetic activation of a subset of mRNAs by eIF4E explains its effects on cell proliferation; citation_author=Y Mamane, E Petroulakis, Y Martineau, TA Sato, O Larsson, VK Rajasekhar; citation_volume=2; citation_publication_date=2007; citation_pages=e242; citation_doi=10.1371/journal.pone.0000242; citation_id=CR39">

    <meta name="citation_reference" content="citation_journal_title=Mol Cell Biol; citation_title=Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor 4E; citation_author=IB Rosenwald, A Lazaris-Karatzas, N Sonenberg, EV Schmidt; citation_volume=13; citation_publication_date=1993; citation_pages=7358-7363; citation_doi=10.1128/MCB.13.12.7358; citation_id=CR40">

    <meta name="citation_reference" content="citation_journal_title=EMBO J; citation_title=mRNAs containing extensive secondary structure in their 5&#8242; non-coding region translate efficiently in cells overexpressing initiation factor eIF-4E; citation_author=AE Koromilas, A Lazaris-Karatzas, N Sonenberg; citation_volume=11; citation_publication_date=1992; citation_pages=4153-4158; citation_doi=10.1002/j.1460-2075.1992.tb05508.x; citation_id=CR41">

    <meta name="citation_reference" content="citation_journal_title=Nature; citation_title=Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5&#8242; cap; citation_author=A Lazaris-Karatzas, KS Montine, N Sonenberg; citation_volume=345; citation_publication_date=1990; citation_pages=544-547; citation_doi=10.1038/345544a0; citation_id=CR42">

    <meta name="citation_reference" content="citation_journal_title=Mol Cell Biol; citation_title=The mRNA 5&#8242; cap-binding protein, eIF-4E, cooperates with v-myc or E1A in the transformation of primary rodent fibroblasts; citation_author=A Lazaris-Karatzas, N Sonenberg; citation_volume=12; citation_publication_date=1992; citation_pages=1234-1238; citation_doi=10.1128/MCB.12.3.1234; citation_id=CR43">

    <meta name="citation_reference" content="citation_journal_title=Cancer Res; citation_title=Targeting the eukaryotic translation initiation factor 4E for cancer therapy; citation_author=JR Graff, BW Konicek, JH Carter, EG Marcusson; citation_volume=68; citation_publication_date=2008; citation_pages=631-634; citation_doi=10.1158/0008-5472.CAN-07-5635; citation_id=CR44">

    <meta name="citation_reference" content="citation_journal_title=Cancer Res; citation_title=MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines; citation_author=LT Bemis, R Chen, CM Amato, EH Classen, SE Robinson, DG Coffey; citation_volume=68; citation_publication_date=2008; citation_pages=1362-1368; citation_doi=10.1158/0008-5472.CAN-07-2912; citation_id=CR45">

    <meta name="citation_reference" content="citation_journal_title=PLoS One; citation_title=miR-148 regulates Mitf in melanoma cells; citation_author=BS Haflidad&#243;ttir, K Bergsteinsd&#243;ttir, C Praetorius, E Steingr&#237;msson; citation_volume=5; citation_publication_date=2010; citation_pages=e11574; citation_doi=10.1371/journal.pone.0011574; citation_id=CR46">

    <meta name="citation_reference" content="citation_journal_title=DNA Cell Biol; citation_title=Intronic MicroRNA: Discovery and biological implications; citation_author=SC Li, P Tang, WC Lin; citation_volume=26; citation_publication_date=2007; citation_pages=195-207; citation_doi=10.1089/dna.2006.0558; citation_id=CR47">

    <meta name="citation_reference" content="citation_journal_title=J Biol Chem; citation_title=Identification and characterization of novel clathrin adaptor-related proteins; citation_author=H Takatsu, M Sakurai, HW Shin, K Murakami, K Nakayama; citation_volume=273; citation_publication_date=1998; citation_pages=24693-24700; citation_doi=10.1074/jbc.273.38.24693; citation_id=CR48">

    <meta name="citation_reference" content="citation_journal_title=Clin Cancer Res; citation_title=A phase 1 dose escalation, pharmacokinetic, and pharmacodynamic evaluation of eIF-4E antisense oligonucleotide LY2275796 in patients with advanced cancer; citation_author=DS Hong, R Kurzrock, Y Oh, J Wheler, A Naing, L Brail; citation_volume=17; citation_publication_date=2011; citation_pages=6582-6591; citation_doi=10.1158/1078-0432.CCR-11-0430; citation_id=CR49">

    <meta name="citation_reference" content="citation_journal_title=Cancer Res; citation_title=MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma; citation_author=AF Ibrahim, U Weirauch, M Thomas, A Gr&#252;nweller, RK Hartmann, A Aigner; citation_volume=71; citation_publication_date=2011; citation_pages=5214-5224; citation_doi=10.1158/0008-5472.CAN-10-4645; citation_id=CR50">

    <meta name="citation_reference" content="citation_journal_title=Cell Death Dis; citation_title=Apoptosis of human melanoma cells induced by inhibition of B-RAFV600E involves preferential splicing of bimS; citation_author=CC Jiang, F Lai, KH Tay, A Croft, H Rizos, TM Becker; citation_volume=2; citation_publication_date=2010; citation_pages=1:e69; citation_id=CR51">

    <meta name="citation_reference" content="citation_journal_title=Oncogene; citation_title=Ets-1 mediates upregulation of Mcl-1 downstream of XBP-1 in human melanoma cells upon ER stress; citation_author=L Dong, CC Jiang, RF Thorne, A Croft, F Yang, H Liu; citation_volume=30; citation_publication_date=2011; citation_pages=3716-3726; citation_doi=10.1038/onc.2011.87; citation_id=CR52">

    <meta name="citation_reference" content="citation_journal_title=Mol Cell Biol; citation_title=Activating transcription factor 4 is translationally regulated by hypoxic stress; citation_author=JD Blais, V Filipenko, M Bi, HP Harding, D Ron, C Koumenis; citation_volume=24; citation_publication_date=2004; citation_pages=7469-7482; citation_doi=10.1128/MCB.24.17.7469-7482.2004; citation_id=CR53">

    <meta name="citation_reference" content="citation_journal_title=PLoS One; citation_title=MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels; citation_author=LM Wulfken, R Moritz, C Ohlmann, S Holdenrieder, V Jung, F Becker; citation_volume=6; citation_publication_date=2011; citation_pages=e25787; citation_doi=10.1371/journal.pone.0025787; citation_id=CR54">

    <meta name="citation_author" content="Jiang, C C">

    <meta name="citation_author_institution" content="Priority Research Centre for Cancer Research, University of Newcastle, Callaghan, Australia">

    <meta name="citation_author_institution" content="School of Medicine and Public Health, University of Newcastle, Callaghan, Australia">

    <meta name="citation_author" content="Croft, A">

    <meta name="citation_author_institution" content="Priority Research Centre for Cancer Research, University of Newcastle, Callaghan, Australia">

    <meta name="citation_author_institution" content="Oncology and Immunology Unit, Calvary Mater Newcastle Hospital, Waratah, Australia">

    <meta name="citation_author" content="Tseng, H-Y">

    <meta name="citation_author_institution" content="Priority Research Centre for Cancer Research, University of Newcastle, Callaghan, Australia">

    <meta name="citation_author_institution" content="School of Medicine and Public Health, University of Newcastle, Callaghan, Australia">

    <meta name="citation_author" content="Guo, S T">

    <meta name="citation_author_institution" content="Department of Molecular Biology, Shanxi Cancer Hospital and Institute, Taiyuan, People&#8217;s Republic of China">

    <meta name="citation_author" content="Jin, L">

    <meta name="citation_author_institution" content="Kolling Institute for Medical Research, University of Sydney, St Leonards, Australia">

    <meta name="citation_author" content="Hersey, P">

    <meta name="citation_author_institution" content="Kolling Institute for Medical Research, University of Sydney, St Leonards, Australia">

    <meta name="citation_author" content="Zhang, X D">

    <meta name="citation_author_institution" content="Priority Research Centre for Cancer Research, University of Newcastle, Callaghan, Australia">

    <meta name="citation_author_institution" content="School of Medicine and Public Health, University of Newcastle, Callaghan, Australia">

    <meta name="citation_author_institution" content="Department of Molecular Biology, Shanxi Cancer Hospital and Institute, Taiyuan, People&#8217;s Republic of China">

    <meta name="access_endpoint" content="https://www.nature.com/platform/readcube-access">

    <meta name="twitter:site" content="@oncogenejournal">

    <meta name="twitter:card" content="summary">

    <meta name="twitter:image:alt" content="Content cover image">

    <meta name="twitter:title" content="Repression of microRNA-768-3p by MEK/ERK signalling contributes to enhanced mRNA translation in human melanoma">

    <meta name="twitter:description" content="Oncogene - Repression of microRNA-768-3p by MEK/ERK signalling contributes to enhanced mRNA translation in human melanoma">

    <meta name="twitter:image" content="https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fonc.2013.237/MediaObjects/41388_2014_Article_BFonc2013237_Fig1_HTML.jpg">


    
        <meta property="og:url" content="https://www.nature.com/articles/onc2013237">
        <meta property="og:type" content="article">
        <meta property="og:site_name" content="Nature">
        <meta property="og:title" content="Repression of microRNA-768-3p by MEK/ERK signalling contributes to enhanced mRNA translation in human melanoma - Oncogene">
        
        <meta property="og:image" content="https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fonc.2013.237/MediaObjects/41388_2014_Article_BFonc2013237_Fig1_HTML.jpg">
    
    <script>
        window.eligibleForRa21 = 'false'; 
    </script>
</head>
<body class="article-page">

<noscript><iframe src="https://collect.nature.com/ns.html?id=GTM-MRVXSHQ"
                  height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>



<div class="position-relative cleared z-index-50 background-white" data-test="top-containers">
    <a class="c-skip-link" href="#content">Skip to main content</a>



<div class="c-grade-c-banner u-hide">
    <div class="c-grade-c-banner__container">
        
        <p>Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
            the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
            Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
            and JavaScript.</p>

    </div>
</div>

    

    <div class="u-lazy-ad-wrapper">
            <div class="deferred-placeholder" data-replace="true"
                 data-placeholder="/placeholder/v1/institutionalBanner?bpids=[bpids] #institutional-banner-container"></div>
            <aside class="c-ad c-ad--728x90">
                <div class="c-ad__inner" data-container-type="banner-advert">
                    <p class="c-ad__label">Advertisement</p>
                    
        
            
    <div id="div-gpt-ad-top-1"
         class="div-gpt-ad advert leaderboard js-ad text-center hide-print grade-c-hide"
         data-ad-type="top"
         data-pa11y-ignore
         data-gpt
         data-gpt-unitpath="/285/onc.nature.com/article"
         data-gpt-sizes="728x90"
         data-gpt-targeting="type=article;pos=top;artid=onc2013237;doi=10.1038/onc.2013.237;subjmeta=1634,1813,331,337,384,574,631,67,692,699,80,86;kwrd=Cell+signalling,Melanoma,miRNAs,Translation">
        <noscript>
            <a href="//pubads.g.doubleclick.net/gampad/jump?iu=/285/onc.nature.com/article&amp;sz=728x90&amp;c=-844253391&amp;t=pos%3Dtop%26type%3Darticle%26artid%3Donc2013237%26doi%3D10.1038/onc.2013.237%26subjmeta%3D1634,1813,331,337,384,574,631,67,692,699,80,86%26kwrd%3DCell+signalling,Melanoma,miRNAs,Translation">
                <img data-test="gpt-advert-fallback-img"
                     src="//pubads.g.doubleclick.net/gampad/ad?iu=/285/onc.nature.com/article&amp;sz=728x90&amp;c=-844253391&amp;t=pos%3Dtop%26type%3Darticle%26artid%3Donc2013237%26doi%3D10.1038/onc.2013.237%26subjmeta%3D1634,1813,331,337,384,574,631,67,692,699,80,86%26kwrd%3DCell+signalling,Melanoma,miRNAs,Translation"
                     alt="Advertisement"
                     width="728"
                     height="90"></a>
        </noscript>
    </div>

        
    
                </div>
            </aside>
        </div>
    <header class="c-header" id="header" data-header data-track-component="nature-150-split-header" style="border-color:#375C2F">
        <div class="c-header__row c-header__row--flush">
            <div class="c-header__container">
                <div class="c-header__split">
                    
                    
                    <div class="c-header__logo-container">
                        
                        <a href="/onc"
                           data-track="click" data-track-action="home" data-track-label="image">
                            <picture class="c-header__logo">
                                <source srcset="//media.springernature.com/full/nature-cms/uploads/product/onc/header-bd278ab8ac625996ea250ba280a31f3c.svg" media="(min-width: 875px)">
                                <img src="//media.springernature.com/full/nature-cms/uploads/product/onc/header-bd278ab8ac625996ea250ba280a31f3c.svg" alt="Oncogene">
                            </picture>
                        </a>
                    
                    </div>
                    
                    <ul class="c-header__menu c-header__menu--global">
                        <li class="c-header__item c-header__item--nature-research">
                            <a class="c-header__link" href="https://www.nature.com/siteindex" data-test="siteindex-link"
                               data-track="click" data-track-action="open nature research index" data-track-label="link">
                                <span>View all journals</span>
                            </a>
                        </li>
                        <li class="c-header__item c-header__item--pipe">
                            <a class="c-header__link"
                               href="#search-menu"
                               data-header-expander
                               data-test="search-link" data-track="click" data-track-action="open search tray" data-track-label="button">
                                <span>Search</span><svg role="img" aria-hidden="true" focusable="false" height="22" width="22" viewBox="0 0 18 18" xmlns="http://www.w3.org/2000/svg"><path d="M16.48 15.455c.283.282.29.749.007 1.032a.738.738 0 01-1.032-.007l-3.045-3.044a7 7 0 111.026-1.026zM8 14A6 6 0 108 2a6 6 0 000 12z"/></svg>
                            </a>
                        </li>
                        <li class="c-header__item">
                            <a href="/nams/svc/myaccount"
    id="my-account"
    class="c-header__link placeholder"
    data-test="login-link" data-track="click" data-track-action="my account" data-track-category="nature-150-split-header" data-track-label="link">
    <span>My Account</span><svg role="img" aria-hidden="true" focusable="false" height="22" width="22" viewBox="0 0 18 18" xmlns="http://www.w3.org/2000/svg"><path d="M10.238 16.905a7.96 7.96 0 003.53-1.48c-.874-2.514-2.065-3.936-3.768-4.319V9.83a3.001 3.001 0 10-2 0v1.277c-1.703.383-2.894 1.805-3.767 4.319A7.96 7.96 0 009 17c.419 0 .832-.032 1.238-.095zm4.342-2.172a8 8 0 10-11.16 0c.757-2.017 1.84-3.608 3.49-4.322a4 4 0 114.182 0c1.649.714 2.731 2.305 3.488 4.322zM9 18A9 9 0 119 0a9 9 0 010 18z" fill="#333" fill-rule="evenodd"/></svg>
</a>
<a href="https://idp.nature.com/authorize/natureuser?client_id&#x3D;grover&amp;redirect_uri&#x3D;https%3A%2F%2Fwww.nature.com%2Farticles%2Fonc2013237"
    id="login-button"
    style="display: none;"
    class="c-header__link placeholder"
    data-test="login-link" data-track="click" data-track-action="login" data-track-category="nature-150-split-header" data-track-label="link">
    <span>Login</span><svg role="img" aria-hidden="true" focusable="false" height="22" width="22" viewBox="0 0 18 18" xmlns="http://www.w3.org/2000/svg"><path d="M10.238 16.905a7.96 7.96 0 003.53-1.48c-.874-2.514-2.065-3.936-3.768-4.319V9.83a3.001 3.001 0 10-2 0v1.277c-1.703.383-2.894 1.805-3.767 4.319A7.96 7.96 0 009 17c.419 0 .832-.032 1.238-.095zm4.342-2.172a8 8 0 10-11.16 0c.757-2.017 1.84-3.608 3.49-4.322a4 4 0 114.182 0c1.649.714 2.731 2.305 3.488 4.322zM9 18A9 9 0 119 0a9 9 0 010 18z" fill="#333" fill-rule="evenodd"/></svg>
</a>

                        </li>
                    </ul>
                </div>
            </div>
        </div>
        
            <div class="c-header__row">
                <div class="c-header__container" data-test="navigation-row">
                    <div class="c-header__split">
                        <div class="c-header__split">
                            <ul class="c-header__menu c-header__menu--journal">
                                
                                    <li class="c-header__item c-header__item--dropdown-menu" data-test="explore-content-button">
                                        <a href="#explore"
                                           class="c-header__link c-header__link--chevron"
                                           data-header-expander
                                           data-test="menu-button--explore"
                                           data-track="click" data-track-action="open explore expander" data-track-label="button">
                                            <span><span class="c-header__show-text">Explore</span> content</span><svg role="img" aria-hidden="true" focusable="false" height="16" viewBox="0 0 16 16" width="16" xmlns="http://www.w3.org/2000/svg"><path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" transform="matrix(0 1 -1 0 11 3)"/></svg>
                                        </a>
                                    </li>
                                
                                <li class="c-header__item c-header__item--dropdown-menu">
                                    <a href="#about-the-journal"
                                       class="c-header__link c-header__link--chevron"
                                       data-header-expander
                                       data-test="menu-button--about-the-journal"
                                       data-track="click" data-track-action="open about the journal expander" data-track-label="button">
                                        <span>About <span class="c-header__show-text">the journal</span></span><svg role="img" aria-hidden="true" focusable="false" height="16" viewBox="0 0 16 16" width="16" xmlns="http://www.w3.org/2000/svg"><path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" transform="matrix(0 1 -1 0 11 3)"/></svg>
                                    </a>
                                </li>
                                
                                    <li class="c-header__item c-header__item--dropdown-menu u-mr-2" data-test="publish-with-us-button">
                                        <a href="#publish-with-us"
                                           class="c-header__link c-header__link--chevron c-header__link--dropdown-menu"
                                           data-header-expander
                                           data-test="menu-button--publish"
                                           data-track="click" data-track-action="open publish with us expander" data-track-label="button">
                                            <span>Publish <span class="c-header__show-text">with us</span></span><svg role="img" aria-hidden="true" focusable="false" height="16" viewBox="0 0 16 16" width="16" xmlns="http://www.w3.org/2000/svg"><path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" transform="matrix(0 1 -1 0 11 3)"/></svg>
                                        </a>
                                    </li>
                                
                            </ul>

                            
                        </div>

                        <ul class="c-header__menu c-header__menu--tools">
                            
                                <li class="c-header__item">
                                    <a class="c-header__link"
                                       href="https://www.nature.com/my-account/alerts/subscribe-journal?list-id&#x3D;51"
                                       rel="nofollow"
                                       data-track="click"
                                       data-track-action="Sign up for alerts"
                                       data-track-label="link (desktop site header)"
                                       data-track-external>
                                        <span>Sign up for alerts</span><svg role="img" aria-hidden="true" focusable="false" height="18" viewBox="0 0 18 18" width="18" xmlns="http://www.w3.org/2000/svg"><path d="m4 10h2.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-3.08578644l-1.12132034 1.1213203c-.18753638.1875364-.29289322.4418903-.29289322.7071068v.1715729h14v-.1715729c0-.2652165-.1053568-.5195704-.2928932-.7071068l-1.7071068-1.7071067v-3.4142136c0-2.76142375-2.2385763-5-5-5-2.76142375 0-5 2.23857625-5 5zm3 4c0 1.1045695.8954305 2 2 2s2-.8954305 2-2zm-5 0c-.55228475 0-1-.4477153-1-1v-.1715729c0-.530433.21071368-1.0391408.58578644-1.4142135l1.41421356-1.4142136v-3c0-3.3137085 2.6862915-6 6-6s6 2.6862915 6 6v3l1.4142136 1.4142136c.3750727.3750727.5857864.8837805.5857864 1.4142135v.1715729c0 .5522847-.4477153 1-1 1h-4c0 1.6568542-1.3431458 3-3 3-1.65685425 0-3-1.3431458-3-3z" fill="#222"/></svg>
                                    </a>
                                </li>
                            
                            
                                <li class="c-header__item c-header__item--pipe">
                                    <a class="c-header__link"
                                       href="http://feeds.nature.com/onc/rss/current"
                                       data-track="click"
                                       data-track-action="rss feed"
                                       data-track-label="link">
                                        <span>RSS feed</span>
                                    </a>
                                </li>
                            
                        </ul>
                    </div>
                </div>
            </div>
        
    </header>


    
    
        <nav class="u-mb-16 u-hide u-show-at-md" aria-label="breadcrumbs">
            <div class="u-container">
                <ol class="c-breadcrumbs" itemscope itemtype="https://schema.org/BreadcrumbList">
                    <li class="c-breadcrumbs__item" id="breadcrumb0" itemprop="itemListElement" itemscope itemtype="https://schema.org/ListItem"><a class="c-breadcrumbs__link"
                               href="/" itemprop="item"
                               data-track="click" data-track-action="breadcrumb" data-track-category="header" data-track-label="link:nature"><span itemprop="name">nature</span></a><meta itemprop="position" content="1">
                                    <svg class="c-breadcrumbs__chevron" role="img" aria-hidden="true" focusable="false" height="10" viewBox="0 0 10 10" width="10"
                                         xmlns="http://www.w3.org/2000/svg">
                                        <path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z"
                                              fill="#666" fill-rule="evenodd" transform="matrix(0 -1 1 0 0 10)"/>
                                    </svg>
                                </li><li class="c-breadcrumbs__item" id="breadcrumb1" itemprop="itemListElement" itemscope itemtype="https://schema.org/ListItem"><a class="c-breadcrumbs__link"
                               href="/onc" itemprop="item"
                               data-track="click" data-track-action="breadcrumb" data-track-category="header" data-track-label="link:oncogene"><span itemprop="name">oncogene</span></a><meta itemprop="position" content="2">
                                    <svg class="c-breadcrumbs__chevron" role="img" aria-hidden="true" focusable="false" height="10" viewBox="0 0 10 10" width="10"
                                         xmlns="http://www.w3.org/2000/svg">
                                        <path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z"
                                              fill="#666" fill-rule="evenodd" transform="matrix(0 -1 1 0 0 10)"/>
                                    </svg>
                                </li><li class="c-breadcrumbs__item" id="breadcrumb2" itemprop="itemListElement" itemscope itemtype="https://schema.org/ListItem"><a class="c-breadcrumbs__link"
                               href="/onc/articles?type&#x3D;original-article" itemprop="item"
                               data-track="click" data-track-action="breadcrumb" data-track-category="header" data-track-label="link:original article"><span itemprop="name">original article</span></a><meta itemprop="position" content="3">
                                    <svg class="c-breadcrumbs__chevron" role="img" aria-hidden="true" focusable="false" height="10" viewBox="0 0 10 10" width="10"
                                         xmlns="http://www.w3.org/2000/svg">
                                        <path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z"
                                              fill="#666" fill-rule="evenodd" transform="matrix(0 -1 1 0 0 10)"/>
                                    </svg>
                                </li><li class="c-breadcrumbs__item" id="breadcrumb3" itemprop="itemListElement" itemscope itemtype="https://schema.org/ListItem">
                                    <span itemprop="name">article</span><meta itemprop="position" content="4"></li>
                </ol>
            </div>
        </nav>
    



    

</div>


<div class="u-container u-mt-32 u-mb-32 u-clearfix" id="content" data-component="article-container"  data-container-type="article">
    <main class="c-article-main-column u-float-left js-main-column" data-track-component="article body">
        
            <div class="c-context-bar u-hide" data-component="context-bar" aria-hidden="true">
                <div class="c-context-bar__container u-container">
                    <div class="c-context-bar__title">
                        Repression of microRNA-768-3p by MEK/ERK signalling contributes to enhanced mRNA translation in human melanoma
                    </div>
                    
    
    <div class="c-pdf-download u-clear-both">
        <a href="/articles/onc2013237.pdf" class="c-pdf-download__link" data-article-pdf="true" data-readcube-pdf-url="true" data-test="download-pdf" data-draft-ignore="true" data-track="click" data-track-action="download pdf" data-track-label="link" data-track-external>
            <span>Download PDF</span>
            <svg aria-hidden="true" focusable="false" width="16" height="16" class="u-icon"><use xlink:href="#global-icon-download"/></svg>
        </a>
    </div>
    

                </div>
            </div>
        
        <article lang="en">
            <div class="c-article-header">
                <header>
                    <ul class="c-article-identifiers" data-test="article-identifier">
                        
    
    
    

                        <li class="c-article-identifiers__item"><a href="#article-info" data-track="click" data-track-action="publication date" data-track-label="link">Published: <time datetime="2013-06-17">17 June 2013</time></a></li>
                    </ul>

                    <h1 class="c-article-title" data-test="article-title" data-article-title="">Repression of microRNA-768-3p by MEK/ERK signalling contributes to enhanced mRNA translation in human melanoma</h1>
                    <ul class="c-article-author-list js-etal-collapsed" data-etal="25" data-etal-small="3" data-test="authors-list" data-component-authors-activator="authors-list"><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-C_C-Jiang" data-author-popup="auth-C_C-Jiang">C C Jiang</a><sup class="u-js-hide"><a href="#Aff1">1</a>,<a href="#Aff2">2</a></sup>, </li><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-A-Croft" data-author-popup="auth-A-Croft">A Croft</a><sup class="u-js-hide"><a href="#Aff1">1</a>,<a href="#Aff3">3</a></sup>, </li><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-H_Y-Tseng" data-author-popup="auth-H_Y-Tseng">H-Y Tseng</a><sup class="u-js-hide"><a href="#Aff1">1</a>,<a href="#Aff2">2</a></sup>, </li><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-S_T-Guo" data-author-popup="auth-S_T-Guo">S T Guo</a><sup class="u-js-hide"><a href="#Aff4">4</a></sup>, </li><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-L-Jin" data-author-popup="auth-L-Jin">L Jin</a><sup class="u-js-hide"><a href="#Aff5">5</a></sup>, </li><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-P-Hersey" data-author-popup="auth-P-Hersey">P Hersey</a><sup class="u-js-hide"><a href="#Aff5">5</a></sup> &amp; </li><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-X_D-Zhang" data-author-popup="auth-X_D-Zhang" data-corresp-id="c1">X D Zhang<svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-email"></use></svg></a><sup class="u-js-hide"><a href="#Aff1">1</a>,<a href="#Aff2">2</a>,<a href="#Aff4">4</a></sup> </li></ul>

                    

                    <p class="c-article-info-details" data-container-section="info">
                        
    <a data-test="journal-link" href="/onc"><i data-test="journal-title">Oncogene</i></a>

                        <b data-test="journal-volume"><span class="u-visually-hidden">volume</span> 33</b>, <span class="u-visually-hidden">pages </span>2577–2588 (<span data-test="article-publication-year">2014</span>)<a href="#citeas" class="c-article-info-details__cite-as u-hide-print" data-track="click" data-track-action="cite this article" data-track-label="link">Cite this article</a>
                    </p>
                    
    <div class="c-article-metrics-bar__wrapper u-clear-both">
        <ul class="c-article-metrics-bar u-list-reset">
            
                <li class=" c-article-metrics-bar__item">
                    <p class="c-article-metrics-bar__count">1558 <span class="c-article-metrics-bar__label">Accesses</span></p>
                </li>
            
            
                <li class="c-article-metrics-bar__item">
                    <p class="c-article-metrics-bar__count">22 <span class="c-article-metrics-bar__label">Citations</span></p>
                </li>
            
            
                
                    <li class="c-article-metrics-bar__item">
                        <p class="c-article-metrics-bar__count">1 <span class="c-article-metrics-bar__label">Altmetric</span></p>
                    </li>
                
            
            <li class="c-article-metrics-bar__item">
                <p class="c-article-metrics-bar__details"><a href="/articles/onc2013237/metrics" data-track="click" data-track-action="view metrics" data-track-label="link" rel="nofollow">Metrics <span class="u-visually-hidden">details</span></a></p>
            </li>
        </ul>
    </div>

                    
                </header>

                
    <div class="u-js-hide" data-component="article-subject-links">
        <h3 class="c-article__sub-heading">Subjects</h3>
        <ul class="c-article-subject-list">
            <li class="c-article-subject-list__subject"><a href="/subjects/cell-signalling" data-track="click" data-track-action="view subject" data-track-label="link">Cell signalling</a></li><li class="c-article-subject-list__subject"><a href="/subjects/melanoma" data-track="click" data-track-action="view subject" data-track-label="link">Melanoma</a></li><li class="c-article-subject-list__subject"><a href="/subjects/mirnas" data-track="click" data-track-action="view subject" data-track-label="link">miRNAs</a></li><li class="c-article-subject-list__subject"><a href="/subjects/translation" data-track="click" data-track-action="view subject" data-track-label="link">Translation</a></li>
        </ul>
    </div>

                
    
        <div class="u-mb-8 c-status-message c-status-message--boxed c-status-message--info">
            <span class="c-status-message__icon">
                <svg class="u-icon" width="18" height="18" aria-hidden="true" focusable="false">
                    <use xlink:href="#icon-info"></use>
                </svg>
            </span>
            
                
                    <p>A <a href="/articles/onc2016144" class="relation-link" data-track="click" data-track-action="view linked article" data-track-label="link">Corrigendum</a> to this article was published on 27 June 2016</p>
                
            
        </div>
    

    

                
            </div>

        <div class="c-article-body">
            <section aria-labelledby="Abs1" data-title="Abstract" lang="en"><div class="c-article-section" id="Abs1-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Abs1">Abstract</h2><div class="c-article-section__content" id="Abs1-content"><p>Increased global protein synthesis and selective translation of mRNAs encoding proteins contributing to malignancy is common in cancer cells. This is often associated with elevated expression of eukaryotic translation initiation factor 4 (eIF4E), the rate-limiting factor of cap-dependent translation initiation. We report here that in human melanoma downregulation of miR-768-3p as a result of activation of the mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK) pathway has an important role in the upregulation of eIF4E and enhancement in protein synthesis. Melanoma cells displayed increased nascent protein production and elevated eIF4E expression, which was associated with the downregulation of miR-768-3p that was predicted to target the 3′-untranslated region of the eIF4E mRNA. Overexpression of miR-768-3p led to the downregulation of the endogenous eIF4E protein, reduction in nascent protein synthesis and inhibition of cell survival and proliferation. These effects were efficiently reversed when eIF4E was co-overexpressed in melanoma cells. On the other hand, introduction of anti-miR-768-3p into melanocytes upregulated endogenous eIF4E protein expression and increased global protein synthesis. Downregulation of miR-768-3p appeared to be mediated by activation of the MEK/ERK pathway, in that treatment of BRAF<sup>V600E</sup> melanoma cells with the mutant BRAF inhibitor PLX4720 or exposure of either BRAF<sup>V600E</sup> or wild-type BRAF melanoma cells to the MEK inhibitor U0126 resulted in the upregulation of miR-768-3p and inhibition of nascent protein synthesis. This inhibition was partially blocked in cells cointroduced with anti-miR-768-3p. Significantly, miR-768-3p was similarly downregulated, which was inversely associated with the expression levels of eIF4E in fresh melanoma isolates. Taken together, these results identify downregulation of miR-768-3p and subsequent upregulation of eIF4E as an important mechanism in addition to phosphorylation of eIF4E responsible for MEK/ERK-mediated enhancement of protein synthesis in melanoma.</p></div></div></section>
            <noscript>
                
            </noscript>

            
                <div class="c-pdf-button__container">
                    
                        
    
    <div class="c-pdf-download u-clear-both">
        <a href="/articles/onc2013237.pdf" class="c-pdf-download__link" data-article-pdf="true" data-readcube-pdf-url="true" data-test="download-pdf" data-draft-ignore="true" data-track="click" data-track-action="download pdf" data-track-label="link" data-track-external>
            <span>Download PDF</span>
            <svg aria-hidden="true" focusable="false" width="16" height="16" class="u-icon"><use xlink:href="#global-icon-download"/></svg>
        </a>
    </div>
    

                    
                </div>
            
            
                <section data-title="Introduction"><div class="c-article-section" id="Sec1-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec1">Introduction</h2><div class="c-article-section__content" id="Sec1-content"><p>Cancer cells require increased protein production to sustain their malignant characteristics such as enhanced survival and proliferation.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 1" title="Silvera D, Formenti SC, Schneider RJ . Translational control in cancer. Nat Rev Cancer 2010; 10: 254–266." href="/articles/onc2013237#ref-CR1" id="ref-link-section-d147300684e529">1</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 2" title="Bilanges B, Stokoe D . Mechanisms of translational deregulation in human tumors and therapeutic intervention strategies. Oncogene 2007; 26: 5973–5990." href="/articles/onc2013237#ref-CR2" id="ref-link-section-d147300684e532">2</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 3" title="Grzmil M, Hemmings BA . Translation regulation as a therapeutic target in cancer. Cancer Res 2012; 72: 3891–3900." href="/articles/onc2013237#ref-CR3" id="ref-link-section-d147300684e535">3</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 4" title="Bitterman PB, Polunovsky VA . Translational control of cell fate: from integration of environmental signals to breaching anticancer defense. Cell Cycle 2012; 11: 1097–1107." href="/articles/onc2013237#ref-CR4" id="ref-link-section-d147300684e538">4</a></sup> The rate of mRNA translation has an important role in regulating protein expression and is primarily controlled at the stage of translation initiation.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 1" title="Silvera D, Formenti SC, Schneider RJ . Translational control in cancer. Nat Rev Cancer 2010; 10: 254–266." href="/articles/onc2013237#ref-CR1" id="ref-link-section-d147300684e542">1</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 2" title="Bilanges B, Stokoe D . Mechanisms of translational deregulation in human tumors and therapeutic intervention strategies. Oncogene 2007; 26: 5973–5990." href="/articles/onc2013237#ref-CR2" id="ref-link-section-d147300684e545">2</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 3" title="Grzmil M, Hemmings BA . Translation regulation as a therapeutic target in cancer. Cancer Res 2012; 72: 3891–3900." href="/articles/onc2013237#ref-CR3" id="ref-link-section-d147300684e548">3</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 4" title="Bitterman PB, Polunovsky VA . Translational control of cell fate: from integration of environmental signals to breaching anticancer defense. Cell Cycle 2012; 11: 1097–1107." href="/articles/onc2013237#ref-CR4" id="ref-link-section-d147300684e551">4</a></sup> Initiation of translation of most mRNAs is mediated by the cap-dependent mechanism, whereas cap-independent initiation is involved in the translation of a subset of mRNAs, especially under cellular stress conditions.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 1" title="Silvera D, Formenti SC, Schneider RJ . Translational control in cancer. Nat Rev Cancer 2010; 10: 254–266." href="/articles/onc2013237#ref-CR1" id="ref-link-section-d147300684e555">1</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 3" title="Grzmil M, Hemmings BA . Translation regulation as a therapeutic target in cancer. Cancer Res 2012; 72: 3891–3900." href="/articles/onc2013237#ref-CR3" id="ref-link-section-d147300684e558">3</a></sup> Cap-dependent translation initiation is governed by the eukaryotic initiation factor (eIF) 4F (eIF4F) complex that consists of the cap-binding protein eIF4E, the RNA helicase eIF4A and the scaffolding protein eIF4G.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 1" title="Silvera D, Formenti SC, Schneider RJ . Translational control in cancer. Nat Rev Cancer 2010; 10: 254–266." href="/articles/onc2013237#ref-CR1" id="ref-link-section-d147300684e562">1</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 2" title="Bilanges B, Stokoe D . Mechanisms of translational deregulation in human tumors and therapeutic intervention strategies. Oncogene 2007; 26: 5973–5990." href="/articles/onc2013237#ref-CR2" id="ref-link-section-d147300684e565">2</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 3" title="Grzmil M, Hemmings BA . Translation regulation as a therapeutic target in cancer. Cancer Res 2012; 72: 3891–3900." href="/articles/onc2013237#ref-CR3" id="ref-link-section-d147300684e568">3</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 4" title="Bitterman PB, Polunovsky VA . Translational control of cell fate: from integration of environmental signals to breaching anticancer defense. Cell Cycle 2012; 11: 1097–1107." href="/articles/onc2013237#ref-CR4" id="ref-link-section-d147300684e571">4</a></sup> Among them, eIF4E is the rate-limiting factor that potentially influences the expression of almost every protein in cells.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 1" title="Silvera D, Formenti SC, Schneider RJ . Translational control in cancer. Nat Rev Cancer 2010; 10: 254–266." href="/articles/onc2013237#ref-CR1" id="ref-link-section-d147300684e575">1</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 5" title="Sonenberg N, Hinnebusch AG . Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell 2009; 136: 731–745." href="/articles/onc2013237#ref-CR5" id="ref-link-section-d147300684e578">5</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 6" title="Jackson RJ, Hellen CU, Pestova TV . The mechanism of eukaryotic translation initiation and principles of its regulation. Nat Rev Mol Cell Biol 2010; 11: 113–127." href="/articles/onc2013237#ref-CR6" id="ref-link-section-d147300684e581">6</a></sup></p><p>The activity of eIF4E is regulated by its availability that is controlled by the eIF4E inhibitory binding proteins (4E-BPs), in particular, 4E-BP1.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 1" title="Silvera D, Formenti SC, Schneider RJ . Translational control in cancer. Nat Rev Cancer 2010; 10: 254–266." href="/articles/onc2013237#ref-CR1" id="ref-link-section-d147300684e587">1</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 5" title="Sonenberg N, Hinnebusch AG . Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell 2009; 136: 731–745." href="/articles/onc2013237#ref-CR5" id="ref-link-section-d147300684e590">5</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 6" title="Jackson RJ, Hellen CU, Pestova TV . The mechanism of eukaryotic translation initiation and principles of its regulation. Nat Rev Mol Cell Biol 2010; 11: 113–127." href="/articles/onc2013237#ref-CR6" id="ref-link-section-d147300684e593">6</a></sup> Hypophosphorylated 4E-BP1 shares the same binding motif with eIF4G and thus competes with eIF4G for binding to and sequestering eIF4E.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 1" title="Silvera D, Formenti SC, Schneider RJ . Translational control in cancer. Nat Rev Cancer 2010; 10: 254–266." href="/articles/onc2013237#ref-CR1" id="ref-link-section-d147300684e597">1</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 5" title="Sonenberg N, Hinnebusch AG . Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell 2009; 136: 731–745." href="/articles/onc2013237#ref-CR5" id="ref-link-section-d147300684e600">5</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 6" title="Jackson RJ, Hellen CU, Pestova TV . The mechanism of eukaryotic translation initiation and principles of its regulation. Nat Rev Mol Cell Biol 2010; 11: 113–127." href="/articles/onc2013237#ref-CR6" id="ref-link-section-d147300684e603">6</a></sup> In addition, phosphorylation of eIF4E at serine 209 upon binding to eIF4G by mitogen-activated protein kinase signal-integrating kinase 1 (MNK1) and MNK2 enhances its activity.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 5" title="Sonenberg N, Hinnebusch AG . Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell 2009; 136: 731–745." href="/articles/onc2013237#ref-CR5" id="ref-link-section-d147300684e607">5</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 7" title="Phillips A, Blaydes JP . MNK1 and EIF4E are downstream effectors of MEKs in the regulation of the nuclear export of HDM2 mRNA. Oncogene 2008; 27: 1645–1649." href="/articles/onc2013237#ref-CR7" id="ref-link-section-d147300684e610">7</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 8" title="Hou J, Lam F, Proud C, Wang S . Targeting Mnks for cancer therapy. Oncotarget 2012; 3: 118–131." href="/articles/onc2013237#ref-CR8" id="ref-link-section-d147300684e613">8</a></sup> Importantly, overexpression of eIF4E promotes cellular transformation and tumourigenesis.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 9" title="Stumpf CR, Ruggero D . The cancerous translation apparatus. Curr Opin Genet Dev 2011; 21: 474–483." href="/articles/onc2013237#ref-CR9" id="ref-link-section-d147300684e617">9</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 10" title="Wendel HG, Silva RL, Malina A, Mills JR, Zhu H, Ueda T et al. Dissecting eIF4E action in tumorigenesis. Genes Dev 2007; 21: 3232–3237." href="/articles/onc2013237#ref-CR10" id="ref-link-section-d147300684e620">10</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 11" title="Rosenwald IB . The role of translation in neoplastic transformation from a pathologist's point of view. Oncogene 2004; 23: 3230–3247." href="/articles/onc2013237#ref-CR11" id="ref-link-section-d147300684e623">11</a></sup> This is associated with increased translation of various mRNAs encoding cancer-promoting proteins.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 1" title="Silvera D, Formenti SC, Schneider RJ . Translational control in cancer. Nat Rev Cancer 2010; 10: 254–266." href="/articles/onc2013237#ref-CR1" id="ref-link-section-d147300684e627">1</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 10" title="Wendel HG, Silva RL, Malina A, Mills JR, Zhu H, Ueda T et al. Dissecting eIF4E action in tumorigenesis. Genes Dev 2007; 21: 3232–3237." href="/articles/onc2013237#ref-CR10" id="ref-link-section-d147300684e630">10</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 11" title="Rosenwald IB . The role of translation in neoplastic transformation from a pathologist's point of view. Oncogene 2004; 23: 3230–3247." href="/articles/onc2013237#ref-CR11" id="ref-link-section-d147300684e633">11</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 12" title="Larsson O, Li S, Issaenko OA, Avdulov S, Peterson M, Smith K et al. Eukaryotic translation initiation factor 4E induced progression of primary human mammary epithelial cells along the cancer pathway is associated with targeted translational deregulation of oncogenic drivers and inhibitors. Cancer Res 2007; 67: 6814–6824." href="/articles/onc2013237#ref-CR12" id="ref-link-section-d147300684e636">12</a></sup> Indeed, eIF4E is expressed at increased levels in many types of cancers, such as those of the breast and colon,<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 13" title="Yang SX, Hewitt SM, Steinberg SM, Liewehr DJ, Swain SM . Expression levels of eIF4E, VEGF, and cyclin D1, and correlation of eIF4E with VEGF and cyclin D1 in multi-tumor tissue microarray. Oncol Rep 2007; 17: 281–287." href="/articles/onc2013237#ref-CR13" id="ref-link-section-d147300684e641">13</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 14" title="Coleman LJ, Peter MB, Teall TJ, Brannan RA, Hanby AM, Honarpisheh H et al. Combined analysis of eIF4E and 4E-binding protein expression predicts breast cancer survival and estimates eIF4E activity. Br J Cancer 2009; 100: 1393–1399." href="/articles/onc2013237#ref-CR14" id="ref-link-section-d147300684e644">14</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 15" title="De Benedetti A, Graff JR . eIF-4E expression and its role in malignancies and metastases. Oncogene 2004; 23: 3189–3199." href="/articles/onc2013237#ref-CR15" id="ref-link-section-d147300684e647">15</a></sup> which is often associated with disease progression and poor prognosis of patients.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 1" title="Silvera D, Formenti SC, Schneider RJ . Translational control in cancer. Nat Rev Cancer 2010; 10: 254–266." href="/articles/onc2013237#ref-CR1" id="ref-link-section-d147300684e651">1</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 13" title="Yang SX, Hewitt SM, Steinberg SM, Liewehr DJ, Swain SM . Expression levels of eIF4E, VEGF, and cyclin D1, and correlation of eIF4E with VEGF and cyclin D1 in multi-tumor tissue microarray. Oncol Rep 2007; 17: 281–287." href="/articles/onc2013237#ref-CR13" id="ref-link-section-d147300684e654">13</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 14" title="Coleman LJ, Peter MB, Teall TJ, Brannan RA, Hanby AM, Honarpisheh H et al. Combined analysis of eIF4E and 4E-binding protein expression predicts breast cancer survival and estimates eIF4E activity. Br J Cancer 2009; 100: 1393–1399." href="/articles/onc2013237#ref-CR14" id="ref-link-section-d147300684e657">14</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 15" title="De Benedetti A, Graff JR . eIF-4E expression and its role in malignancies and metastases. Oncogene 2004; 23: 3189–3199." href="/articles/onc2013237#ref-CR15" id="ref-link-section-d147300684e660">15</a></sup> However, the mechanism(s) responsible for the upregulation of eIF4E in cancer cells remains elusive.</p><p>MicroRNAs (miRs) regulate gene expression in a sequence-specific manner through binding to 3′-untranslated regions (UTRs) of target mRNAs, either targeting the transcripts for degradation or blocking their translation.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 16" title="He L, Hannon GJ . 2004. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004; 5: 522–531." href="/articles/onc2013237#ref-CR16" id="ref-link-section-d147300684e667">16</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 17" title="Iorio MV, Croce CM . MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol 2009; 27: 5848–5856." href="/articles/onc2013237#ref-CR17" id="ref-link-section-d147300684e670">17</a></sup> They can also inhibit translation by directly targeting the eIF4F complex.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 18" title="Humphreys DT, Westman BJ, Martin DI, Preiss T . MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function. Proc Natl Acad Sci USA 2005; 102: 16961–16966." href="/articles/onc2013237#ref-CR18" id="ref-link-section-d147300684e674">18</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 19" title="Mathonnet G, Fabian MR, Svitkin YV, Parsyan A, Huck L, Murata T et al. MicroRNA inhibition of translation initiation in vitro by targeting the cap-binding complex eIF4F. Science 2007; 317: 1764–1767." href="/articles/onc2013237#ref-CR19" id="ref-link-section-d147300684e677">19</a></sup> The expression of miRs is frequently deregulated in cancer cells and many miRs are oncogenic or tumour suppressive.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 17" title="Iorio MV, Croce CM . MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol 2009; 27: 5848–5856." href="/articles/onc2013237#ref-CR17" id="ref-link-section-d147300684e681">17</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 20" title="Lujambio A, Lowe SW . The microcosmos of cancer. Nature 2012; 482: 347–355." href="/articles/onc2013237#ref-CR20" id="ref-link-section-d147300684e684">20</a></sup> In particular, a number of miRs such as miR-221/222 and miR-149* are known to regulate melanoma cell survival or proliferation.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 21" title="Felicetti F, Errico MC, Bottero L, Segnalini P, Stoppacciaro A et al. The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms. Cancer Res 2008; 68: 2745–2754." href="/articles/onc2013237#ref-CR21" id="ref-link-section-d147300684e688">21</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 22" title="Jin L, Hu WL, Jiang CC, Wang JX, Han CC, Chu P et al. MicroRNA-149*, a p53-responsive microRNA, functions as an oncogenic regulator in human melanoma. Proc Natl Acad Sci USA 2011; 108: 15840–15845." href="/articles/onc2013237#ref-CR22" id="ref-link-section-d147300684e691">22</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 23" title="Bonazzi VF, Stark MS, Hayward NK . MicroRNA regulation of melanoma progression. Melanoma Res 2012; 22: 101–113." href="/articles/onc2013237#ref-CR23" id="ref-link-section-d147300684e694">23</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 24" title="Mueller DW, Bosserhoff AK . The evolving concept of ‘melano-miRs’-microRNAs in melanomagenesis. Pigment Cell Melanoma Res 2010; 23: 620–626." href="/articles/onc2013237#ref-CR24" id="ref-link-section-d147300684e697">24</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 25" title="Wilmott JS, Zhang XD, Hersey P, Scolyer RA . The emerging important role of microRNAs in the pathogenesis, diagnosis and treatment of human cancers. Pathology 2011; 43: 657–671." href="/articles/onc2013237#ref-CR25" id="ref-link-section-d147300684e700">25</a></sup> Diverse mechanisms are involved in the regulation of miR expression in a tissue- and cell type-specific manner. These include genomic alterations, epigenetic changes and transcription factor-mediated transactivation or repression.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 16" title="He L, Hannon GJ . 2004. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004; 5: 522–531." href="/articles/onc2013237#ref-CR16" id="ref-link-section-d147300684e704">16</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 26" title="Croce CM . Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 2009; 10: 704–714." href="/articles/onc2013237#ref-CR26" id="ref-link-section-d147300684e707">26</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 27" title="Guo ST, Jiang CC, Wang GP, Li YP, Wang CY, Guo XY et al. MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer. Oncogene 2012; 32: 1910–1920." href="/articles/onc2013237#ref-CR27" id="ref-link-section-d147300684e710">27</a></sup></p><p>A characteristic of human melanoma is oncogenic activation of the mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK) pathway.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 28" title="Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S et al. Mutations of the BRAF gene in human cancer. Nature 2002; 417: 949–954." href="/articles/onc2013237#ref-CR28" id="ref-link-section-d147300684e716">28</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 29" title="Platz A, Egyhazi S, Ringborg U, Hansson J . Human cutaneous melanoma; a review of NRAS and BRAF mutation frequencies in relation to histogenetic subclass and body site. Mol Oncol 2008; 1: 395–405." href="/articles/onc2013237#ref-CR29" id="ref-link-section-d147300684e719">29</a></sup> This stems primarily from activating mutations of BRAF, with the most common mutation being a glutamic acid for valine substitution at position 600 (BRAF<sup>V600E</sup>).<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 28" title="Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S et al. Mutations of the BRAF gene in human cancer. Nature 2002; 417: 949–954." href="/articles/onc2013237#ref-CR28" id="ref-link-section-d147300684e725">28</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 29" title="Platz A, Egyhazi S, Ringborg U, Hansson J . Human cutaneous melanoma; a review of NRAS and BRAF mutation frequencies in relation to histogenetic subclass and body site. Mol Oncol 2008; 1: 395–405." href="/articles/onc2013237#ref-CR29" id="ref-link-section-d147300684e728">29</a></sup> Noticeably, a number of miRs such as miR-193a, miR-338 and miR-768-3p have been reported to be regulated by oncogenic activation of MEK/ERK signalling in melanoma.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 30" title="Couts KL, Anderson EM, Gross MM, Sullivan K, Ahn NG . Oncogenic B-Raf signaling in melanoma cells controls a network of microRNAs with combinatorial functions. Oncogene 2012; 32: 1959–1970." href="/articles/onc2013237#ref-CR30" id="ref-link-section-d147300684e732">30</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 31" title="Caramuta S, Egyházi S, Rodolfo M, Witten D, Hansson J, Larsson C et al. MicroRNA expression profiles associated with mutational status and survival in malignant melanoma. J Invest Dermatol 2010; 130: 2062–2070." href="/articles/onc2013237#ref-CR31" id="ref-link-section-d147300684e735">31</a></sup> Although activation of the MEK/ERK pathway is known to promote protein synthesis by phosphorylation of eIF4E through activation of MNK1 and MNK2,<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 1" title="Silvera D, Formenti SC, Schneider RJ . Translational control in cancer. Nat Rev Cancer 2010; 10: 254–266." href="/articles/onc2013237#ref-CR1" id="ref-link-section-d147300684e739">1</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 2" title="Bilanges B, Stokoe D . Mechanisms of translational deregulation in human tumors and therapeutic intervention strategies. Oncogene 2007; 26: 5973–5990." href="/articles/onc2013237#ref-CR2" id="ref-link-section-d147300684e742">2</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 3" title="Grzmil M, Hemmings BA . Translation regulation as a therapeutic target in cancer. Cancer Res 2012; 72: 3891–3900." href="/articles/onc2013237#ref-CR3" id="ref-link-section-d147300684e745">3</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 4" title="Bitterman PB, Polunovsky VA . Translational control of cell fate: from integration of environmental signals to breaching anticancer defense. Cell Cycle 2012; 11: 1097–1107." href="/articles/onc2013237#ref-CR4" id="ref-link-section-d147300684e748">4</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 7" title="Phillips A, Blaydes JP . MNK1 and EIF4E are downstream effectors of MEKs in the regulation of the nuclear export of HDM2 mRNA. Oncogene 2008; 27: 1645–1649." href="/articles/onc2013237#ref-CR7" id="ref-link-section-d147300684e751">7</a></sup> we have found in this study that upregulation of the expression of eIF4E also has an important role in MEK/ERK-mediated enhancement of mRNA translation in melanoma. We demonstrate here that MEK/ERK-mediated upregulation of eIF4E is due to its inhibitory effect on the expression of miR-768-3p. The latter targets eIF4E and is commonly downregulated in melanoma cells.</p></div></div></section><section data-title="Results"><div class="c-article-section" id="Sec2-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec2">Results</h2><div class="c-article-section__content" id="Sec2-content"><h3 class="c-article__sub-heading" id="Sec3">eIF4E is upregulated in melanoma cells</h3><p>Increased mRNA translation has an important role in the pathogenesis of cancer.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 1" title="Silvera D, Formenti SC, Schneider RJ . Translational control in cancer. Nat Rev Cancer 2010; 10: 254–266." href="/articles/onc2013237#ref-CR1" id="ref-link-section-d147300684e767">1</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 2" title="Bilanges B, Stokoe D . Mechanisms of translational deregulation in human tumors and therapeutic intervention strategies. Oncogene 2007; 26: 5973–5990." href="/articles/onc2013237#ref-CR2" id="ref-link-section-d147300684e770">2</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 3" title="Grzmil M, Hemmings BA . Translation regulation as a therapeutic target in cancer. Cancer Res 2012; 72: 3891–3900." href="/articles/onc2013237#ref-CR3" id="ref-link-section-d147300684e773">3</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 4" title="Bitterman PB, Polunovsky VA . Translational control of cell fate: from integration of environmental signals to breaching anticancer defense. Cell Cycle 2012; 11: 1097–1107." href="/articles/onc2013237#ref-CR4" id="ref-link-section-d147300684e776">4</a></sup> In line with this, the magnitude of nascent protein synthesis appeared significantly increased in cultured melanoma cells compared with melanocytes (<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/onc2013237#Fig1">Figures 1a and b</a>). Similarly, the relative amount of polysome-associated mRNA in melanoma cells was also increased (<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/onc2013237#Fig1">Figure 1c</a>). This was associated with increased expression and phosphorylation of the eIF4E protein (<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/onc2013237#Fig1">Figures 1d and e</a>). The elevated levels of protein production and eIF4E expression and phosphorylation in melanoma cells compared with melanocytes was not due to the differences in culture conditions, in that Mel-RM and Mel-CV cells grown in melanocyte culture medium displayed even further increases, albeit moderately, in protein synthesis and eIF4E expression and phosphorylation. In contrast, when melanocytes were switched to melanoma cell culture medium, the levels of protein synthesis and eIF4E expression and phosphorylation were reduced (<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/onc2013237#MOESM47">Supplementary Figure 1</a>).</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-1" data-title="Figure 1"><figure><figcaption><b id="Fig1" class="c-article-section__figure-caption" data-test="figure-caption-text">Figure 1</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/onc2013237/figures/1" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fonc.2013.237/MediaObjects/41388_2014_Article_BFonc2013237_Fig1_HTML.jpg?as=webp"><img aria-describedby="Fig1" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fonc.2013.237/MediaObjects/41388_2014_Article_BFonc2013237_Fig1_HTML.jpg" alt="figure 1" loading="lazy" width="685" height="802"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-1-desc"><p>Nascent protein synthesis is increased, and eIF4E is upregulated, in melanoma cells. (<b>a</b>) Representative flow cytometric histograms of quantitation of nascent protein synthesis using the Click-iT protein synthesis assay kit in HEMn-MP melanocytes and Mel-RM melanoma cells. Filled histograms: cells without labelling with metabolic labelling reagent; open histograms: cells were labelled with metabolic labelling reagent. MFI: mean fluorescence intensity. The data shown are representative of three individual experiments. (<b>b</b>) Quantitation of nascent protein synthesis in a panel of melanoma cell lines relative to the HEMn-MP and HEMn-DP melanocyte lines using the Click-iT protein synthesis assay kit as described in (<b>a</b>). The MFI of each sample was normalized against the corresponding sample without labelling with the metabolic labelling reagent. The relative magnitude of nascent protein synthesis of HEMn-MP was arbitrarily designated as 1. The data shown are the mean±s.e. of three individual experiments. (<b>c</b>) Polysome fractions of HEMn-MP melanocytes and Mel-RM and Mel-CV melanoma cells were collected using sucrose-gradient centrifugation and were subjected to polysome profiling where the absorbance of each fraction was measured at 254 nm. The data shown are representative of three individual experiments. (<b>d</b>) Whole-cell lysates from melanocytes (HEMn-MP and HEMn-DP) and melanoma cells as indicated were subjected to western blot analysis of phosphorylated eIF4E, eIF4E and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (as a loading control). The data shown are representative of three individual experiments. (<b>e</b>) Comparison of eIF4E expression levels between melanocytes and melanoma cells as shown in (<b>d</b>). Levels of eIF4E were normalized to those of GAPDH. Quantitation of each band was determined using the NIH Image J software (NIMH, Bethesda, MD, USA). The mean eIF4E expression level of HEMn-MP and HEMn-DP melanocytes was arbitrarily designated as 1. The data shown are mean±s.e. of three individual experiments. The average eIF4E expression levels in melanoma cells are <span class="stix">∼</span>6-fold higher than melanoctyes. (<b>f</b>) Mel-RM and Mel-CV cells were transfected with the control or eIF4E siRNA. After 24 h, whole-cell lysates were subjected to western blot analysis of eIF4E, 4E-BP1 and GAPDH (as a loading control). The data shown are representative of three individual experiments. (<b>g</b>) Mel-RM and Mel-CV cells were transfected with the control or eIF4E siRNA. After 24 h, cells were subjected to measurement of nascent protein synthesis using the Click-iT protein synthesis assay kit by flow cytometry. The MFI of each sample was normalized against the corresponding sample without labelling with the metabolic labelling reagent. The relative magnitude of nascent protein synthesis in cells from each line transfected with the control siRNA was arbitrarily designated as 1. The data shown are mean±s.e. of three individual experiments. (<b>h</b>) Mel-RM cells were transfected with the control or eIF4E siRNA. After 24 h, cells were treated with 4EGI-1 (5 μ<span class="u-small-caps">M</span>) for a further 24 h. Cells were then subjected to measurement of nascent protein synthesis using the Click-iT protein synthesis assay kit by flow cytometry. The MFI of each sample was normalized against the corresponding sample without labelling with the metabolic labelling reagent. The relative magnitude of nascent protein synthesis in cells transfected with the control siRNA without exposure to 4EGI-1 was arbitrarily designated as 1. The data shown are mean±s.e. of three individual experiments.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/onc2013237/figures/1" data-track-dest="link:Figure1 Full size image" aria-label="Full size image figure 1" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-chevron-right"></use></svg></a></div></figure></div><p>The role of eIF4E in increased protein synthesis in melanoma cells is confirmed by small RNA interference (siRNA) knockdown of eIF4E, which caused marked reduction in nascent protein synthesis in Mel-CV cells (<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/onc2013237#Fig1">Figures 1f and g</a>). However, it displayed less pronounced effect in Mel-RM cells. This was conceivably due to the residual eIF4E protein that might remain adequate to drive mRNA translation as the endogenous eIF4E inhibitor 4E-BP1 was also downregulated when eIF4E was knocked down in the cells (<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/onc2013237#Fig1">Figure 1f</a>).<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 32" title="Yanagiya A, Suyama E, Adachi H, Svitkin YV, Aza-Blanc P, Imataka H et al. Translational homeostasis via the mRNA cap-binding protein, eIF4E. Mol Cell 2012; 46: 847–858." href="/articles/onc2013237#ref-CR32" id="ref-link-section-d147300684e854">32</a></sup> Nonetheless, knockdown of eIF4E rendered Mel-RM cells more sensitive to 4EGI-1, a small molecule that inhibits the interaction between eIF4E and eIF4G (<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/onc2013237#Fig1">Figure 1h</a>).<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 33" title="Moerke NJ, Aktas H, Chen H, Cantel S, Reibarkh MY, Fahmy A et al. Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G. Cell 2007; 128: 257–267." href="/articles/onc2013237#ref-CR33" id="ref-link-section-d147300684e861">33</a></sup> Collectively, these results indicate that mRNA translation is enhanced, which is at least, in part, due to the upregulation of eIF4E, in melanoma cells.</p><p>Contrary to its <span class="stix">∼</span>6-fold increases at the protein level (<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/onc2013237#Fig1">Figure 1e</a>), the eIF4E transcript was elevated &lt;2-folds and displayed comparable turnover rates in melanoma cells compared with melanocytes (<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/onc2013237#Fig2">Figures 2a and b</a>). Moreover, the half-life time of the eIF4E protein did not appear to prolong in melanoma cells (<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/onc2013237#Fig2">Figures 2c and d</a>). These data suggest that translational upregulation may have an important role in increased expression of eIF4E in melanoma cells.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-2" data-title="Figure 2"><figure><figcaption><b id="Fig2" class="c-article-section__figure-caption" data-test="figure-caption-text">Figure 2</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/onc2013237/figures/2" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fonc.2013.237/MediaObjects/41388_2014_Article_BFonc2013237_Fig2_HTML.jpg?as=webp"><img aria-describedby="Fig2" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fonc.2013.237/MediaObjects/41388_2014_Article_BFonc2013237_Fig2_HTML.jpg" alt="figure 2" loading="lazy" width="685" height="325"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-2-desc"><p>The increase in eIF4E expression in melanoma cells may be mediated by translational upregulation. (<b>a</b>) Total RNA from HEMn-MP melanocytes and Mel-RM and Mel-CV melanoma cells was subjected to qPCR analysis of eIF4E mRNA expression. The relative expression level of eIF4E mRNA in each sample was normalized against β-actin mRNA. The relative abundance of eIF4E mRNA in HEMn-MP melanocytes was arbitrarily designated as 1. The data shown are mean±s.e. of three individual experiments. (<b>b</b>) HEMn-MP melanocytes and Mel-RM and Mel-CV melanoma cells were treated with actinomycin D (Act.D) (100 ng/ml) for indicated periods. Total RNA was subjected to qPCR analysis of eIF4E mRNA expression. The relative expression level of eIF4E mRNA in each sample was normalized against β-actin mRNA. The relative abundance of eIF4E mRNA in each cell line before treatment was arbitrarily designated as 1. The data shown are mean±s.e. of three individual experiments. (<b>c</b>) Whole-cell lysates from HEMn-MP melanocytes, Mel-RM and Mel-CV melanoma cells with or without treatment with cycloheximide (CHX) (100 μg/ml) for indicated periods were subjected to western blot analysis of eIF4E and GPADH (as a loading control). The data shown are representative of three individual experiments. (<b>d</b>) Comparison of eIF4E expression levels in each cell line before and after treatment with cycloheximide as shown in (<b>c</b>). Levels of eIF4E were normalized to those of glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Quantitation of each band was determined using the NIH Image J software. The eIF4E expression level of each cell line before treatment was arbitrarily designated as 100. The data shown are mean±s.e. of three individual experiments.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/onc2013237/figures/2" data-track-dest="link:Figure2 Full size image" aria-label="Full size image figure 2" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-chevron-right"></use></svg></a></div></figure></div><h3 class="c-article__sub-heading" id="Sec4">MiR-768-3p is downregulated in melanoma cells</h3><p>We sought to determine if miRNAs that commonly target transcripts to block their translation are involved in the regulation of eIF4E by comparing miRNA expression profiles between Mel-RM and Mel-CV melanoma cell lines and HEMn-MP and HEMn-DP melanocyte lines using TaqMan low-density array (Applied Biosystems, Mulgrave, VIC, Australia). Among miRNAs that were differentially expressed, a decrease in miR-768-3p, whose ‘seed’ region matched perfectly to a region (nucleotides 2645–2652) at the 3′-UTR of the eIF4E mRNA, in melanoma cells was one of the most pronounced ( Genes-to-System Breast Cancer Database: <a href="http://www.itb.cnr.it/breastcancer//index.htm">http://www.itb.cnr.it/breastcancer//index.htm</a>) (<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/onc2013237#Fig3">Figures 3a and b</a> and <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/onc2013237#MOESM47">Supplementary Table 1</a>). This was subsequently confirmed in 10 melanoma cell lines (<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/onc2013237#Fig3">Figure 3c</a>). In contrast, other miRNAs that are predicted to target eIF4E (MiRanda (<a href="http://www.microrna.org">http://www.microrna.org</a>) and Target Scan (<a href="http://www.targetscan.org">http://www.targetscan.org</a>)) such as miR-150b and miR-382 did not significantly alter in expression in melanoma cells compared with melanocytes (<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/onc2013237#MOESM47">Supplementary Table 1</a>). Of importance, miR-768-3p was expressed at reduced levels in 48/50 of metastatic melanoma isolates relative to primary melanocytes (<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/onc2013237#Fig3">Figure 3d</a>), suggesting that inhibition of miR-768-3p expression may have functional significance in melanoma biology <i>in vivo</i>.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-3" data-title="Figure 3"><figure><figcaption><b id="Fig3" class="c-article-section__figure-caption" data-test="figure-caption-text">Figure 3</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/onc2013237/figures/3" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fonc.2013.237/MediaObjects/41388_2014_Article_BFonc2013237_Fig3_HTML.jpg?as=webp"><img aria-describedby="Fig3" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fonc.2013.237/MediaObjects/41388_2014_Article_BFonc2013237_Fig3_HTML.jpg" alt="figure 3" loading="lazy" width="685" height="556"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-3-desc"><p>MiR-768-3p is downregulated in melanoma cells. (<b>a</b>) A schematic illustration of base-paring between miR-768-3p and the 3′-UTR of eIF4E mRNA. (<b>b</b>) Total miRNA from HEMn-MP and HEMn-DP melanocytes, Mel-RM and Mel-CV melanoma cells was subjected to miRNA expression profiling using TaqMan low-density array. The average abundance of miR-768-3p in HEMn-MP and HEMn-DP melanocytes was arbitrarily designated as 1. The relative abundance of miR-768-3p in melanoma cell lines was depicted. The data shown are mean±s.e. of three individual experiments. (<b>c</b>) Total miRNA from HEMn-MP and HEMn-DP melanocytes and melanoma cells as indicated was subjected to qPCR analysis of miR-768-3p expression. The average level miR-768-3p in HEMn-MP and HEMn-DP melanocytes was arbitrarily designated as 1. The relative abundance of miR-768-3p in each melanoma cell line was depicted as folds of decreases (shown as negative values). The data shown are mean±s.e. of three individual experiments. (<b>d</b>) Total miRNA from HEMn-MP and HEMn-DP melanocytes and 50 fresh melanoma isolates were subjected to qPCR analysis of miR-768-3p expression. The average level miR-768-3p in HEMn-MP and HEMn-DP melanocytes was arbitrarily designated as 1 (the first column: 1). The relative abundance of miR-768-3p in each isolate was depicted as folds of decreases (shown as negative values) (columns: 2–51). The data shown are mean±s.e. of three individual experiments.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/onc2013237/figures/3" data-track-dest="link:Figure3 Full size image" aria-label="Full size image figure 3" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-chevron-right"></use></svg></a></div></figure></div><h3 class="c-article__sub-heading" id="Sec5">MiR-768-3p downregulates eIF4E</h3><p>As miR-768-3p overlaps with the small nucleolar RNA HBII-239,<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 34" title="Valleron W, Ysebaert L, Berquet L, Fataccioli V, Quelen C, Martin A et al. Small nucleolar RNA expression profiling identifies potential prognostic markers in peripheral T-cell lymphoma. Blood 2012; 120: 3997–4005." href="/articles/onc2013237#ref-CR34" id="ref-link-section-d147300684e996">34</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 35" title="Miyoshi K, Miyoshi T, Siomi H . Many ways to generate microRNA-like small RNAs: non-canonical pathways for microRNA production. Mol Genet Genom 2010; 284: 95–103." href="/articles/onc2013237#ref-CR35" id="ref-link-section-d147300684e999">35</a></sup> we interrogated the potential interaction of this RNA with Argonaute (Ago) proteins, a core component of the RNA-induced silencing complex (RISC) by co-immunoprecipitation using an Ago (pan) antibody.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 36" title="Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA 2011; 108: 5003–5008." href="/articles/onc2013237#ref-CR36" id="ref-link-section-d147300684e1003">36</a></sup> MiR-221 that is functionally verified in melanoma cells was included as a positive control,<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 21" title="Felicetti F, Errico MC, Bottero L, Segnalini P, Stoppacciaro A et al. The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms. Cancer Res 2008; 68: 2745–2754." href="/articles/onc2013237#ref-CR21" id="ref-link-section-d147300684e1007">21</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 23" title="Bonazzi VF, Stark MS, Hayward NK . MicroRNA regulation of melanoma progression. Melanoma Res 2012; 22: 101–113." href="/articles/onc2013237#ref-CR23" id="ref-link-section-d147300684e1010">23</a></sup> and the small nuclear RNA U6, as a negative control.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 37" title="Kiss T . Biogenesis of small nuclear RNPs. J Cell Sci 2004; 117: 5949–5951." href="/articles/onc2013237#ref-CR37" id="ref-link-section-d147300684e1014">37</a></sup> Similar to miR-221, the majority of this RNA (more than 80% in comparison with the input in both Mel-RM and Mel-CV cells) was associated with Ago proteins, whereas, as expected, U6 was not enriched in the Ago precipitates (<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/onc2013237#Fig4">Figure 4a</a>). These results indicate that this RNA is indeed processed into a mature miR (miR-768-3p) in melanoma cells.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 36" title="Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA 2011; 108: 5003–5008." href="/articles/onc2013237#ref-CR36" id="ref-link-section-d147300684e1022">36</a></sup></p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-4" data-title="Figure 4"><figure><figcaption><b id="Fig4" class="c-article-section__figure-caption" data-test="figure-caption-text">Figure 4</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/onc2013237/figures/4" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fonc.2013.237/MediaObjects/41388_2014_Article_BFonc2013237_Fig4_HTML.jpg?as=webp"><img aria-describedby="Fig4" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fonc.2013.237/MediaObjects/41388_2014_Article_BFonc2013237_Fig4_HTML.jpg" alt="figure 4" loading="lazy" width="685" height="834"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-4-desc"><p>MiR-768-3p targets eIF4E. (<b>a</b>) Upper panel: whole-cell lysates were subjected to immunoprecipitation with a mouse anti Ago (pan) antibody or purified mouse immunoglobulin G (IgG) (as a control). The resulting precipitates were subjected to western blot analysis of Ago proteins. Lower panel: Total miRNA isolated from the precipitates subjected to qPCR analysis of miR-768-3p, miR-221 (as a positive control) and U6 (as a negative control) expression. Total miRNA from each cell line was also analysed (input). The abundance of total miR-221, miR-768-3p and U6 in each cell line was arbitrarily designated as 1. The relative abundance of miR-221, miR-768-3p and U6 coprecipitated with Ago was depicted against 1. The data shown are mean±s.e. of three individual experiments. The miRs were not detected in precipitates resulting from purified mouse IgG. (<b>b</b>) HEMn-MP melanocytes and Mel-RM melanoma cells were co-transfected with the indicated reporter constructs and luciferase plasmids. After 24 h, the reporter activity was measured using luciferase assays. Fold-activation values were measured relative to the levels of <i>Renilla</i> luciferase activity in cells transfected with vector alone (pSI-vector) and normalized by firefly luciferase activities. The data shown are the mean ±s.e. of three individual experiments. (<b>c</b>) Left panel: HEMn-MP melanocytes and Mel-RM melanoma cells were co-transfected with the indicated reporter constructs and <i>Renilla</i> luciferase plasmids. Scrambled or anti-miR-768-3p oligonucleotides were also co-transfected. After 24 h, the reporter activity was measured using luciferase assays. Fold-activation values were measured relative to the levels of <i>Renilla</i> luciferase activity in cells transfected with vector alone (pSI-vector) and scrambled oligonucleotides (scramble) and normalized by firefly luciferase activities. Right panel: qRT-PCR analysis of miR-768-3p in total miRNA from HEMn-MP and Mel-RM cells transfected with scrambled or anti-miR-768-3p oligonucleotides. The relative abundance of miR-768-3p in cells transfected with scrambled oligonucleotides (scramble) was arbitrarily designated as 1. The data shown are the mean±s.e. of three individual experiments. (<b>d</b>) Left panel: HEMn-MP melanocytes and Mel-RM melanoma cells were co-transfected with the indicated reporter constructs and <i>Renilla</i> luciferase plasmids. Scrambled or miR-768-3p mimics were also co-transfected. After 24 h, the reporter activity was measured using luciferase assays. Right panel: qPCR analysis of miR-768-3p in total miRNA from HEMn-MP and Mel-RM cells transfected with scrambles or miR-768-3p mimics. The relative abundance of miR-768-3p in cells transfected with scrambled oligonucleotides (scramble) was arbitrarily designated as 1. The data shown are the mean±s.e. of three individual experiments. (<b>e</b>) Left panel: Mel-RM melanoma cells were transfected with scrambled or miR-768-3p mimics oligonucleotides. After 24 h, whole-cell lysates were subjected to western blot analysis of eIF4E and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (as a loading control). Right panel: HEMn-MP melanocytes were transfected with scrambled or anti-miR-768-3p. After 24 h, whole-cell lysates were subjected to western blot analysis of eIF4E and GAPDH (as a loading control). The data shown are representative of three individual western blot analyses. (<b>f</b>) Whole-cell lysates from fresh melanoma isolates sampled by expression of relatively high, intermediate and low levels of miR-768-3p as shown in <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/onc2013237#Fig3">Figure 3d</a> were subjected to western blot analysis of eIF4E and GAPDH (as a loading control). The data shown are representative of three individual western blot analyses.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/onc2013237/figures/4" data-track-dest="link:Figure4 Full size image" aria-label="Full size image figure 4" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-chevron-right"></use></svg></a></div></figure></div><p>To verify that miR-768-3p targets eIF4E, we introduced luciferase reporter plasmids of the 3′-UTR of eIF4E into Mel-RM cells and HEMn-MP melanocytes (<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/onc2013237#Fig4">Figure 4b</a> and <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/onc2013237#MOESM47">Supplementary Figure 2</a>). The reporter activity was markedly suppressed by the presence of the 3′-UTR of eIF4E in HEMn-MP, and to a lesser extent in Mel-RM cells, which was however reversed when the 3′-UTR was mutated (<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/onc2013237#Fig4">Figure 4b</a>), suggesting that the 3′-UTR of eIF4E was inhibited by endogenous miR-768-3p. In support, cointroduction of anti-miR-768-3p into Mel-RM and HEMn-MP cells increased (<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/onc2013237#Fig4">Figure 4c</a>), whereas the addition of miR-768-3p mimics further reduced the reporter activity (<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/onc2013237#Fig4">Figure 4d</a>). Therefore, miR-768-3p targets the 3′-UTR of eIF4E in both melanoma cells and melanocytes. The fragment of DNA cloned into luciferase reporter plasmids was indeed present at the endogenous 3′-UTR of eIF4E in Mel-RM and HEMn-MP cells as verified by polymerase chain reaction (PCR) analysis (<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/onc2013237#MOESM47">Supplementary Figures 2 and 3</a>).</p><p>Introduction of miR-768-3p mimics into Mel-RM cells downregulated the endogenous eIF4E protein levels, whereas introduction of anti-miR-768-3p into HEMn-MP resulted in an increase in the eIF4E protein expression (<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/onc2013237#Fig4">Figure 4e</a>). These results substantiate that eIF4E is a <i>bona fide</i> target of miR-768-3p that is downregulated in melanoma cells. The endogenous levels of another two predicted miR-768-3p targets, Bcl-2 and ATF6, were not affected by the introduction of miR-768-3p mimics or anti-miR-768-3p (<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/onc2013237#MOESM47">Supplementary Figure 4</a>), suggesting that suppression of eIF4E by miR-768-3p is highly selective in melanoma cells.</p><p>We also examined representative fresh melanoma isolates sampled by relatively low (<i>n</i>=3), intermediate (<i>n</i>=3) and high (<i>n</i>=3) levels of miR-768-3p for the expression of eIF4E. The results showed that melanomas with low miR-768-3p expression displayed relatively high levels of eIF4E, whereas intermediate and high miR-768-3p expression associated with progressively less eIF4E (<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/onc2013237#Fig4">Figure 4f</a>). Therefore, the inhibitory effect of miR-768-3p on eIF4E <i>in vivo</i> is in accordance with the regulatory model identified <i>in vitro</i> (<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/onc2013237#Fig4">Figures 4c–f</a>).</p><h3 class="c-article__sub-heading" id="Sec6">Downregulation of miR-768-3p contributes to increased nascent protein synthesis</h3><p>Having established the role of miR-768-3p in the suppression of eIF4E, we examined whether it is involved in increased nascent protein synthesis in melanoma cells. Introduction of miR-768-3p into Mel-RM and Mel-CV cells led to decreased global protein production (<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/onc2013237#Fig5">Figure 5a</a>), which recapitulated the effect of knockdown of eIF4E (<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/onc2013237#Fig1">Figure 1g</a>). In contrast, introduction of anti-miR-768-3p into HEMn-MP melanocytes resulted in increased nascent protein synthesis, which could be abolished by the cointroduction of eIF4E siRNA (<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/onc2013237#Fig5">Figures 5b and c</a>). These results indicate that downregulation of miR-768-3p has an important role in increased protein synthesis in melanoma cells through the upregulation of eIF4E.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-5" data-title="Figure 5"><figure><figcaption><b id="Fig5" class="c-article-section__figure-caption" data-test="figure-caption-text">Figure 5</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/onc2013237/figures/5" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fonc.2013.237/MediaObjects/41388_2014_Article_BFonc2013237_Fig5_HTML.jpg?as=webp"><img aria-describedby="Fig5" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fonc.2013.237/MediaObjects/41388_2014_Article_BFonc2013237_Fig5_HTML.jpg" alt="figure 5" loading="lazy" width="685" height="193"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-5-desc"><p>MiR-768-3p regulates nascent protein synthesis. (<b>a</b>) Mel-RM and Mel-CV cells were transfected with scrambled or miR-768-3p mimics. After 24 h, cells were subjected to measurement of nascent protein synthesis using the Click-iT protein synthesis assay kit by flow cytometry. The MFI of each sample was normalized against the corresponding sample without labelling with the metabolic labelling reagent. The relative magnitude of nascent protein synthesis in cells from each line transfected with the control scramble was arbitrarily designated as 1. The data shown are mean±s.e. of three individual experiments. (<b>b</b>) HEMn-MP melanocytes were co-transfected with scrambled or anti-miR-768-3p oligonucleotides and the control or eIF4E siRNA. After 24 h, cells were subjected to measurement of nascent protein synthesis using the Click-iT protein synthesis assay kit by flow cytometry. The MFI of each sample was normalized against the corresponding sample without labelling with the metabolic labelling reagent. The relative magnitude of nascent protein synthesis in cells co-transfected with scrambled oligonucleotides and the control siRNA was arbitrarily designated as 1. The data shown are mean±s.e. of three individual experiments. (<b>c</b>) HEMn-MP melanocytes were co-transfected with scrambled or anti-miR-768-3p oligonucleotides and the control or eIF4E siRNA. After 24 h, whole-cell lysates were subjected to western blot analysis of eIF4E and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (as a loading control). The data shown are representative of three individual western blot analyses.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/onc2013237/figures/5" data-track-dest="link:Figure5 Full size image" aria-label="Full size image figure 5" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-chevron-right"></use></svg></a></div></figure></div><h3 class="c-article__sub-heading" id="Sec7">MiR-768-3p is responsive to the MEK/ERK pathway</h3><p>The MEK/ERK pathway that has an important role in the regulation of mRNA translation is constitutively activated in the majority of melanomas.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 28" title="Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S et al. Mutations of the BRAF gene in human cancer. Nature 2002; 417: 949–954." href="/articles/onc2013237#ref-CR28" id="ref-link-section-d147300684e1189">28</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 29" title="Platz A, Egyhazi S, Ringborg U, Hansson J . Human cutaneous melanoma; a review of NRAS and BRAF mutation frequencies in relation to histogenetic subclass and body site. Mol Oncol 2008; 1: 395–405." href="/articles/onc2013237#ref-CR29" id="ref-link-section-d147300684e1192">29</a></sup> We therefore examined whether miR-768-3p is involved in MEK/ERK-mediated regulation of protein synthesis in melanoma cells. Comparison of miRNA expression profiles in Mel-CV (BRAF<sup>V600E</sup>) cells before and after treatment with the mutant BRAF inhibitor PLX4720 showed that an increase in miR-768-3p (<span class="stix">∼</span>8-fold) was among the most significant changes in miRNA expression (<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/onc2013237#Fig6">Figure 6a</a> and <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/onc2013237#MOESM47">Supplementary Table 2</a>). This was confirmed in a panel of BRAF<sup>V600E</sup> melanoma cell lines (<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/onc2013237#Fig6">Figure 6b</a>). Similarly, treatment with the MEK inhibitor U0126 caused increases in miR-768-3p in both BRAF<sup>V600E</sup> and wild-type BRAF melanoma cell lines (<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/onc2013237#Fig6">Figure 6c</a>). These results suggest that the MEK/ERK pathway has an important role in the suppression of miR-768-3p in melanoma cells.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-6" data-title="Figure 6"><figure><figcaption><b id="Fig6" class="c-article-section__figure-caption" data-test="figure-caption-text">Figure 6</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/onc2013237/figures/6" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fonc.2013.237/MediaObjects/41388_2014_Article_BFonc2013237_Fig6_HTML.jpg?as=webp"><img aria-describedby="Fig6" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fonc.2013.237/MediaObjects/41388_2014_Article_BFonc2013237_Fig6_HTML.jpg" alt="figure 6" loading="lazy" width="685" height="914"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-6-desc"><p>MiR-768-3p is responsive to the MEK/ERK pathway. (<b>a</b>) Total miRNA from Mel-CV cells (BRAF<sup>V600E</sup>) with or without treatment with PLX4720 (5 μm) for 24 h was subjected to miRNA expression profiling using TaqMan low-density array. The average abundance of miR-768-3p in cells without treatment was arbitrarily designated as 1. The data shown are mean±s.e. of three individual experiments. (<b>b</b>) Total miRNA from cells of a panel of BRAF<sup>V600E</sup> melanoma cell lines with or without treatment with PLX4720 (5 μm) as indicated was subjected to qPCR analysis of miR-768-3p expression. The average abundance of miR-768-3p in cells of each line without treatment was arbitrarily designated as 1. The data shown are mean±s.e. of three individual experiments. (<b>c</b>) Total miRNA from cells of a panel of melanoma cell lines with different BRAF mutational status as indicated with or without treatment with U0126 (20 μm) was subjected to qPCR analysis of miR-768-3p expression. The average abundance of miR-768-3p in cells of each line without treatment was arbitrarily designated as 1. The data shown are mean±s.e. of three individual experiments. (<b>d</b>) Left panel: Mel-CV cells with or without treatment with PLX4720 (5 μm) or U0126 (20 μm) for indicated periods were subjected to measurement of nascent protein synthesis using the Click-iT protein synthesis assay kit by flow cytometry. The MFI of each sample was normalized against the corresponding sample without labelling with the metabolic labelling reagent. The relative magnitude of nascent protein synthesis in cells without treatment was arbitrarily designated as 1. Right panel: Mel-RM cells with or without treatment with U0126 (20 μm) for 24 h were subjected to measurement of nascent protein synthesis using the Click-iT protein synthesis assay kit by flow cytometry. The relative magnitude of nascent protein synthesis in cells without treatment was arbitrarily designated as 1. The data shown are mean±s.e. of three individual experiments. (<b>e</b>) Left panel: Mel-CV cells were transfected with scrambled or anti-miR-768-3p oligonucleotides. After 24 h, cells were treated with PLX4720 (5 μm) or U0126 (20 μm) for a further 24 h. Cells were then subjected to measurement of nascent protein synthesis using the Click-iT protein synthesis assay kit by flow cytometry. The MFI of each sample was normalized against the corresponding sample without labelling with the metabolic labelling reagent. The relative magnitude of nascent protein synthesis in Mel-CV cells transfected with scrambles without treatment was arbitrarily designated as 1. Right panel: Mel-RM cells were transfected with scrambled or anti-miR-768-3p oligonucleotides. After 24 h, cells were treated with U0126 (20 μm) for a further 24 h. Cells were then subjected to measurement of nascent protein synthesis using the Click-iT protein synthesis assay kit by flow cytometry. The MFI of each sample was normalized against the corresponding sample without labelling with the metabolic labelling reagent. The relative magnitude of nascent protein synthesis in Mel-RM cells transfected with scramble without treatment was arbitrarily designated as 1. The data shown are mean±s.e. of three individual experiments. (<b>f</b>) Upper panel: Mel-CV cells were co-transfected with scrambled or anti-miR-768-3p oligonucleotides and the control or eIF4E siRNA. After 24 h, cells were treated with PLX4720 (5 μm) or U0126 (20 μm) for a further 24 h. Cells were then subjected to measurement of nascent protein synthesis using the Click-iT protein synthesis assay kit by flow cytometry. The MFI of each sample was normalized against the corresponding sample without labelling with the metabolic labelling reagent. The relative magnitude of nascent protein synthesis in Mel-CV cells transfected with scramble and the control siRNA without treatment was arbitrarily designated as 1. Lower panel: Mel-RM cells were co-transfected with scrambled or anti-miR-768-3p oligonucleotides and the control or eIF4E siRNA. After 24 h, cells were treated with U0126 (20 μm) for a further 24 h. Cells were then subjected to measurement of nascent protein synthesis using the Click-iT protein synthesis assay kit by flow cytometry. The MFI of each sample was normalized against the corresponding sample without labelling with the metabolic labelling reagent. The relative magnitude of nascent protein synthesis in Mel-RM cells transfected with scramble and the control siRNA without treatment was arbitrarily designated as 1. The data shown are mean±s.e. of three individual experiments. (<b>g</b>) Whole-cell lysates from Mel-CV cells with or without treatment with PLX4720 (5 μm) or U0126 (20 μm) for 24 h and Mel-RM cells with or without treatment with U0126 (20 μm) for 24 h were subjected to western blot analysis of phosphorylated eIF4E (p-eIF4E), eIF4E, phosphorylated ERK (p-ERK) and ERK. The data shown are representative of three individual experiments.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/onc2013237/figures/6" data-track-dest="link:Figure6 Full size image" aria-label="Full size image figure 6" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-chevron-right"></use></svg></a></div></figure></div><p>PLX4720 inhibited nascent protein production in BRAF<sup>V600E</sup> melanoma cells, whereas U0126 in both BRAF<sup>V600E</sup> and wild-type BRAF melanoma cells (<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/onc2013237#Fig6">Figure 6d</a>). However, this inhibition was partially reversed in cells introduced with anti-miR-768-3p (<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/onc2013237#Fig6">Figure 6e</a>), which in part recapitulated the inhibitory effect on protein synthesis afforded by knockdown of eIF4E (<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/onc2013237#Fig1">Figures 1g</a> and <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/onc2013237#Fig6">6f</a>), indicating that suppression of miR-768-3p and subsequent upregulation of eIF4E is involved in enhancement of mRNA translation mediated by MEK/ERK. Taken together, results from the above studies identify a novel MEK/ERK-dependent, miR-768-3p-mediated signalling pathway that contributes to increased nascent protein synthesis in melanoma cells. As anticipated, PLX4720 downregulated the levels of phosphorylated eIF4E in Mel-CV (BRAF<sup>V600E</sup>) cells, whereas U0126 in both Mel-CV and Mel-RM (wild-type BRAF) cells (<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/onc2013237#Fig6">Figure 6g</a>). However, the kinetics of inhibition of eIF4E phosphorylation by PLX4720 and U0126 was more rapid than their inhibitory effects on the expression of eIF4E. Therefore, activation of MEK/ERK promotes mRNA translation by impinging on both eIF4E expression and its phosphorylation in a biphasic manner.</p><h3 class="c-article__sub-heading" id="Sec8">MiR-768-3p inhibits melanoma cell proliferation and survival</h3><p>Although introduction of miR-768-3p mimics, alike knockdown of eIF4E, triggered apoptosis in a proportion of Mel-RM and Mel-CV cells (<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/onc2013237#Fig7">Figures 7a–c</a>), inhibition of cell proliferation appeared to be the predominant consequence as shown in 5-bromo-2′-deoxyuridine (BrdU) incorporation and clonogenic assays (<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/onc2013237#Fig7">Figure 7d</a>). In addition, cointroduction of miR-768-3p mimics and eIF4E siRNA further enhanced inhibition of cell survival and proliferation (<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/onc2013237#Fig7">Figure 7e</a>). On the other hand, the inhibitory effect of miR-768-3p on cell proliferation was abolished in Mel-RM and Mel-CV cells overexpressing eIF4E (<a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/onc2013237#Fig7">Figure 7f</a>). Therefore, downregulation of miR-768-3p contributes to melanoma cell survival and proliferation by impinging on the expression of eIF4E.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-7" data-title="Figure 7"><figure><figcaption><b id="Fig7" class="c-article-section__figure-caption" data-test="figure-caption-text">Figure 7</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/onc2013237/figures/7" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fonc.2013.237/MediaObjects/41388_2014_Article_BFonc2013237_Fig7_HTML.jpg?as=webp"><img aria-describedby="Fig7" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fonc.2013.237/MediaObjects/41388_2014_Article_BFonc2013237_Fig7_HTML.jpg" alt="figure 7" loading="lazy" width="685" height="708"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-7-desc"><p>MiR-768-3p inhibits melanoma cell proliferation and survival. (<b>a</b>) Mel-RM and Mel-CV cells were transfected with scrambled or miR-768-3p mimics. After 48 h, cells were subjected to quantitation of apoptosis by measurement of sub-G1 DNA content. The data shown are mean±s.e. of three individual experiments. (<b>b</b>) Mel-RM and Mel-CV cells were transfected with scrambled or miR-768-3p mimics. After 48 h, whole-cell lysates were subjected to western blot analysis of caspase-3, poly (ADP-ribose) polymerase (PARP) and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (as a loading control). The data shown are representative of three individual experiments. (<b>c</b>) Mel-RM and Mel-CV cells were transfected with the control or eIF4E siRNA. After 48 h, cells were subjected to quantitation of apoptosis by measurement of sub-G1 DNA content. The data shown are mean±s.e. of three individual experiments. (<b>d</b>) Left panel: Mel-RM and Mel-CV cells were transfected with scrambled or miR-768-3p mimics. After 48 h, cells were subjected to proliferation assays using the BrdU incorporation method. The data shown are mean±s.e. of three individual experiments. Right panel: Mel-RM and Mel-CV cells were transfected with scrambled or miR-768-3p mimics. After 24 h, viable cells (2000 cells per well in 6-well plates) were allowed to grow for 12 days before being fixed with methanol and stained with crystal violet. The data shown are representative of three individual experiments. (<b>e</b>) Upper panel: Mel-RM and Mel-CV cells were co-transfected with scrambled or miR-768-3p mimics and the control or eIF4E siRNA. After 48 h, cells were subjected to quantitation of apoptosis by measurement of sub-G1 DNA content. Lower panel: Mel-RM and Mel-CV cells were co-transfected with scrambled or miR-768-3p mimics and the control or eIF4E siRNA. After 48 h later, cells were subjected to proliferation assays using the BrdU incorporation method. The data shown are mean±s.e. of three individual experiments. (<b>f</b>) Upper panel: Mel-RM and Mel-CV cells were co-transfected with scrambled or miR-768-3p mimics and vector alone or eIF4E cDNA. After 48 h, cells were subjected to proliferation assays using the BrdU incorporation method. The data shown are mean±s.e. of three individual experiments. Lower panel: Mel-RM and Mel-CV cells were co-transfected with miR-768-3p mimics and vector alone or eIF4E cDNA. After 48 h, whole-cell lysates were subjected to western blot analysis of eIF4E and GAPDH (as a loading control). The data shown are representative of three individual experiments. Mel-JR and Mel-BE fresh melanoma isolates were transfected with scrambles or miR-768-3p mimics. After 48 h, cells were subjected to proliferation assays using the BrdU incorporation method. The data shown are mean±s.e. of three individual experiments.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/onc2013237/figures/7" data-track-dest="link:Figure7 Full size image" aria-label="Full size image figure 7" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-chevron-right"></use></svg></a></div></figure></div><p>To exclude possible off-target effects of the massive increase (a more than 15 000-fold increase in Mel-RM cells) in miR-768-3p expression, resulting from the introduction of miR-768-3p mimics, we introduced an miR-768-3p precursor-expressing construct into Mel-RM and Mel-CV cells. This led to a 24- and 34-fold increase in miR-768-3p in Mel-RM and Mel-CV cells, respectively (<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/onc2013237#MOESM47">Supplementary Figure 5</a>). Introduction of the construct caused apoptosis and inhibition of proliferation to a similar extent to that triggered by miR-768-3p mimics (<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/onc2013237#MOESM47">Supplementary Figure 5</a>), suggesting that the effect of miR-768-3p on melanoma cell survival and proliferation is specific.</p><p>To further validate the role of miR-768-3p in melanoma cell survival and proliferation, we introduced miR-768-3p mimics into two fresh metastatic melanoma isolates, Mel-JR and Mel-BE. As shown in <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/onc2013237#Fig7">Figure 7g</a>, introduction of miR-768-3p mimics also resulted in reduced proliferation rates of these fresh melanoma isolates, which may reflect more closely melanoma cell responses to altered miR-768-3p expression <i>in vivo</i>.</p></div></div></section><section data-title="Discussion"><div class="c-article-section" id="Sec9-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec9">Discussion</h2><div class="c-article-section__content" id="Sec9-content"><p>In this report, we present evidence that miR-768-3p has an important role in inhibiting eIF4E expression and mRNA translation, and in regulating melanoma cell proliferation and survival. While its expression is commonly reduced in cultured melanoma cells and fresh melanoma isolates, introduction of exogenous miR-768-3p into melanoma cells resulted in the downregulation of eIF4E and reduction in nascent protein synthesis. This was associated with inhibition of cell proliferation and survival. Our results also reveal that downregulation of miR-768-3p in melanoma cells is mediated by activation of the MEK/ERK pathway.</p><p>Cancer cells require greater protein synthesis output to sustain their malignancy.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 1" title="Silvera D, Formenti SC, Schneider RJ . Translational control in cancer. Nat Rev Cancer 2010; 10: 254–266." href="/articles/onc2013237#ref-CR1" id="ref-link-section-d147300684e1371">1</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 2" title="Bilanges B, Stokoe D . Mechanisms of translational deregulation in human tumors and therapeutic intervention strategies. Oncogene 2007; 26: 5973–5990." href="/articles/onc2013237#ref-CR2" id="ref-link-section-d147300684e1374">2</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 3" title="Grzmil M, Hemmings BA . Translation regulation as a therapeutic target in cancer. Cancer Res 2012; 72: 3891–3900." href="/articles/onc2013237#ref-CR3" id="ref-link-section-d147300684e1377">3</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 4" title="Bitterman PB, Polunovsky VA . Translational control of cell fate: from integration of environmental signals to breaching anticancer defense. Cell Cycle 2012; 11: 1097–1107." href="/articles/onc2013237#ref-CR4" id="ref-link-section-d147300684e1380">4</a></sup> Consistent with this, we found that global mRNA translation and nascent protein production were increased in melanoma cells compared with melanocytes. Although we did not examine the translation rate of any particular mRNA, it is conceivable that translation of mRNAs encoding cancer-promoting proteins are accelerated in melanoma cells, as the increase in global protein synthesis is associated with an increase in the expression of eIF4E. While the latter is known to have the potential to mediate translation of almost every mRNA, its overexpression preferentially stimulates synthesis of a number of proteins that are associated with cancers such as c-MYC, cyclin-D1 and VEGF.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 1" title="Silvera D, Formenti SC, Schneider RJ . Translational control in cancer. Nat Rev Cancer 2010; 10: 254–266." href="/articles/onc2013237#ref-CR1" id="ref-link-section-d147300684e1384">1</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 38" title="Rosenwald IB, Rhoads DB, Callanan LD, Isselbacher KJ, Schmidt EV . Increased expression of eukaryotic translation initiation factors eIF-4E and eIF-2 alpha in response to growth induction by c-myc. Proc Natl Acad Sci USA 1993; 90: 6175–6178." href="/articles/onc2013237#ref-CR38" id="ref-link-section-d147300684e1387">38</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 39" title="Mamane Y, Petroulakis E, Martineau Y, Sato TA, Larsson O, Rajasekhar VK et al. Epigenetic activation of a subset of mRNAs by eIF4E explains its effects on cell proliferation. PLoS One 2007; 2: e242." href="/articles/onc2013237#ref-CR39" id="ref-link-section-d147300684e1390">39</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 40" title="Rosenwald IB, Lazaris-Karatzas A, Sonenberg N, Schmidt EV . Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor 4E. Mol Cell Biol 1993; 13: 7358–7363." href="/articles/onc2013237#ref-CR40" id="ref-link-section-d147300684e1393">40</a></sup> mRNAs encoding these proteins have highly structured 5′-UTRs, which result in their translation repression under normal conditions.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 1" title="Silvera D, Formenti SC, Schneider RJ . Translational control in cancer. Nat Rev Cancer 2010; 10: 254–266." href="/articles/onc2013237#ref-CR1" id="ref-link-section-d147300684e1397">1</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 41" title="Koromilas AE, Lazaris-Karatzas A, Sonenberg N . mRNAs containing extensive secondary structure in their 5′ non-coding region translate efficiently in cells overexpressing initiation factor eIF-4E. EMBO J 1992; 11: 4153–4158." href="/articles/onc2013237#ref-CR41" id="ref-link-section-d147300684e1400">41</a></sup> Nevertheless, these mRNAs respond more efficiently to elevated eIF4E.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 1" title="Silvera D, Formenti SC, Schneider RJ . Translational control in cancer. Nat Rev Cancer 2010; 10: 254–266." href="/articles/onc2013237#ref-CR1" id="ref-link-section-d147300684e1404">1</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 38" title="Rosenwald IB, Rhoads DB, Callanan LD, Isselbacher KJ, Schmidt EV . Increased expression of eukaryotic translation initiation factors eIF-4E and eIF-2 alpha in response to growth induction by c-myc. Proc Natl Acad Sci USA 1993; 90: 6175–6178." href="/articles/onc2013237#ref-CR38" id="ref-link-section-d147300684e1407">38</a></sup> Indeed, c-MYC, cyclin-D1 and VEGF have all been reported to increase in expression in melanoma compared with nevus tissues.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 38" title="Rosenwald IB, Rhoads DB, Callanan LD, Isselbacher KJ, Schmidt EV . Increased expression of eukaryotic translation initiation factors eIF-4E and eIF-2 alpha in response to growth induction by c-myc. Proc Natl Acad Sci USA 1993; 90: 6175–6178." href="/articles/onc2013237#ref-CR38" id="ref-link-section-d147300684e1411">38</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 39" title="Mamane Y, Petroulakis E, Martineau Y, Sato TA, Larsson O, Rajasekhar VK et al. Epigenetic activation of a subset of mRNAs by eIF4E explains its effects on cell proliferation. PLoS One 2007; 2: e242." href="/articles/onc2013237#ref-CR39" id="ref-link-section-d147300684e1414">39</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 40" title="Rosenwald IB, Lazaris-Karatzas A, Sonenberg N, Schmidt EV . Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor 4E. Mol Cell Biol 1993; 13: 7358–7363." href="/articles/onc2013237#ref-CR40" id="ref-link-section-d147300684e1417">40</a></sup></p><p>In experimental systems, overexpression of eIF4E promotes cancer development and progression, whereas inhibition of eIF4E suppresses malignancy.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 42" title="Lazaris-Karatzas A, Montine KS, Sonenberg N . Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5′ cap. Nature 1990; 345: 544–547." href="/articles/onc2013237#ref-CR42" id="ref-link-section-d147300684e1423">42</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 43" title="Lazaris-Karatzas A, Sonenberg N . The mRNA 5′ cap-binding protein, eIF-4E, cooperates with v-myc or E1A in the transformation of primary rodent fibroblasts. Mol Cell Biol 1992; 12: 1234–1238." href="/articles/onc2013237#ref-CR43" id="ref-link-section-d147300684e1426">43</a></sup> Consistently, the expression of eIF4E is increased in many types of cancers including melanoma <i>in vivo</i>,<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 13" title="Yang SX, Hewitt SM, Steinberg SM, Liewehr DJ, Swain SM . Expression levels of eIF4E, VEGF, and cyclin D1, and correlation of eIF4E with VEGF and cyclin D1 in multi-tumor tissue microarray. Oncol Rep 2007; 17: 281–287." href="/articles/onc2013237#ref-CR13" id="ref-link-section-d147300684e1433">13</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 14" title="Coleman LJ, Peter MB, Teall TJ, Brannan RA, Hanby AM, Honarpisheh H et al. Combined analysis of eIF4E and 4E-binding protein expression predicts breast cancer survival and estimates eIF4E activity. Br J Cancer 2009; 100: 1393–1399." href="/articles/onc2013237#ref-CR14" id="ref-link-section-d147300684e1436">14</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 15" title="De Benedetti A, Graff JR . eIF-4E expression and its role in malignancies and metastases. Oncogene 2004; 23: 3189–3199." href="/articles/onc2013237#ref-CR15" id="ref-link-section-d147300684e1439">15</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 44" title="Graff JR, Konicek BW, Carter JH, Marcusson EG . Targeting the eukaryotic translation initiation factor 4E for cancer therapy. Cancer Res 2008; 68: 631–634." href="/articles/onc2013237#ref-CR44" id="ref-link-section-d147300684e1442">44</a></sup> which is commonly correlated with disease progression and poor prognosis of patients, and is associated with resistance to therapeutic agents.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 13" title="Yang SX, Hewitt SM, Steinberg SM, Liewehr DJ, Swain SM . Expression levels of eIF4E, VEGF, and cyclin D1, and correlation of eIF4E with VEGF and cyclin D1 in multi-tumor tissue microarray. Oncol Rep 2007; 17: 281–287." href="/articles/onc2013237#ref-CR13" id="ref-link-section-d147300684e1446">13</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 14" title="Coleman LJ, Peter MB, Teall TJ, Brannan RA, Hanby AM, Honarpisheh H et al. Combined analysis of eIF4E and 4E-binding protein expression predicts breast cancer survival and estimates eIF4E activity. Br J Cancer 2009; 100: 1393–1399." href="/articles/onc2013237#ref-CR14" id="ref-link-section-d147300684e1449">14</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 15" title="De Benedetti A, Graff JR . eIF-4E expression and its role in malignancies and metastases. Oncogene 2004; 23: 3189–3199." href="/articles/onc2013237#ref-CR15" id="ref-link-section-d147300684e1452">15</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 44" title="Graff JR, Konicek BW, Carter JH, Marcusson EG . Targeting the eukaryotic translation initiation factor 4E for cancer therapy. Cancer Res 2008; 68: 631–634." href="/articles/onc2013237#ref-CR44" id="ref-link-section-d147300684e1455">44</a></sup> However, although it is well known that the eIF4E activity is regulated by its availability and phosphorylation, the mechanisms responsible for its upregulation remain less understood. We found in this study that the eIF4E protein was increased to a noticeably greater degree than its transcript in melanoma cells compared with melanocytes (<span class="stix">∼</span>6 vs<span class="stix">∼</span>1.6 times), and that the stability of the protein and transcript remained similar between the two types of cells, suggesting that the increase in eIF4E is primarily mediated by translational regulation. We were thus promoted to explore the potential role of miRs in the regulation of eIF4E expression and identified downregulation of miR-768-3p as an important mechanism responsible for the upregulation of eIF4E in melanoma cells.</p><p>As miR-768-3p is located within the sequence of the small nucleolar RNA HBII-239,<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 34" title="Valleron W, Ysebaert L, Berquet L, Fataccioli V, Quelen C, Martin A et al. Small nucleolar RNA expression profiling identifies potential prognostic markers in peripheral T-cell lymphoma. Blood 2012; 120: 3997–4005." href="/articles/onc2013237#ref-CR34" id="ref-link-section-d147300684e1462">34</a></sup> its existence as an miR has been challenged and its entry has been removed from miRBASE. However, we found that miR-768-3p was associated with Ago proteins, a core component of the RNA-induced silencing complex, to the same extent as miR-221, a well-established miR that is increased in melanoma cells, indicating that miR-768-3p possesses the characteristics of a functional miR in melanoma cells.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 36" title="Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA 2011; 108: 5003–5008." href="/articles/onc2013237#ref-CR36" id="ref-link-section-d147300684e1466">36</a></sup> In support, it has been recently reported that miRs could be generated by small nucleolar RNA.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 35" title="Miyoshi K, Miyoshi T, Siomi H . Many ways to generate microRNA-like small RNAs: non-canonical pathways for microRNA production. Mol Genet Genom 2010; 284: 95–103." href="/articles/onc2013237#ref-CR35" id="ref-link-section-d147300684e1470">35</a></sup> It is conceivable that miR-768-3p is processed into a mature miR through a non-canonical miR biogenesis pathway as proposed by others.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 35" title="Miyoshi K, Miyoshi T, Siomi H . Many ways to generate microRNA-like small RNAs: non-canonical pathways for microRNA production. Mol Genet Genom 2010; 284: 95–103." href="/articles/onc2013237#ref-CR35" id="ref-link-section-d147300684e1474">35</a></sup></p><p>The expression and functional importance of miRs in melanoma have been studied extensively in recent years.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 21" title="Felicetti F, Errico MC, Bottero L, Segnalini P, Stoppacciaro A et al. The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms. Cancer Res 2008; 68: 2745–2754." href="/articles/onc2013237#ref-CR21" id="ref-link-section-d147300684e1481">21</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 22" title="Jin L, Hu WL, Jiang CC, Wang JX, Han CC, Chu P et al. MicroRNA-149*, a p53-responsive microRNA, functions as an oncogenic regulator in human melanoma. Proc Natl Acad Sci USA 2011; 108: 15840–15845." href="/articles/onc2013237#ref-CR22" id="ref-link-section-d147300684e1484">22</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 23" title="Bonazzi VF, Stark MS, Hayward NK . MicroRNA regulation of melanoma progression. Melanoma Res 2012; 22: 101–113." href="/articles/onc2013237#ref-CR23" id="ref-link-section-d147300684e1487">23</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 24" title="Mueller DW, Bosserhoff AK . The evolving concept of ‘melano-miRs’-microRNAs in melanomagenesis. Pigment Cell Melanoma Res 2010; 23: 620–626." href="/articles/onc2013237#ref-CR24" id="ref-link-section-d147300684e1490">24</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 25" title="Wilmott JS, Zhang XD, Hersey P, Scolyer RA . The emerging important role of microRNAs in the pathogenesis, diagnosis and treatment of human cancers. Pathology 2011; 43: 657–671." href="/articles/onc2013237#ref-CR25" id="ref-link-section-d147300684e1493">25</a></sup> Not only a number of miRs such as miR-211 have been found to be differentially expressed between melanocytes and melanoma cells<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 23" title="Bonazzi VF, Stark MS, Hayward NK . MicroRNA regulation of melanoma progression. Melanoma Res 2012; 22: 101–113." href="/articles/onc2013237#ref-CR23" id="ref-link-section-d147300684e1497">23</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 25" title="Wilmott JS, Zhang XD, Hersey P, Scolyer RA . The emerging important role of microRNAs in the pathogenesis, diagnosis and treatment of human cancers. Pathology 2011; 43: 657–671." href="/articles/onc2013237#ref-CR25" id="ref-link-section-d147300684e1500">25</a></sup> but also changes in the expression of a number of miRs have been demonstrated to be associated with melanoma progression and invasion.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 23" title="Bonazzi VF, Stark MS, Hayward NK . MicroRNA regulation of melanoma progression. Melanoma Res 2012; 22: 101–113." href="/articles/onc2013237#ref-CR23" id="ref-link-section-d147300684e1504">23</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 24" title="Mueller DW, Bosserhoff AK . The evolving concept of ‘melano-miRs’-microRNAs in melanomagenesis. Pigment Cell Melanoma Res 2010; 23: 620–626." href="/articles/onc2013237#ref-CR24" id="ref-link-section-d147300684e1507">24</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 25" title="Wilmott JS, Zhang XD, Hersey P, Scolyer RA . The emerging important role of microRNAs in the pathogenesis, diagnosis and treatment of human cancers. Pathology 2011; 43: 657–671." href="/articles/onc2013237#ref-CR25" id="ref-link-section-d147300684e1510">25</a></sup> We have also previously shown that miR-149* protects against apoptosis by stabilizing Mcl-1 via targeting glycogen synthase kinase 3α (GSK3α) in melanoma cells under endoplasmic reticulum stress.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 22" title="Jin L, Hu WL, Jiang CC, Wang JX, Han CC, Chu P et al. MicroRNA-149*, a p53-responsive microRNA, functions as an oncogenic regulator in human melanoma. Proc Natl Acad Sci USA 2011; 108: 15840–15845." href="/articles/onc2013237#ref-CR22" id="ref-link-section-d147300684e1514">22</a></sup> Although inhibition of mRNA translation is a common mechanism by which an miR regulates its target gene expression,<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 16" title="He L, Hannon GJ . 2004. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004; 5: 522–531." href="/articles/onc2013237#ref-CR16" id="ref-link-section-d147300684e1518">16</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 17" title="Iorio MV, Croce CM . MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol 2009; 27: 5848–5856." href="/articles/onc2013237#ref-CR17" id="ref-link-section-d147300684e1521">17</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 18" title="Humphreys DT, Westman BJ, Martin DI, Preiss T . MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function. Proc Natl Acad Sci USA 2005; 102: 16961–16966." href="/articles/onc2013237#ref-CR18" id="ref-link-section-d147300684e1524">18</a></sup> our results reveal that miR-768-3p inhibits global protein synthesis by targeting eIF4E in melanoma cells. Targeting eIF4E by miR-768-3p appeared to be highly selective, in that the expression of Bcl-2 and ATF6, both of which are predicted targets of miR-768-3p, did not respond to overexpression or inhibition of miR-768-3p. Regulation of target expression by miRs is known to be tissue- and cell type-specific.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 17" title="Iorio MV, Croce CM . MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol 2009; 27: 5848–5856." href="/articles/onc2013237#ref-CR17" id="ref-link-section-d147300684e1529">17</a></sup></p><p>The expression of miRs can be regulated by diverse mechanisms. These include genetic alterations, epigenetic changes and transcription factor-mediated transactivation or repression.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 17" title="Iorio MV, Croce CM . MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol 2009; 27: 5848–5856." href="/articles/onc2013237#ref-CR17" id="ref-link-section-d147300684e1535">17</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 20" title="Lujambio A, Lowe SW . The microcosmos of cancer. Nature 2012; 482: 347–355." href="/articles/onc2013237#ref-CR20" id="ref-link-section-d147300684e1538">20</a></sup> Of interest, many miRs are associated with signalling pathways important for the pathogenesis of melanoma. For example, miR-221/222 has been identified as regulators of c-KIT, whereas miR-137 and miR-148 as regulators of microphthalmia-associated transcription factor.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 21" title="Felicetti F, Errico MC, Bottero L, Segnalini P, Stoppacciaro A et al. The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms. Cancer Res 2008; 68: 2745–2754." href="/articles/onc2013237#ref-CR21" id="ref-link-section-d147300684e1542">21</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 45" title="Bemis LT, Chen R, Amato CM, Classen EH, Robinson SE, Coffey DG et al. MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines. Cancer Res 2008; 68: 1362–1368." href="/articles/onc2013237#ref-CR45" id="ref-link-section-d147300684e1545">45</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 46" title="Haflidadóttir BS, Bergsteinsdóttir K, Praetorius C, Steingrímsson E . miR-148 regulates Mitf in melanoma cells. PLoS One 2010; 5: e11574." href="/articles/onc2013237#ref-CR46" id="ref-link-section-d147300684e1548">46</a></sup> In particular, it has been recently reported that a number of miRs such as miR-193a, miR-338 and miR-768-3p are subjected to regulation by oncogenic activation of MEK/ERK signalling in melanoma.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 30" title="Couts KL, Anderson EM, Gross MM, Sullivan K, Ahn NG . Oncogenic B-Raf signaling in melanoma cells controls a network of microRNAs with combinatorial functions. Oncogene 2012; 32: 1959–1970." href="/articles/onc2013237#ref-CR30" id="ref-link-section-d147300684e1552">30</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 31" title="Caramuta S, Egyházi S, Rodolfo M, Witten D, Hansson J, Larsson C et al. MicroRNA expression profiles associated with mutational status and survival in malignant melanoma. J Invest Dermatol 2010; 130: 2062–2070." href="/articles/onc2013237#ref-CR31" id="ref-link-section-d147300684e1555">31</a></sup> Our finding that suppression of miR-768-3p by MEK/ERK contributes to enhanced mRNA translation through the upregulation of eIF4E indicates that miR-768-3p is a build-in component of the MEK/ERK pathway in melanoma cells. Therefore, activation of MEK/ERK signalling enhances protein synthesis not only by phosphorylating eIF4E vial activation of MNK1 and MNK2<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 1" title="Silvera D, Formenti SC, Schneider RJ . Translational control in cancer. Nat Rev Cancer 2010; 10: 254–266." href="/articles/onc2013237#ref-CR1" id="ref-link-section-d147300684e1559">1</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 2" title="Bilanges B, Stokoe D . Mechanisms of translational deregulation in human tumors and therapeutic intervention strategies. Oncogene 2007; 26: 5973–5990." href="/articles/onc2013237#ref-CR2" id="ref-link-section-d147300684e1562">2</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 3" title="Grzmil M, Hemmings BA . Translation regulation as a therapeutic target in cancer. Cancer Res 2012; 72: 3891–3900." href="/articles/onc2013237#ref-CR3" id="ref-link-section-d147300684e1565">3</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 4" title="Bitterman PB, Polunovsky VA . Translational control of cell fate: from integration of environmental signals to breaching anticancer defense. Cell Cycle 2012; 11: 1097–1107." href="/articles/onc2013237#ref-CR4" id="ref-link-section-d147300684e1568">4</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 7" title="Phillips A, Blaydes JP . MNK1 and EIF4E are downstream effectors of MEKs in the regulation of the nuclear export of HDM2 mRNA. Oncogene 2008; 27: 1645–1649." href="/articles/onc2013237#ref-CR7" id="ref-link-section-d147300684e1571">7</a></sup> but also through the upregulation of eIF4E expression.</p><p>Of note, miR-768-3p is embedded within intron 12 of the human gene encoding adaptor-related protein complex 1, gamma 1 subunit (AP1G1),<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 47" title="Li SC, Tang P, Lin WC . Intronic MicroRNA: Discovery and biological implications. DNA Cell Biol 2007; 26: 195–207." href="/articles/onc2013237#ref-CR47" id="ref-link-section-d147300684e1578">47</a></sup> which was also increased by inhibition of MEK (<a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/onc2013237#MOESM47">Supplementary Figure 6</a>), suggesting that miR-768-3p may be regulated along with the <i>AP1G1</i> gene in response to MEK/ERK signalling. However, the exact mechanism involved and the functional significance of the regulation of APIG1 by MEK/ERK remains to be investigated. APIG1 is known to have an important role in protein transportation mediated by clathrin-coated vesicles.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 48" title="Takatsu H, Sakurai M, Shin HW, Murakami K, Nakayama K . Identification and characterization of novel clathrin adaptor-related proteins. J Biol Chem 1998; 273: 24693–24700." href="/articles/onc2013237#ref-CR48" id="ref-link-section-d147300684e1588">48</a></sup></p><p>The functional significance of miR-768-3p in melanoma was demonstrated by inhibition of cell survival and proliferation with its overexpression, which was also echoed by its downregulation in fresh melanoma isolates and the negative association between its expression levels and the levels of eIF4E. Multiple molecules conceivably contribute to the regulation of melanoma cell survival and proliferation by miR-768-3p, such as c-MYC and cyclin D1, which are sensitive to changes in the expression levels of eIF4E.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 33" title="Moerke NJ, Aktas H, Chen H, Cantel S, Reibarkh MY, Fahmy A et al. Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G. Cell 2007; 128: 257–267." href="/articles/onc2013237#ref-CR33" id="ref-link-section-d147300684e1594">33</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 38" title="Rosenwald IB, Rhoads DB, Callanan LD, Isselbacher KJ, Schmidt EV . Increased expression of eukaryotic translation initiation factors eIF-4E and eIF-2 alpha in response to growth induction by c-myc. Proc Natl Acad Sci USA 1993; 90: 6175–6178." href="/articles/onc2013237#ref-CR38" id="ref-link-section-d147300684e1597">38</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 39" title="Mamane Y, Petroulakis E, Martineau Y, Sato TA, Larsson O, Rajasekhar VK et al. Epigenetic activation of a subset of mRNAs by eIF4E explains its effects on cell proliferation. PLoS One 2007; 2: e242." href="/articles/onc2013237#ref-CR39" id="ref-link-section-d147300684e1600">39</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 40" title="Rosenwald IB, Lazaris-Karatzas A, Sonenberg N, Schmidt EV . Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor 4E. Mol Cell Biol 1993; 13: 7358–7363." href="/articles/onc2013237#ref-CR40" id="ref-link-section-d147300684e1603">40</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 41" title="Koromilas AE, Lazaris-Karatzas A, Sonenberg N . mRNAs containing extensive secondary structure in their 5′ non-coding region translate efficiently in cells overexpressing initiation factor eIF-4E. EMBO J 1992; 11: 4153–4158." href="/articles/onc2013237#ref-CR41" id="ref-link-section-d147300684e1606">41</a></sup> Targeting eIF4E is in development for clinical use in the treatment of cancer.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 3" title="Grzmil M, Hemmings BA . Translation regulation as a therapeutic target in cancer. Cancer Res 2012; 72: 3891–3900." href="/articles/onc2013237#ref-CR3" id="ref-link-section-d147300684e1610">3</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 49" title="Hong DS, Kurzrock R, Oh Y, Wheler J, Naing A, Brail L et al. A phase 1 dose escalation, pharmacokinetic, and pharmacodynamic evaluation of eIF-4E antisense oligonucleotide LY2275796 in patients with advanced cancer. Clin Cancer Res 2011; 17: 6582–6591." href="/articles/onc2013237#ref-CR49" id="ref-link-section-d147300684e1613">49</a></sup> Our results suggest that restoration of the expression of miR-768-3p may be a useful alternative strategy for inhibition of eIF4E in melanoma. As a precedent, replacement therapy has been shown to be efficacious in a mouse model of colon cancer for miR-145 and miR-33a.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 50" title="Ibrahim AF, Weirauch U, Thomas M, Grünweller A, Hartmann RK, Aigner A . MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma. Cancer Res 2011; 71: 5214–5224." href="/articles/onc2013237#ref-CR50" id="ref-link-section-d147300684e1617">50</a></sup> With continuing investigations into <i>in vivo</i> delivery systems for miRs, this approach is likely to be achievable.</p></div></div></section><section data-title="Materials and methods"><div class="c-article-section" id="Sec10-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec10">Materials and methods</h2><div class="c-article-section__content" id="Sec10-content"><h3 class="c-article__sub-heading" id="Sec11">Cell culture and reagents</h3><p>The human melanoma cell lines used have been described previously and are summarized in <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/onc2013237#MOESM47">Supplementary Table 3</a>.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 51" title="Jiang CC, Lai F, Tay KH, Croft A, Rizos H, Becker TM et al. Apoptosis of human melanoma cells induced by inhibition of B-RAFV600E involves preferential splicing of bimS. Cell Death Dis 2010; 2: 1:e69." href="/articles/onc2013237#ref-CR51" id="ref-link-section-d147300684e1639">51</a></sup> They were cultured in Dulbecco’s modified Eagle’s medium containing 5% foetal calf serum (Commonwealth Serum Laboratories, Melbourne, VIC, Australia). The melanocyte lines HEMn-MP and HEMn-DP and melanocyte culture medium (M-254) were purchased from Banksia Scientific (Bulimba, QLD, Australia). Antibodies against p-eIF4E, eIF4E, p-ERK and the eIF4E inhibitor 4EGI-1 were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Antibodies against 4E-BP1 and ERK were purchased from Cell Signalling Technology (Beverly, MA, USA). PLX4720 was provided by Plexxikon Inc. (Berkeley, CA, USA), which was dissolved in dimethylsulphoxide and made up in stock solutions of 4 m<span class="u-small-caps">M</span>. The MEK inhibitor U0126 was purchased from Promega (Madison, WI, USA). Mature hsa-miR-768-3p mimics and anti-miR-768-3p were purchased from Applied Biosystems (Mulgrave, VIC, Australia). Human fresh melanoma isolates were prepared according to a published method.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 52" title="Dong L, Jiang CC, Thorne RF, Croft A, Yang F, Liu H et al. Ets-1 mediates upregulation of Mcl-1 downstream of XBP-1 in human melanoma cells upon ER stress. Oncogene 2011; 30: 3716–3726." href="/articles/onc2013237#ref-CR52" id="ref-link-section-d147300684e1646">52</a></sup> Studies using human tissues were approved by the Human Research Ethics Committee of University of Newcastle.</p><h3 class="c-article__sub-heading" id="Sec12">Nascent protein synthesis</h3><p>Nascent protein synthesis was detected by the Click-iT protein synthesis assay kit according to the manufacturer’s instruction (Life Technologies, Mulgrave, VIC, Australia). Briefly, cells were seeded at a density of 6 × 10<sup>5</sup> per well in a 6-well plate. After 24 h, cells were washed with warm phosphate-buffered saline (PBS) and incubated with methionine-free medium for 1 h at 37 °C. Fifty micromolar metabolic labelling reagent was then added, followed by incubating at 37 °C for 3 h. Cells were then scraped off into fluorescence-activated cell sorter tubes and washed with PBS and fixed with 4% paraformaldehyde, followed by permeabilization in PBS with supplemented with 0.1% saponin and 1% bovine serum albumin for 15 min. Permeabilized cells were then incubated with Click-iT reaction cocktail (Life Technologies) for 30 min at room temperature in dark. Cells were finally stained with Alexa Fluor 488 azide, followed by flow cytometry analysis. The mean fluorescence intensity (MFI) of each sample was corrected by extracting the background MFI detected in the corresponding sample without labelling with the metabolic labelling reagent. The relative magnitude of nascent protein synthesis in each sample represented by its MFI was then normalized against the MFI of the control sample in each experiment.</p><h3 class="c-article__sub-heading" id="Sec13">Polysome profiling</h3><p>Polysome profiling was performed as reported previously.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 53" title="Blais JD, Filipenko V, Bi M, Harding HP, Ron D, Koumenis C et al. Activating transcription factor 4 is translationally regulated by hypoxic stress. Mol Cell Biol 2004; 24: 7469–7482." href="/articles/onc2013237#ref-CR53" id="ref-link-section-d147300684e1668">53</a></sup> Briefly, cells were seeded at a density of 7.5 × 10<sup>6</sup> cells in a T150 flask. After 24 h, cells were washed with PBS and incubated in 0.1 mg/ml cycloheximide (Sigma-Aldrich, Castle Hill, NSW, Australia) in PBS for 3 min at 37 °C. Cells were washed two times with PBS containing CHX (0.1 mg/ml) and lysed in RNA lysis buffer. Nuclei were subsequently removed by centrifugation, and cell debris was further removed from the supernatant. The lysate was layered onto 10-ml continuous sucrose gradients. After 90 min of centrifugation at 39 000 r.p.m. in an SW41-Ti rotor at 4 °C, the absorbance at 254 nm was measured continuously as a function of gradient depth.</p><h3 class="c-article__sub-heading" id="Sec14">BrdU incorporation</h3><p>BrdU incorporation assays were performed by using FITC BrdU Flow Kit (BD Biosciences, North Ryde, NSW, Australia). Briefly, 10 μl BrdU solution was added into the tissue culture medium followed with desired treatment. Cells were then harvested and analysed using a flow cytometer.</p><h3 class="c-article__sub-heading" id="Sec15">Apoptosis</h3><p>Quantitation of apoptotic cells was carried out by measurement of sub-G1 DNA content using propidium iodide on a flow cytometer as described elsewhere.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 51" title="Jiang CC, Lai F, Tay KH, Croft A, Rizos H, Becker TM et al. Apoptosis of human melanoma cells induced by inhibition of B-RAFV600E involves preferential splicing of bimS. Cell Death Dis 2010; 2: 1:e69." href="/articles/onc2013237#ref-CR51" id="ref-link-section-d147300684e1691">51</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 52" title="Dong L, Jiang CC, Thorne RF, Croft A, Yang F, Liu H et al. Ets-1 mediates upregulation of Mcl-1 downstream of XBP-1 in human melanoma cells upon ER stress. Oncogene 2011; 30: 3716–3726." href="/articles/onc2013237#ref-CR52" id="ref-link-section-d147300684e1694">52</a></sup></p><h3 class="c-article__sub-heading" id="Sec16">Western blot analysis</h3><p>Western blot analysis and quantitation of protein bands were carried out as described previously.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 46" title="Haflidadóttir BS, Bergsteinsdóttir K, Praetorius C, Steingrímsson E . miR-148 regulates Mitf in melanoma cells. PLoS One 2010; 5: e11574." href="/articles/onc2013237#ref-CR46" id="ref-link-section-d147300684e1705">46</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 48" title="Takatsu H, Sakurai M, Shin HW, Murakami K, Nakayama K . Identification and characterization of novel clathrin adaptor-related proteins. J Biol Chem 1998; 273: 24693–24700." href="/articles/onc2013237#ref-CR48" id="ref-link-section-d147300684e1708">48</a></sup></p><h3 class="c-article__sub-heading" id="Sec17">Co-immunoprecipitation of Ago and miRs</h3><p>Co-immunoprecipitation of Ago and miRs was carried out as described by others.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 36" title="Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA 2011; 108: 5003–5008." href="/articles/onc2013237#ref-CR36" id="ref-link-section-d147300684e1719">36</a></sup> Briefly, 200 μl of MagnaBind goat anti-mouse immunoglobulin G Magnetic Beads (Thermo Fisher Scientific, Scoresby, VIC, Australia) was washed with PBS and incubated with 10 μg of a mouse anti-pan-Ago antibody (MABE56; Millipore, Kilsyth, VIC, Australia) or purified mouse normal immunoglobulin G (Santa Cruz Biotechnology) for 2 h at 4 °C. The beads were then added into the 400 μl of whole-cell lysates and incubated overnight at 4 °C, followed by washing three times with 1% Nonidet P-40 buffer. The beads were then divided equally into two parts. Proteins from half of the beads were eluted in 2 × sodium dodecyl sulphate sample buffer, followed by sodium dodecyl sulphate–polyacrylamide gel electrophoresis and western blot analysis of Ago. The other half of the beads was processed for RNA isolation using QIAzol, followed by quantitative reverse transcription and real-time PCR (qPCR) analysis of miRs.</p><h3 class="c-article__sub-heading" id="Sec18">TaqMan low-density array miR array</h3><p>miRNA array was performed using TaqMan TaqMan low-density array card (Applied Biosystems). Briefly, miRNA was purified by using miRNeasy Mini Kit (Qiagen, Chadstone Centre, VIC, Australia). Purified miRNA was reversed transcribed using the Megaplex Reverse transcription primer pool (Applied Biosystems). Hundred nanogram cDNA was mixed with TaqMan Universal PCR Master Mix and then loaded onto the TaqMan low-density array card followed with qPCR analysis using an ABI Fast 7900HT sequence detection system (Applied Biosystems). Analysis of TaqMan low-density array data (Applied Biosystems) was performed using the SDS software v.2.4 (Applied Biosystems). Relative microRNA abundance was calculated with the RQ Manager v.1.2.1 (Applied Biosystems), and data were analysed with DataAssist v.2.0 (Applied Biosystems).<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 54" title="Wulfken LM, Moritz R, Ohlmann C, Holdenrieder S, Jung V, Becker F et al. MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels. PLoS One 2011; 6: e25787." href="/articles/onc2013237#ref-CR54" id="ref-link-section-d147300684e1731">54</a></sup> MiRs with cycle threshold (<i>C</i><sub>t</sub>) values <span class="stix">⩾</span>40 were excluded from further analysis. The expression levels of remaining miRs were calculated against the Ct value of RNU48 as 2<sup>(–ΔCt)</sup>/2<sup>(–ΔCtreference)</sup>.</p><h3 class="c-article__sub-heading" id="Sec19">Quantitative reverse transcription and real-time PCR</h3><p>Quantitation of miR-768-3p by qPCR was performed using TaqMan microRNA (Applied Biosystems). Briefly, target miRNA was reverse transcripted from 2 ng purified total miRNA by using TaqMan MicroRNA Reverse Transcription Kit (Applied Biosystems). qPCR was performed using an ABI Fast 7900HT sequence detection system. <i>C</i><sub>t</sub> values for miR-768-3p were normalized to the <i>C</i><sub>t</sub> value of RNU48.</p><p>qPCR analysis of eIF4E or AP1G1 mRNA expression was also carried out as described previously.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 27" title="Guo ST, Jiang CC, Wang GP, Li YP, Wang CY, Guo XY et al. MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer. Oncogene 2012; 32: 1910–1920." href="/articles/onc2013237#ref-CR27" id="ref-link-section-d147300684e1762">27</a></sup> Assay-on-demand for eIF4E (Assay ID: Hs00854166_g1) and for AP1G1 (Assay ID: Hs00964419_m1) were used according to the manufacturer’s protocol (Applied Biosystems). The relative expression level of eIF4E mRNA in each sample was normalized against β-actin mRNA.</p><h3 class="c-article__sub-heading" id="Sec20">Plasmid vectors and transfection</h3><p>The Myc-DDK-tagged ORF clone of eIF4E was purchased from Origene (Australian Biosearch, Perth, WA, Australia). Cells were transfected with 2 μg plasmid or the empty vector in Opti-MEM medium with Lipofectamine 2000 reagent (Invitrogen, Mulgrave, VIC, Australia) according to the manufacturer’s protocol.</p><h3 class="c-article__sub-heading" id="Sec21">Overexpression of miR-768-3p</h3><p>The bacterial stock of Human Pre-microRNA Expression Construct (pCDH-CMV-MCS-EF1-copGFP-miR-768) and the scramble control hairpin in pCDH-CMV-MCS-EF1-copGFP were purchased from System Biosciences (Mountain View, CA, USA). Plasmids were purified by Qiagen Endotoxin-free Plasmid Kit (Qiagen), and were then transfected into cells by Lipofectamine 2000 reagent (Invitrogen) according to the manufacturer’s protocol.</p><h3 class="c-article__sub-heading" id="Sec22">Small RNA interference</h3><p>The siRNA constructs for eIF4E were obtained as the siGENOME SMARTpool reagents from Dharmacon (Thermo Fisher Scientific). The siGENOME SMARTpool eIF4E (M-003884-03-0010) and SiConTRolNontargeting SiRNA pool (D-001206-13-20) were used (Dharmacon).</p><h3 class="c-article__sub-heading" id="Sec23">Luciferase reporter assays</h3><p>Luciferase report assays to analyse eIF4E-3′-UTR activity was performed as described previously.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 22" title="Jin L, Hu WL, Jiang CC, Wang JX, Han CC, Chu P et al. MicroRNA-149*, a p53-responsive microRNA, functions as an oncogenic regulator in human melanoma. Proc Natl Acad Sci USA 2011; 108: 15840–15845." href="/articles/onc2013237#ref-CR22" id="ref-link-section-d147300684e1799">22</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 27" title="Guo ST, Jiang CC, Wang GP, Li YP, Wang CY, Guo XY et al. MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer. Oncogene 2012; 32: 1910–1920." href="/articles/onc2013237#ref-CR27" id="ref-link-section-d147300684e1802">27</a></sup> The full-length sequence of eIF4E 3′-UTR is located at the position between 2178 and 4749 of eIF4E mRNA (NM_001968.3). The fragment cloned into the luciferase report plasmid is at a region between 2178 and 3144 of eIF4E mRNA. In brief, eIF4E-3′-UTR and eIF4E-3′-UTR-mut were constructed into pSI-CHECK2-report plasmid (Promega, Sydney, NSW, Australia). Plasmids and miR-768-3p mimics or anti-miR-768-3p were co-transfected into cells (0.5 × 10<sup>4</sup> cells per well in 96-well plate) by using Lipofectamine 2000 reagent (Invitrogen). The luciferase activity was measured using the Dual Luciferase Reporter Assay System (Promega) and detected by Synergy 2 multidetection microplate reader (BioTek, Winooski, VT, USA) eIF4E 3′-UTR report RNA levels represented by <i>Renilla</i> luciferase activity were normalized against luciferase activity of firefly that served as the intraplasmid transfection normalization reporter.</p></div></div></section>
            

            <div id="MagazineFulltextArticleBodySuffix"><section aria-labelledby="Bib1" data-title="References"><div class="c-article-section" id="Bib1-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Bib1">References</h2><div class="c-article-section__content" id="Bib1-content"><div data-container-section="references"><ol class="c-article-references"><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="1"><p class="c-article-references__text" id="ref-CR1">Silvera D, Formenti SC, Schneider RJ . Translational control in cancer. <i>Nat Rev Cancer</i> 2010; <b>10</b>: 254–266.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BC3cXjslWiu7o%3D" aria-label="CAS reference 1">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2Fnrc2824" aria-label="Article reference 1">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 1" href="http://scholar.google.com/scholar_lookup?&amp;title=Translational%20control%20in%20cancer&amp;journal=Nat%20Rev%20Cancer&amp;volume=10&amp;pages=254-266&amp;publication_year=2010&amp;author=Silvera%2CD&amp;author=Formenti%2CSC&amp;author=Schneider%2CRJ">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="2"><p class="c-article-references__text" id="ref-CR2">Bilanges B, Stokoe D . Mechanisms of translational deregulation in human tumors and therapeutic intervention strategies. <i>Oncogene</i> 2007; <b>26</b>: 5973–5990.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD2sXpvFWmur8%3D" aria-label="CAS reference 2">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2Fsj.onc.1210431" aria-label="Article reference 2">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 2" href="http://scholar.google.com/scholar_lookup?&amp;title=Mechanisms%20of%20translational%20deregulation%20in%20human%20tumors%20and%20therapeutic%20intervention%20strategies&amp;journal=Oncogene&amp;volume=26&amp;pages=5973-5990&amp;publication_year=2007&amp;author=Bilanges%2CB&amp;author=Stokoe%2CD">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="3"><p class="c-article-references__text" id="ref-CR3">Grzmil M, Hemmings BA . Translation regulation as a therapeutic target in cancer. <i>Cancer Res</i> 2012; <b>72</b>: 3891–3900.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BC38XhtF2rtr3M" aria-label="CAS reference 3">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1158%2F0008-5472.CAN-12-0026" aria-label="Article reference 3">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 3" href="http://scholar.google.com/scholar_lookup?&amp;title=Translation%20regulation%20as%20a%20therapeutic%20target%20in%20cancer&amp;journal=Cancer%20Res&amp;volume=72&amp;pages=3891-3900&amp;publication_year=2012&amp;author=Grzmil%2CM&amp;author=Hemmings%2CBA">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="4"><p class="c-article-references__text" id="ref-CR4">Bitterman PB, Polunovsky VA . Translational control of cell fate: from integration of environmental signals to breaching anticancer defense. <i>Cell Cycle</i> 2012; <b>11</b>: 1097–1107.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BC38XmslWntrY%3D" aria-label="CAS reference 4">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.4161%2Fcc.11.6.19610" aria-label="Article reference 4">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 4" href="http://scholar.google.com/scholar_lookup?&amp;title=Translational%20control%20of%20cell%20fate%3A%20from%20integration%20of%20environmental%20signals%20to%20breaching%20anticancer%20defense&amp;journal=Cell%20Cycle&amp;volume=11&amp;pages=1097-1107&amp;publication_year=2012&amp;author=Bitterman%2CPB&amp;author=Polunovsky%2CVA">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="5"><p class="c-article-references__text" id="ref-CR5">Sonenberg N, Hinnebusch AG . Regulation of translation initiation in eukaryotes: mechanisms and biological targets. <i>Cell</i> 2009; <b>136</b>: 731–745.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD1MXkvFGksbc%3D" aria-label="CAS reference 5">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1016%2Fj.cell.2009.01.042" aria-label="Article reference 5">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 5" href="http://scholar.google.com/scholar_lookup?&amp;title=Regulation%20of%20translation%20initiation%20in%20eukaryotes%3A%20mechanisms%20and%20biological%20targets&amp;journal=Cell&amp;volume=136&amp;pages=731-745&amp;publication_year=2009&amp;author=Sonenberg%2CN&amp;author=Hinnebusch%2CAG">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="6"><p class="c-article-references__text" id="ref-CR6">Jackson RJ, Hellen CU, Pestova TV . The mechanism of eukaryotic translation initiation and principles of its regulation. <i>Nat Rev Mol Cell Biol</i> 2010; <b>11</b>: 113–127.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BC3cXps1Cnuw%3D%3D" aria-label="CAS reference 6">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2Fnrm2838" aria-label="Article reference 6">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 6" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20mechanism%20of%20eukaryotic%20translation%20initiation%20and%20principles%20of%20its%20regulation&amp;journal=Nat%20Rev%20Mol%20Cell%20Biol&amp;volume=11&amp;pages=113-127&amp;publication_year=2010&amp;author=Jackson%2CRJ&amp;author=Hellen%2CCU&amp;author=Pestova%2CTV">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="7"><p class="c-article-references__text" id="ref-CR7">Phillips A, Blaydes JP . MNK1 and EIF4E are downstream effectors of MEKs in the regulation of the nuclear export of HDM2 mRNA. <i>Oncogene</i> 2008; <b>27</b>: 1645–1649.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD1cXivFyrt7c%3D" aria-label="CAS reference 7">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2Fsj.onc.1210785" aria-label="Article reference 7">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 7" href="http://scholar.google.com/scholar_lookup?&amp;title=MNK1%20and%20EIF4E%20are%20downstream%20effectors%20of%20MEKs%20in%20the%20regulation%20of%20the%20nuclear%20export%20of%20HDM2%20mRNA&amp;journal=Oncogene&amp;volume=27&amp;pages=1645-1649&amp;publication_year=2008&amp;author=Phillips%2CA&amp;author=Blaydes%2CJP">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="8"><p class="c-article-references__text" id="ref-CR8">Hou J, Lam F, Proud C, Wang S . Targeting Mnks for cancer therapy. <i>Oncotarget</i> 2012; <b>3</b>: 118–131.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.18632%2Foncotarget.453" aria-label="Article reference 8">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 8" href="http://scholar.google.com/scholar_lookup?&amp;title=Targeting%20Mnks%20for%20cancer%20therapy&amp;journal=Oncotarget&amp;volume=3&amp;pages=118-131&amp;publication_year=2012&amp;author=Hou%2CJ&amp;author=Lam%2CF&amp;author=Proud%2CC&amp;author=Wang%2CS">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="9"><p class="c-article-references__text" id="ref-CR9">Stumpf CR, Ruggero D . The cancerous translation apparatus. <i>Curr Opin Genet Dev</i> 2011; <b>21</b>: 474–483.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BC3MXps1ejt7w%3D" aria-label="CAS reference 9">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1016%2Fj.gde.2011.03.007" aria-label="Article reference 9">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 9" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20cancerous%20translation%20apparatus&amp;journal=Curr%20Opin%20Genet%20Dev&amp;volume=21&amp;pages=474-483&amp;publication_year=2011&amp;author=Stumpf%2CCR&amp;author=Ruggero%2CD">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="10"><p class="c-article-references__text" id="ref-CR10">Wendel HG, Silva RL, Malina A, Mills JR, Zhu H, Ueda T <i>et al</i>. Dissecting eIF4E action in tumorigenesis. <i>Genes Dev</i> 2007; <b>21</b>: 3232–3237.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD2sXhsVOrsb7K" aria-label="CAS reference 10">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1101%2Fgad.1604407" aria-label="Article reference 10">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 10" href="http://scholar.google.com/scholar_lookup?&amp;title=Dissecting%20eIF4E%20action%20in%20tumorigenesis&amp;journal=Genes%20Dev&amp;volume=21&amp;pages=3232-3237&amp;publication_year=2007&amp;author=Wendel%2CHG&amp;author=Silva%2CRL&amp;author=Malina%2CA&amp;author=Mills%2CJR&amp;author=Zhu%2CH&amp;author=Ueda%2CT">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="11"><p class="c-article-references__text" id="ref-CR11">Rosenwald IB . The role of translation in neoplastic transformation from a pathologist's point of view. <i>Oncogene</i> 2004; <b>23</b>: 3230–3247.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD2cXjtFOmtr8%3D" aria-label="CAS reference 11">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2Fsj.onc.1207552" aria-label="Article reference 11">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 11" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20role%20of%20translation%20in%20neoplastic%20transformation%20from%20a%20pathologist%27s%20point%20of%20view&amp;journal=Oncogene&amp;volume=23&amp;pages=3230-3247&amp;publication_year=2004&amp;author=Rosenwald%2CIB">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="12"><p class="c-article-references__text" id="ref-CR12">Larsson O, Li S, Issaenko OA, Avdulov S, Peterson M, Smith K <i>et al</i>. Eukaryotic translation initiation factor 4E induced progression of primary human mammary epithelial cells along the cancer pathway is associated with targeted translational deregulation of oncogenic drivers and inhibitors. <i>Cancer Res</i> 2007; <b>67</b>: 6814–6824.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD2sXnslOis7g%3D" aria-label="CAS reference 12">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1158%2F0008-5472.CAN-07-0752" aria-label="Article reference 12">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 12" href="http://scholar.google.com/scholar_lookup?&amp;title=Eukaryotic%20translation%20initiation%20factor%204E%20induced%20progression%20of%20primary%20human%20mammary%20epithelial%20cells%20along%20the%20cancer%20pathway%20is%20associated%20with%20targeted%20translational%20deregulation%20of%20oncogenic%20drivers%20and%20inhibitors&amp;journal=Cancer%20Res&amp;volume=67&amp;pages=6814-6824&amp;publication_year=2007&amp;author=Larsson%2CO&amp;author=Li%2CS&amp;author=Issaenko%2COA&amp;author=Avdulov%2CS&amp;author=Peterson%2CM&amp;author=Smith%2CK">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="13"><p class="c-article-references__text" id="ref-CR13">Yang SX, Hewitt SM, Steinberg SM, Liewehr DJ, Swain SM . Expression levels of eIF4E, VEGF, and cyclin D1, and correlation of eIF4E with VEGF and cyclin D1 in multi-tumor tissue microarray. <i>Oncol Rep</i> 2007; <b>17</b>: 281–287.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD2sXhvFyltb8%3D" aria-label="CAS reference 13">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=17203162" aria-label="PubMed reference 13" rel="nofollow">PubMed</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 13" href="http://scholar.google.com/scholar_lookup?&amp;title=Expression%20levels%20of%20eIF4E%2C%20VEGF%2C%20and%20cyclin%20D1%2C%20and%20correlation%20of%20eIF4E%20with%20VEGF%20and%20cyclin%20D1%20in%20multi-tumor%20tissue%20microarray&amp;journal=Oncol%20Rep&amp;volume=17&amp;pages=281-287&amp;publication_year=2007&amp;author=Yang%2CSX&amp;author=Hewitt%2CSM&amp;author=Steinberg%2CSM&amp;author=Liewehr%2CDJ&amp;author=Swain%2CSM">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="14"><p class="c-article-references__text" id="ref-CR14">Coleman LJ, Peter MB, Teall TJ, Brannan RA, Hanby AM, Honarpisheh H <i>et al</i>. Combined analysis of eIF4E and 4E-binding protein expression predicts breast cancer survival and estimates eIF4E activity. <i>Br J Cancer</i> 2009; <b>100</b>: 1393–1399.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD1MXltFGitrY%3D" aria-label="CAS reference 14">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2Fsj.bjc.6605044" aria-label="Article reference 14">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 14" href="http://scholar.google.com/scholar_lookup?&amp;title=Combined%20analysis%20of%20eIF4E%20and%204E-binding%20protein%20expression%20predicts%20breast%20cancer%20survival%20and%20estimates%20eIF4E%20activity&amp;journal=Br%20J%20Cancer&amp;volume=100&amp;pages=1393-1399&amp;publication_year=2009&amp;author=Coleman%2CLJ&amp;author=Peter%2CMB&amp;author=Teall%2CTJ&amp;author=Brannan%2CRA&amp;author=Hanby%2CAM&amp;author=Honarpisheh%2CH">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="15"><p class="c-article-references__text" id="ref-CR15">De Benedetti A, Graff JR . eIF-4E expression and its role in malignancies and metastases. <i>Oncogene</i> 2004; <b>23</b>: 3189–3199.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD2cXjtFOmsbo%3D" aria-label="CAS reference 15">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2Fsj.onc.1207545" aria-label="Article reference 15">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 15" href="http://scholar.google.com/scholar_lookup?&amp;title=eIF-4E%20expression%20and%20its%20role%20in%20malignancies%20and%20metastases&amp;journal=Oncogene&amp;volume=23&amp;pages=3189-3199&amp;publication_year=2004&amp;author=De%20Benedetti%2CA&amp;author=Graff%2CJR">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="16"><p class="c-article-references__text" id="ref-CR16">He L, Hannon GJ . 2004. MicroRNAs: small RNAs with a big role in gene regulation. <i>Nat Rev Genet</i> 2004; <b>5</b>: 522–531.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD2cXltVSmsbw%3D" aria-label="CAS reference 16">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2Fnrg1379" aria-label="Article reference 16">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 16" href="http://scholar.google.com/scholar_lookup?&amp;title=MicroRNAs%3A%20small%20RNAs%20with%20a%20big%20role%20in%20gene%20regulation&amp;journal=Nat%20Rev%20Genet&amp;volume=5&amp;pages=522-531&amp;publication_year=2004&amp;author=He%2CL&amp;author=Hannon%2CGJ">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="17"><p class="c-article-references__text" id="ref-CR17">Iorio MV, Croce CM . MicroRNAs in cancer: small molecules with a huge impact. <i>J Clin Oncol</i> 2009; <b>27</b>: 5848–5856.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BC3cXhtVWitrs%3D" aria-label="CAS reference 17">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1200%2FJCO.2009.24.0317" aria-label="Article reference 17">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 17" href="http://scholar.google.com/scholar_lookup?&amp;title=MicroRNAs%20in%20cancer%3A%20small%20molecules%20with%20a%20huge%20impact&amp;journal=J%20Clin%20Oncol&amp;volume=27&amp;pages=5848-5856&amp;publication_year=2009&amp;author=Iorio%2CMV&amp;author=Croce%2CCM">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="18"><p class="c-article-references__text" id="ref-CR18">Humphreys DT, Westman BJ, Martin DI, Preiss T . MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function. <i>Proc Natl Acad Sci USA</i> 2005; <b>102</b>: 16961–16966.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD2MXht1yksLvJ" aria-label="CAS reference 18">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1073%2Fpnas.0506482102" aria-label="Article reference 18">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 18" href="http://scholar.google.com/scholar_lookup?&amp;title=MicroRNAs%20control%20translation%20initiation%20by%20inhibiting%20eukaryotic%20initiation%20factor%204E%2Fcap%20and%20poly%28A%29%20tail%20function&amp;journal=Proc%20Natl%20Acad%20Sci%20USA&amp;volume=102&amp;pages=16961-16966&amp;publication_year=2005&amp;author=Humphreys%2CDT&amp;author=Westman%2CBJ&amp;author=Martin%2CDI&amp;author=Preiss%2CT">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="19"><p class="c-article-references__text" id="ref-CR19">Mathonnet G, Fabian MR, Svitkin YV, Parsyan A, Huck L, Murata T <i>et al</i>. MicroRNA inhibition of translation initiation <i>in vitro</i> by targeting the cap-binding complex eIF4F. <i>Science</i> 2007; <b>317</b>: 1764–1767.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD2sXhtVGmsLbO" aria-label="CAS reference 19">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1126%2Fscience.1146067" aria-label="Article reference 19">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 19" href="http://scholar.google.com/scholar_lookup?&amp;title=MicroRNA%20inhibition%20of%20translation%20initiation%20in%20vitro%20by%20targeting%20the%20cap-binding%20complex%20eIF4F&amp;journal=Science&amp;volume=317&amp;pages=1764-1767&amp;publication_year=2007&amp;author=Mathonnet%2CG&amp;author=Fabian%2CMR&amp;author=Svitkin%2CYV&amp;author=Parsyan%2CA&amp;author=Huck%2CL&amp;author=Murata%2CT">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="20"><p class="c-article-references__text" id="ref-CR20">Lujambio A, Lowe SW . The microcosmos of cancer. <i>Nature</i> 2012; <b>482</b>: 347–355.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BC38Xit12htb8%3D" aria-label="CAS reference 20">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2Fnature10888" aria-label="Article reference 20">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 20" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20microcosmos%20of%20cancer&amp;journal=Nature&amp;volume=482&amp;pages=347-355&amp;publication_year=2012&amp;author=Lujambio%2CA&amp;author=Lowe%2CSW">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="21"><p class="c-article-references__text" id="ref-CR21">Felicetti F, Errico MC, Bottero L, Segnalini P, Stoppacciaro A <i>et al</i>. The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms. <i>Cancer Res</i> 2008; <b>68</b>: 2745–2754.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD1cXks1Gitbk%3D" aria-label="CAS reference 21">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1158%2F0008-5472.CAN-07-2538" aria-label="Article reference 21">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 21" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20promyelocytic%20leukemia%20zinc%20finger-microRNA-221%2F-222%20pathway%20controls%20melanoma%20progression%20through%20multiple%20oncogenic%20mechanisms&amp;journal=Cancer%20Res&amp;volume=68&amp;pages=2745-2754&amp;publication_year=2008&amp;author=Felicetti%2CF&amp;author=Errico%2CMC&amp;author=Bottero%2CL&amp;author=Segnalini%2CP&amp;author=Stoppacciaro%2CA">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="22"><p class="c-article-references__text" id="ref-CR22">Jin L, Hu WL, Jiang CC, Wang JX, Han CC, Chu P <i>et al</i>. MicroRNA-149*, a p53-responsive microRNA, functions as an oncogenic regulator in human melanoma. <i>Proc Natl Acad Sci USA</i> 2011; <b>108</b>: 15840–15845.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BC3MXht1emt7%2FJ" aria-label="CAS reference 22">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1073%2Fpnas.1019312108" aria-label="Article reference 22">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 22" href="http://scholar.google.com/scholar_lookup?&amp;title=MicroRNA-149%2A%2C%20a%20p53-responsive%20microRNA%2C%20functions%20as%20an%20oncogenic%20regulator%20in%20human%20melanoma&amp;journal=Proc%20Natl%20Acad%20Sci%20USA&amp;volume=108&amp;pages=15840-15845&amp;publication_year=2011&amp;author=Jin%2CL&amp;author=Hu%2CWL&amp;author=Jiang%2CCC&amp;author=Wang%2CJX&amp;author=Han%2CCC&amp;author=Chu%2CP">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="23"><p class="c-article-references__text" id="ref-CR23">Bonazzi VF, Stark MS, Hayward NK . MicroRNA regulation of melanoma progression. <i>Melanoma Res</i> 2012; <b>22</b>: 101–113.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BC38XjsVCgu70%3D" aria-label="CAS reference 23">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1097%2FCMR.0b013e32834f6fbb" aria-label="Article reference 23">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 23" href="http://scholar.google.com/scholar_lookup?&amp;title=MicroRNA%20regulation%20of%20melanoma%20progression&amp;journal=Melanoma%20Res&amp;volume=22&amp;pages=101-113&amp;publication_year=2012&amp;author=Bonazzi%2CVF&amp;author=Stark%2CMS&amp;author=Hayward%2CNK">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="24"><p class="c-article-references__text" id="ref-CR24">Mueller DW, Bosserhoff AK . The evolving concept of ‘melano-miRs’-microRNAs in melanomagenesis. <i>Pigment Cell Melanoma Res</i> 2010; <b>23</b>: 620–626.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BC3cXht1GrtrzL" aria-label="CAS reference 24">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1111%2Fj.1755-148X.2010.00734.x" aria-label="Article reference 24">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 24" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20evolving%20concept%20of%20%E2%80%98melano-miRs%E2%80%99-microRNAs%20in%20melanomagenesis&amp;journal=Pigment%20Cell%20Melanoma%20Res&amp;volume=23&amp;pages=620-626&amp;publication_year=2010&amp;author=Mueller%2CDW&amp;author=Bosserhoff%2CAK">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="25"><p class="c-article-references__text" id="ref-CR25">Wilmott JS, Zhang XD, Hersey P, Scolyer RA . The emerging important role of microRNAs in the pathogenesis, diagnosis and treatment of human cancers. <i>Pathology</i> 2011; <b>43</b>: 657–671.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BC3MXhtl2hs7%2FN" aria-label="CAS reference 25">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1097%2FPAT.0b013e32834a7358" aria-label="Article reference 25">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 25" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20emerging%20important%20role%20of%20microRNAs%20in%20the%20pathogenesis%2C%20diagnosis%20and%20treatment%20of%20human%20cancers&amp;journal=Pathology&amp;volume=43&amp;pages=657-671&amp;publication_year=2011&amp;author=Wilmott%2CJS&amp;author=Zhang%2CXD&amp;author=Hersey%2CP&amp;author=Scolyer%2CRA">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="26"><p class="c-article-references__text" id="ref-CR26">Croce CM . Causes and consequences of microRNA dysregulation in cancer. <i>Nat Rev Genet</i> 2009; <b>10</b>: 704–714.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD1MXhtFCqurjE" aria-label="CAS reference 26">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2Fnrg2634" aria-label="Article reference 26">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 26" href="http://scholar.google.com/scholar_lookup?&amp;title=Causes%20and%20consequences%20of%20microRNA%20dysregulation%20in%20cancer&amp;journal=Nat%20Rev%20Genet&amp;volume=10&amp;pages=704-714&amp;publication_year=2009&amp;author=Croce%2CCM">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="27"><p class="c-article-references__text" id="ref-CR27">Guo ST, Jiang CC, Wang GP, Li YP, Wang CY, Guo XY <i>et al</i>. MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer. <i>Oncogene</i> 2012; <b>32</b>: 1910–1920.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2Fonc.2012.214" aria-label="Article reference 27">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 27" href="http://scholar.google.com/scholar_lookup?&amp;title=MicroRNA-497%20targets%20insulin-like%20growth%20factor%201%20receptor%20and%20has%20a%20tumour%20suppressive%20role%20in%20human%20colorectal%20cancer&amp;journal=Oncogene&amp;volume=32&amp;pages=1910-1920&amp;publication_year=2012&amp;author=Guo%2CST&amp;author=Jiang%2CCC&amp;author=Wang%2CGP&amp;author=Li%2CYP&amp;author=Wang%2CCY&amp;author=Guo%2CXY">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="28"><p class="c-article-references__text" id="ref-CR28">Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S <i>et al</i>. Mutations of the BRAF gene in human cancer. <i>Nature</i> 2002; <b>417</b>: 949–954.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD38XkvVagsLo%3D" aria-label="CAS reference 28">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2Fnature00766" aria-label="Article reference 28">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 28" href="http://scholar.google.com/scholar_lookup?&amp;title=Mutations%20of%20the%20BRAF%20gene%20in%20human%20cancer&amp;journal=Nature&amp;volume=417&amp;pages=949-954&amp;publication_year=2002&amp;author=Davies%2CH&amp;author=Bignell%2CGR&amp;author=Cox%2CC&amp;author=Stephens%2CP&amp;author=Edkins%2CS&amp;author=Clegg%2CS">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="29"><p class="c-article-references__text" id="ref-CR29">Platz A, Egyhazi S, Ringborg U, Hansson J . Human cutaneous melanoma; a review of NRAS and BRAF mutation frequencies in relation to histogenetic subclass and body site. <i>Mol Oncol</i> 2008; <b>1</b>: 395–405.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1016%2Fj.molonc.2007.12.003" aria-label="Article reference 29">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 29" href="http://scholar.google.com/scholar_lookup?&amp;title=Human%20cutaneous%20melanoma%3B%20a%20review%20of%20NRAS%20and%20BRAF%20mutation%20frequencies%20in%20relation%20to%20histogenetic%20subclass%20and%20body%20site&amp;journal=Mol%20Oncol&amp;volume=1&amp;pages=395-405&amp;publication_year=2008&amp;author=Platz%2CA&amp;author=Egyhazi%2CS&amp;author=Ringborg%2CU&amp;author=Hansson%2CJ">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="30"><p class="c-article-references__text" id="ref-CR30">Couts KL, Anderson EM, Gross MM, Sullivan K, Ahn NG . Oncogenic B-Raf signaling in melanoma cells controls a network of microRNAs with combinatorial functions. <i>Oncogene</i> 2012; <b>32</b>: 1959–1970.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2Fonc.2012.209" aria-label="Article reference 30">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 30" href="http://scholar.google.com/scholar_lookup?&amp;title=Oncogenic%20B-Raf%20signaling%20in%20melanoma%20cells%20controls%20a%20network%20of%20microRNAs%20with%20combinatorial%20functions&amp;journal=Oncogene&amp;volume=32&amp;pages=1959-1970&amp;publication_year=2012&amp;author=Couts%2CKL&amp;author=Anderson%2CEM&amp;author=Gross%2CMM&amp;author=Sullivan%2CK&amp;author=Ahn%2CNG">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="31"><p class="c-article-references__text" id="ref-CR31">Caramuta S, Egyházi S, Rodolfo M, Witten D, Hansson J, Larsson C <i>et al</i>. MicroRNA expression profiles associated with mutational status and survival in malignant melanoma. <i>J Invest Dermatol</i> 2010; <b>130</b>: 2062–2070.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BC3cXovVCmsLo%3D" aria-label="CAS reference 31">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2Fjid.2010.63" aria-label="Article reference 31">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 31" href="http://scholar.google.com/scholar_lookup?&amp;title=MicroRNA%20expression%20profiles%20associated%20with%20mutational%20status%20and%20survival%20in%20malignant%20melanoma&amp;journal=J%20Invest%20Dermatol&amp;volume=130&amp;pages=2062-2070&amp;publication_year=2010&amp;author=Caramuta%2CS&amp;author=Egyh%C3%A1zi%2CS&amp;author=Rodolfo%2CM&amp;author=Witten%2CD&amp;author=Hansson%2CJ&amp;author=Larsson%2CC">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="32"><p class="c-article-references__text" id="ref-CR32">Yanagiya A, Suyama E, Adachi H, Svitkin YV, Aza-Blanc P, Imataka H <i>et al</i>. Translational homeostasis via the mRNA cap-binding protein, eIF4E. <i>Mol Cell</i> 2012; <b>46</b>: 847–858.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BC38XmvFGqu7w%3D" aria-label="CAS reference 32">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1016%2Fj.molcel.2012.04.004" aria-label="Article reference 32">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 32" href="http://scholar.google.com/scholar_lookup?&amp;title=Translational%20homeostasis%20via%20the%20mRNA%20cap-binding%20protein%2C%20eIF4E&amp;journal=Mol%20Cell&amp;volume=46&amp;pages=847-858&amp;publication_year=2012&amp;author=Yanagiya%2CA&amp;author=Suyama%2CE&amp;author=Adachi%2CH&amp;author=Svitkin%2CYV&amp;author=Aza-Blanc%2CP&amp;author=Imataka%2CH">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="33"><p class="c-article-references__text" id="ref-CR33">Moerke NJ, Aktas H, Chen H, Cantel S, Reibarkh MY, Fahmy A <i>et al</i>. Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G. <i>Cell</i> 2007; <b>128</b>: 257–267.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD2sXhsVOru7Y%3D" aria-label="CAS reference 33">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1016%2Fj.cell.2006.11.046" aria-label="Article reference 33">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 33" href="http://scholar.google.com/scholar_lookup?&amp;title=Small-molecule%20inhibition%20of%20the%20interaction%20between%20the%20translation%20initiation%20factors%20eIF4E%20and%20eIF4G&amp;journal=Cell&amp;volume=128&amp;pages=257-267&amp;publication_year=2007&amp;author=Moerke%2CNJ&amp;author=Aktas%2CH&amp;author=Chen%2CH&amp;author=Cantel%2CS&amp;author=Reibarkh%2CMY&amp;author=Fahmy%2CA">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="34"><p class="c-article-references__text" id="ref-CR34">Valleron W, Ysebaert L, Berquet L, Fataccioli V, Quelen C, Martin A <i>et al</i>. Small nucleolar RNA expression profiling identifies potential prognostic markers in peripheral T-cell lymphoma. <i>Blood</i> 2012; <b>120</b>: 3997–4005.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BC38XhsleqsL%2FK" aria-label="CAS reference 34">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1182%2Fblood-2012-06-438135" aria-label="Article reference 34">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 34" href="http://scholar.google.com/scholar_lookup?&amp;title=Small%20nucleolar%20RNA%20expression%20profiling%20identifies%20potential%20prognostic%20markers%20in%20peripheral%20T-cell%20lymphoma&amp;journal=Blood&amp;volume=120&amp;pages=3997-4005&amp;publication_year=2012&amp;author=Valleron%2CW&amp;author=Ysebaert%2CL&amp;author=Berquet%2CL&amp;author=Fataccioli%2CV&amp;author=Quelen%2CC&amp;author=Martin%2CA">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="35"><p class="c-article-references__text" id="ref-CR35">Miyoshi K, Miyoshi T, Siomi H . Many ways to generate microRNA-like small RNAs: non-canonical pathways for microRNA production. <i>Mol Genet Genom</i> 2010; <b>284</b>: 95–103.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BC3cXoslaitL4%3D" aria-label="CAS reference 35">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1007%2Fs00438-010-0556-1" aria-label="Article reference 35">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 35" href="http://scholar.google.com/scholar_lookup?&amp;title=Many%20ways%20to%20generate%20microRNA-like%20small%20RNAs%3A%20non-canonical%20pathways%20for%20microRNA%20production&amp;journal=Mol%20Genet%20Genom&amp;volume=284&amp;pages=95-103&amp;publication_year=2010&amp;author=Miyoshi%2CK&amp;author=Miyoshi%2CT&amp;author=Siomi%2CH">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="36"><p class="c-article-references__text" id="ref-CR36">Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF <i>et al</i>. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. <i>Proc Natl Acad Sci USA</i> 2011; <b>108</b>: 5003–5008.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BC3MXktVCjsro%3D" aria-label="CAS reference 36">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1073%2Fpnas.1019055108" aria-label="Article reference 36">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 36" href="http://scholar.google.com/scholar_lookup?&amp;title=Argonaute2%20complexes%20carry%20a%20population%20of%20circulating%20microRNAs%20independent%20of%20vesicles%20in%20human%20plasma&amp;journal=Proc%20Natl%20Acad%20Sci%20USA&amp;volume=108&amp;pages=5003-5008&amp;publication_year=2011&amp;author=Arroyo%2CJD&amp;author=Chevillet%2CJR&amp;author=Kroh%2CEM&amp;author=Ruf%2CIK&amp;author=Pritchard%2CCC&amp;author=Gibson%2CDF">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="37"><p class="c-article-references__text" id="ref-CR37">Kiss T . Biogenesis of small nuclear RNPs. <i>J Cell Sci</i> 2004; <b>117</b>: 5949–5951.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD2MXnvFahuw%3D%3D" aria-label="CAS reference 37">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1242%2Fjcs.01487" aria-label="Article reference 37">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 37" href="http://scholar.google.com/scholar_lookup?&amp;title=Biogenesis%20of%20small%20nuclear%20RNPs&amp;journal=J%20Cell%20Sci&amp;volume=117&amp;pages=5949-5951&amp;publication_year=2004&amp;author=Kiss%2CT">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="38"><p class="c-article-references__text" id="ref-CR38">Rosenwald IB, Rhoads DB, Callanan LD, Isselbacher KJ, Schmidt EV . Increased expression of eukaryotic translation initiation factors eIF-4E and eIF-2 alpha in response to growth induction by c-myc. <i>Proc Natl Acad Sci USA</i> 1993; <b>90</b>: 6175–6178.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK3sXltlKmtbo%3D" aria-label="CAS reference 38">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1073%2Fpnas.90.13.6175" aria-label="Article reference 38">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 38" href="http://scholar.google.com/scholar_lookup?&amp;title=Increased%20expression%20of%20eukaryotic%20translation%20initiation%20factors%20eIF-4E%20and%20eIF-2%20alpha%20in%20response%20to%20growth%20induction%20by%20c-myc&amp;journal=Proc%20Natl%20Acad%20Sci%20USA&amp;volume=90&amp;pages=6175-6178&amp;publication_year=1993&amp;author=Rosenwald%2CIB&amp;author=Rhoads%2CDB&amp;author=Callanan%2CLD&amp;author=Isselbacher%2CKJ&amp;author=Schmidt%2CEV">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="39"><p class="c-article-references__text" id="ref-CR39">Mamane Y, Petroulakis E, Martineau Y, Sato TA, Larsson O, Rajasekhar VK <i>et al</i>. Epigenetic activation of a subset of mRNAs by eIF4E explains its effects on cell proliferation. <i>PLoS One</i> 2007; <b>2</b>: e242.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1371%2Fjournal.pone.0000242" aria-label="Article reference 39">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 39" href="http://scholar.google.com/scholar_lookup?&amp;title=Epigenetic%20activation%20of%20a%20subset%20of%20mRNAs%20by%20eIF4E%20explains%20its%20effects%20on%20cell%20proliferation&amp;journal=PLoS%20One&amp;volume=2&amp;publication_year=2007&amp;author=Mamane%2CY&amp;author=Petroulakis%2CE&amp;author=Martineau%2CY&amp;author=Sato%2CTA&amp;author=Larsson%2CO&amp;author=Rajasekhar%2CVK">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="40"><p class="c-article-references__text" id="ref-CR40">Rosenwald IB, Lazaris-Karatzas A, Sonenberg N, Schmidt EV . Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor 4E. <i>Mol Cell Biol</i> 1993; <b>13</b>: 7358–7363.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK2cXltFSmug%3D%3D" aria-label="CAS reference 40">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1128%2FMCB.13.12.7358" aria-label="Article reference 40">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 40" href="http://scholar.google.com/scholar_lookup?&amp;title=Elevated%20levels%20of%20cyclin%20D1%20protein%20in%20response%20to%20increased%20expression%20of%20eukaryotic%20initiation%20factor%204E&amp;journal=Mol%20Cell%20Biol&amp;volume=13&amp;pages=7358-7363&amp;publication_year=1993&amp;author=Rosenwald%2CIB&amp;author=Lazaris-Karatzas%2CA&amp;author=Sonenberg%2CN&amp;author=Schmidt%2CEV">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="41"><p class="c-article-references__text" id="ref-CR41">Koromilas AE, Lazaris-Karatzas A, Sonenberg N . mRNAs containing extensive secondary structure in their 5′ non-coding region translate efficiently in cells overexpressing initiation factor eIF-4E. <i>EMBO J</i> 1992; <b>11</b>: 4153–4158.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK38Xmt1ymtb8%3D" aria-label="CAS reference 41">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1002%2Fj.1460-2075.1992.tb05508.x" aria-label="Article reference 41">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 41" href="http://scholar.google.com/scholar_lookup?&amp;title=mRNAs%20containing%20extensive%20secondary%20structure%20in%20their%205%E2%80%B2%20non-coding%20region%20translate%20efficiently%20in%20cells%20overexpressing%20initiation%20factor%20eIF-4E&amp;journal=EMBO%20J&amp;volume=11&amp;pages=4153-4158&amp;publication_year=1992&amp;author=Koromilas%2CAE&amp;author=Lazaris-Karatzas%2CA&amp;author=Sonenberg%2CN">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="42"><p class="c-article-references__text" id="ref-CR42">Lazaris-Karatzas A, Montine KS, Sonenberg N . Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5′ cap. <i>Nature</i> 1990; <b>345</b>: 544–547.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK3cXktlygsrg%3D" aria-label="CAS reference 42">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2F345544a0" aria-label="Article reference 42">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 42" href="http://scholar.google.com/scholar_lookup?&amp;title=Malignant%20transformation%20by%20a%20eukaryotic%20initiation%20factor%20subunit%20that%20binds%20to%20mRNA%205%E2%80%B2%20cap&amp;journal=Nature&amp;volume=345&amp;pages=544-547&amp;publication_year=1990&amp;author=Lazaris-Karatzas%2CA&amp;author=Montine%2CKS&amp;author=Sonenberg%2CN">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="43"><p class="c-article-references__text" id="ref-CR43">Lazaris-Karatzas A, Sonenberg N . The mRNA 5′ cap-binding protein, eIF-4E, cooperates with v-myc or E1A in the transformation of primary rodent fibroblasts. <i>Mol Cell Biol</i> 1992; <b>12</b>: 1234–1238.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK38XhslWhtL0%3D" aria-label="CAS reference 43">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1128%2FMCB.12.3.1234" aria-label="Article reference 43">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 43" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20mRNA%205%E2%80%B2%20cap-binding%20protein%2C%20eIF-4E%2C%20cooperates%20with%20v-myc%20or%20E1A%20in%20the%20transformation%20of%20primary%20rodent%20fibroblasts&amp;journal=Mol%20Cell%20Biol&amp;volume=12&amp;pages=1234-1238&amp;publication_year=1992&amp;author=Lazaris-Karatzas%2CA&amp;author=Sonenberg%2CN">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="44"><p class="c-article-references__text" id="ref-CR44">Graff JR, Konicek BW, Carter JH, Marcusson EG . Targeting the eukaryotic translation initiation factor 4E for cancer therapy. <i>Cancer Res</i> 2008; <b>68</b>: 631–634.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD1cXhtlyhurg%3D" aria-label="CAS reference 44">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1158%2F0008-5472.CAN-07-5635" aria-label="Article reference 44">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 44" href="http://scholar.google.com/scholar_lookup?&amp;title=Targeting%20the%20eukaryotic%20translation%20initiation%20factor%204E%20for%20cancer%20therapy&amp;journal=Cancer%20Res&amp;volume=68&amp;pages=631-634&amp;publication_year=2008&amp;author=Graff%2CJR&amp;author=Konicek%2CBW&amp;author=Carter%2CJH&amp;author=Marcusson%2CEG">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="45"><p class="c-article-references__text" id="ref-CR45">Bemis LT, Chen R, Amato CM, Classen EH, Robinson SE, Coffey DG <i>et al</i>. MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines. <i>Cancer Res</i> 2008; <b>68</b>: 1362–1368.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD1cXislagur8%3D" aria-label="CAS reference 45">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1158%2F0008-5472.CAN-07-2912" aria-label="Article reference 45">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 45" href="http://scholar.google.com/scholar_lookup?&amp;title=MicroRNA-137%20targets%20microphthalmia-associated%20transcription%20factor%20in%20melanoma%20cell%20lines&amp;journal=Cancer%20Res&amp;volume=68&amp;pages=1362-1368&amp;publication_year=2008&amp;author=Bemis%2CLT&amp;author=Chen%2CR&amp;author=Amato%2CCM&amp;author=Classen%2CEH&amp;author=Robinson%2CSE&amp;author=Coffey%2CDG">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="46"><p class="c-article-references__text" id="ref-CR46">Haflidadóttir BS, Bergsteinsdóttir K, Praetorius C, Steingrímsson E . miR-148 regulates Mitf in melanoma cells. <i>PLoS One</i> 2010; <b>5</b>: e11574.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1371%2Fjournal.pone.0011574" aria-label="Article reference 46">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 46" href="http://scholar.google.com/scholar_lookup?&amp;title=miR-148%20regulates%20Mitf%20in%20melanoma%20cells&amp;journal=PLoS%20One&amp;volume=5&amp;publication_year=2010&amp;author=Haflidad%C3%B3ttir%2CBS&amp;author=Bergsteinsd%C3%B3ttir%2CK&amp;author=Praetorius%2CC&amp;author=Steingr%C3%ADmsson%2CE">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="47"><p class="c-article-references__text" id="ref-CR47">Li SC, Tang P, Lin WC . Intronic MicroRNA: Discovery and biological implications. <i>DNA Cell Biol</i> 2007; <b>26</b>: 195–207.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1089%2Fdna.2006.0558" aria-label="Article reference 47">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 47" href="http://scholar.google.com/scholar_lookup?&amp;title=Intronic%20MicroRNA%3A%20Discovery%20and%20biological%20implications&amp;journal=DNA%20Cell%20Biol&amp;volume=26&amp;pages=195-207&amp;publication_year=2007&amp;author=Li%2CSC&amp;author=Tang%2CP&amp;author=Lin%2CWC">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="48"><p class="c-article-references__text" id="ref-CR48">Takatsu H, Sakurai M, Shin HW, Murakami K, Nakayama K . Identification and characterization of novel clathrin adaptor-related proteins. <i>J Biol Chem</i> 1998; <b>273</b>: 24693–24700.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK1cXmtlyqt7g%3D" aria-label="CAS reference 48">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1074%2Fjbc.273.38.24693" aria-label="Article reference 48">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 48" href="http://scholar.google.com/scholar_lookup?&amp;title=Identification%20and%20characterization%20of%20novel%20clathrin%20adaptor-related%20proteins&amp;journal=J%20Biol%20Chem&amp;volume=273&amp;pages=24693-24700&amp;publication_year=1998&amp;author=Takatsu%2CH&amp;author=Sakurai%2CM&amp;author=Shin%2CHW&amp;author=Murakami%2CK&amp;author=Nakayama%2CK">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="49"><p class="c-article-references__text" id="ref-CR49">Hong DS, Kurzrock R, Oh Y, Wheler J, Naing A, Brail L <i>et al</i>. A phase 1 dose escalation, pharmacokinetic, and pharmacodynamic evaluation of eIF-4E antisense oligonucleotide LY2275796 in patients with advanced cancer. <i>Clin Cancer Res</i> 2011; <b>17</b>: 6582–6591.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BC3MXhtlSksrrJ" aria-label="CAS reference 49">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1158%2F1078-0432.CCR-11-0430" aria-label="Article reference 49">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 49" href="http://scholar.google.com/scholar_lookup?&amp;title=A%20phase%201%20dose%20escalation%2C%20pharmacokinetic%2C%20and%20pharmacodynamic%20evaluation%20of%20eIF-4E%20antisense%20oligonucleotide%20LY2275796%20in%20patients%20with%20advanced%20cancer&amp;journal=Clin%20Cancer%20Res&amp;volume=17&amp;pages=6582-6591&amp;publication_year=2011&amp;author=Hong%2CDS&amp;author=Kurzrock%2CR&amp;author=Oh%2CY&amp;author=Wheler%2CJ&amp;author=Naing%2CA&amp;author=Brail%2CL">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="50"><p class="c-article-references__text" id="ref-CR50">Ibrahim AF, Weirauch U, Thomas M, Grünweller A, Hartmann RK, Aigner A . MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma. <i>Cancer Res</i> 2011; <b>71</b>: 5214–5224.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BC3MXpsVOhu7o%3D" aria-label="CAS reference 50">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1158%2F0008-5472.CAN-10-4645" aria-label="Article reference 50">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 50" href="http://scholar.google.com/scholar_lookup?&amp;title=MicroRNA%20replacement%20therapy%20for%20miR-145%20and%20miR-33a%20is%20efficacious%20in%20a%20model%20of%20colon%20carcinoma&amp;journal=Cancer%20Res&amp;volume=71&amp;pages=5214-5224&amp;publication_year=2011&amp;author=Ibrahim%2CAF&amp;author=Weirauch%2CU&amp;author=Thomas%2CM&amp;author=Gr%C3%BCnweller%2CA&amp;author=Hartmann%2CRK&amp;author=Aigner%2CA">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="51"><p class="c-article-references__text" id="ref-CR51">Jiang CC, Lai F, Tay KH, Croft A, Rizos H, Becker TM <i>et al</i>. Apoptosis of human melanoma cells induced by inhibition of B-RAFV600E involves preferential splicing of bimS. <i>Cell Death Dis</i> 2010; <b>2</b>: 1:e69.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 51" href="http://scholar.google.com/scholar_lookup?&amp;title=Apoptosis%20of%20human%20melanoma%20cells%20induced%20by%20inhibition%20of%20B-RAFV600E%20involves%20preferential%20splicing%20of%20bimS&amp;journal=Cell%20Death%20Dis&amp;volume=2&amp;publication_year=2010&amp;author=Jiang%2CCC&amp;author=Lai%2CF&amp;author=Tay%2CKH&amp;author=Croft%2CA&amp;author=Rizos%2CH&amp;author=Becker%2CTM">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="52"><p class="c-article-references__text" id="ref-CR52">Dong L, Jiang CC, Thorne RF, Croft A, Yang F, Liu H <i>et al</i>. Ets-1 mediates upregulation of Mcl-1 downstream of XBP-1 in human melanoma cells upon ER stress. <i>Oncogene</i> 2011; <b>30</b>: 3716–3726.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BC3MXjsF2hsL8%3D" aria-label="CAS reference 52">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2Fonc.2011.87" aria-label="Article reference 52">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 52" href="http://scholar.google.com/scholar_lookup?&amp;title=Ets-1%20mediates%20upregulation%20of%20Mcl-1%20downstream%20of%20XBP-1%20in%20human%20melanoma%20cells%20upon%20ER%20stress&amp;journal=Oncogene&amp;volume=30&amp;pages=3716-3726&amp;publication_year=2011&amp;author=Dong%2CL&amp;author=Jiang%2CCC&amp;author=Thorne%2CRF&amp;author=Croft%2CA&amp;author=Yang%2CF&amp;author=Liu%2CH">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="53"><p class="c-article-references__text" id="ref-CR53">Blais JD, Filipenko V, Bi M, Harding HP, Ron D, Koumenis C <i>et al</i>. Activating transcription factor 4 is translationally regulated by hypoxic stress. <i>Mol Cell Biol</i> 2004; <b>24</b>: 7469–7482.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD2cXntVKhtb0%3D" aria-label="CAS reference 53">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1128%2FMCB.24.17.7469-7482.2004" aria-label="Article reference 53">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 53" href="http://scholar.google.com/scholar_lookup?&amp;title=Activating%20transcription%20factor%204%20is%20translationally%20regulated%20by%20hypoxic%20stress&amp;journal=Mol%20Cell%20Biol&amp;volume=24&amp;pages=7469-7482&amp;publication_year=2004&amp;author=Blais%2CJD&amp;author=Filipenko%2CV&amp;author=Bi%2CM&amp;author=Harding%2CHP&amp;author=Ron%2CD&amp;author=Koumenis%2CC">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="54"><p class="c-article-references__text" id="ref-CR54">Wulfken LM, Moritz R, Ohlmann C, Holdenrieder S, Jung V, Becker F <i>et al</i>. MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels. <i>PLoS One</i> 2011; <b>6</b>: e25787.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BC3MXhtlGmt7nM" aria-label="CAS reference 54">CAS</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1371%2Fjournal.pone.0025787" aria-label="Article reference 54">Article</a> 
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 54" href="http://scholar.google.com/scholar_lookup?&amp;title=MicroRNAs%20in%20renal%20cell%20carcinoma%3A%20diagnostic%20implications%20of%20serum%20miR-1233%20levels&amp;journal=PLoS%20One&amp;volume=6&amp;publication_year=2011&amp;author=Wulfken%2CLM&amp;author=Moritz%2CR&amp;author=Ohlmann%2CC&amp;author=Holdenrieder%2CS&amp;author=Jung%2CV&amp;author=Becker%2CF">
                    Google Scholar</a> 
                </p></li></ol><p class="c-article-references__download u-hide-print"><a data-track="click" data-track-action="download citation references" data-track-label="link" href="https://citation-needed.springer.com/v2/references/10.1038/onc.2013.237?format=refman&amp;flavour=references">Download references<svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-download"></use></svg></a></p></div></div></div></section></div><section data-title="Acknowledgements"><div class="c-article-section" id="Ack1-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Ack1">Acknowledgements</h2><div class="c-article-section__content" id="Ack1-content"><p>This work was supported by the NSW State Cancer Council, Cancer Institute NSW, and National Health and Medical Research Council (NHMRC), Australia. CCJ is a recipient of postdoctoral training Fellowship of NHMRC. XDZ is supported by a senior research fellowship of NHMRC.</p></div></div></section><section aria-labelledby="author-information" data-title="Author information"><div class="c-article-section" id="author-information-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="author-information">Author information</h2><div class="c-article-section__content" id="author-information-content"><h3 class="c-article__sub-heading" id="affiliations">Affiliations</h3><ol class="c-article-author-affiliation__list"><li id="Aff1"><p class="c-article-author-affiliation__address">Priority Research Centre for Cancer Research, University of Newcastle, Callaghan, NSW, Australia</p><p class="c-article-author-affiliation__authors-list">C C Jiang, A Croft, H-Y Tseng &amp; X D Zhang</p></li><li id="Aff2"><p class="c-article-author-affiliation__address">School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia</p><p class="c-article-author-affiliation__authors-list">C C Jiang, H-Y Tseng &amp; X D Zhang</p></li><li id="Aff3"><p class="c-article-author-affiliation__address">Oncology and Immunology Unit, Calvary Mater Newcastle Hospital, Waratah, NSW, Australia</p><p class="c-article-author-affiliation__authors-list">A Croft</p></li><li id="Aff4"><p class="c-article-author-affiliation__address">Department of Molecular Biology, Shanxi Cancer Hospital and Institute, Taiyuan, Shanxi, People’s Republic of China</p><p class="c-article-author-affiliation__authors-list">S T Guo &amp; X D Zhang</p></li><li id="Aff5"><p class="c-article-author-affiliation__address">Kolling Institute for Medical Research, University of Sydney, St Leonards, NSW, Australia</p><p class="c-article-author-affiliation__authors-list">L Jin &amp; P Hersey</p></li></ol><div class="u-js-hide u-hide-print" data-test="author-info"><span class="c-article__sub-heading">Authors</span><ol class="c-article-authors-search u-list-reset"><li id="auth-C_C-Jiang"><span class="c-article-authors-search__title u-h3 js-search-name">C C Jiang</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=%22C%20C%20Jiang%22" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text">You can also search for this author in
                        <span class="c-article-identifiers"><a class="c-article-identifiers__item" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=C%20C%20Jiang" data-track="click" data-track-action="author link - pubmed" data-track-label="link">PubMed</a><span class="u-hide"> </span><a class="c-article-identifiers__item" href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22C%20C%20Jiang%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link">Google Scholar</a></span></p></div></div></li><li id="auth-A-Croft"><span class="c-article-authors-search__title u-h3 js-search-name">A Croft</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=%22A%20Croft%22" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text">You can also search for this author in
                        <span class="c-article-identifiers"><a class="c-article-identifiers__item" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=A%20Croft" data-track="click" data-track-action="author link - pubmed" data-track-label="link">PubMed</a><span class="u-hide"> </span><a class="c-article-identifiers__item" href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22A%20Croft%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link">Google Scholar</a></span></p></div></div></li><li id="auth-H_Y-Tseng"><span class="c-article-authors-search__title u-h3 js-search-name">H-Y Tseng</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=%22H-Y%20Tseng%22" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text">You can also search for this author in
                        <span class="c-article-identifiers"><a class="c-article-identifiers__item" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=H-Y%20Tseng" data-track="click" data-track-action="author link - pubmed" data-track-label="link">PubMed</a><span class="u-hide"> </span><a class="c-article-identifiers__item" href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22H-Y%20Tseng%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link">Google Scholar</a></span></p></div></div></li><li id="auth-S_T-Guo"><span class="c-article-authors-search__title u-h3 js-search-name">S T Guo</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=%22S%20T%20Guo%22" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text">You can also search for this author in
                        <span class="c-article-identifiers"><a class="c-article-identifiers__item" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=S%20T%20Guo" data-track="click" data-track-action="author link - pubmed" data-track-label="link">PubMed</a><span class="u-hide"> </span><a class="c-article-identifiers__item" href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22S%20T%20Guo%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link">Google Scholar</a></span></p></div></div></li><li id="auth-L-Jin"><span class="c-article-authors-search__title u-h3 js-search-name">L Jin</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=%22L%20Jin%22" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text">You can also search for this author in
                        <span class="c-article-identifiers"><a class="c-article-identifiers__item" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=L%20Jin" data-track="click" data-track-action="author link - pubmed" data-track-label="link">PubMed</a><span class="u-hide"> </span><a class="c-article-identifiers__item" href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22L%20Jin%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link">Google Scholar</a></span></p></div></div></li><li id="auth-P-Hersey"><span class="c-article-authors-search__title u-h3 js-search-name">P Hersey</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=%22P%20Hersey%22" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text">You can also search for this author in
                        <span class="c-article-identifiers"><a class="c-article-identifiers__item" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=P%20Hersey" data-track="click" data-track-action="author link - pubmed" data-track-label="link">PubMed</a><span class="u-hide"> </span><a class="c-article-identifiers__item" href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22P%20Hersey%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link">Google Scholar</a></span></p></div></div></li><li id="auth-X_D-Zhang"><span class="c-article-authors-search__title u-h3 js-search-name">X D Zhang</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=%22X%20D%20Zhang%22" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text">You can also search for this author in
                        <span class="c-article-identifiers"><a class="c-article-identifiers__item" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=X%20D%20Zhang" data-track="click" data-track-action="author link - pubmed" data-track-label="link">PubMed</a><span class="u-hide"> </span><a class="c-article-identifiers__item" href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22X%20D%20Zhang%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link">Google Scholar</a></span></p></div></div></li></ol></div><h3 class="c-article__sub-heading" id="corresponding-author">Corresponding author</h3><p id="corresponding-author-list">Correspondence to
                <a id="corresp-c1" href="mailto:Xu.Zhang@newcastle.edu.au">X D Zhang</a>.</p></div></div></section><section data-title="Ethics declarations"><div class="c-article-section" id="ethics-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="ethics">Ethics declarations</h2><div class="c-article-section__content" id="ethics-content">
              
                <h3 class="c-article__sub-heading">Competing interests</h3>
                <p>The authors declare no conflict of interest.</p>
              
            </div></div></section><section data-title="Additional information"><div class="c-article-section" id="additional-information-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="additional-information">Additional information</h2><div class="c-article-section__content" id="additional-information-content"><p><a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/onc2013237#MOESM47">Supplementary Information</a> accompanies this paper on the Oncogene website</p></div></div></section><section data-title="Supplementary information"><div class="c-article-section" id="Sec24-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec24">Supplementary information</h2><div class="c-article-section__content" id="Sec24-content"><div data-test="supplementary-info"><div id="figshareContainer" class="c-article-figshare-container" data-test="figshare-container"></div>
                  
                <div class="c-article-supplementary__item" data-test="supp-item" id="MOESM47"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-track-label="link" data-test="supp-info-link" href="https://static-content.springer.com/esm/art%3A10.1038%2Fonc.2013.237/MediaObjects/41388_2014_BFonc2013237_MOESM47_ESM.pdf" data-supp-info-image="">Supplementary Infornation (PDF 393 kb)</a></h3></div></div></div></div></section><section data-title="Rights and permissions"><div class="c-article-section" id="rightslink-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="rightslink">Rights and permissions</h2><div class="c-article-section__content" id="rightslink-content"><p class="c-article-rights"><a data-track="click" data-track-action="view rights and permissions" data-track-label="link" href="https://s100.copyright.com/AppDispatchServlet?title=Repression%20of%20microRNA-768-3p%20by%20MEK%2FERK%20signalling%20contributes%20to%20enhanced%20mRNA%20translation%20in%20human%20melanoma&amp;author=C%20C%20Jiang%20et%20al&amp;contentID=10.1038%2Fonc.2013.237&amp;copyright=Macmillan%20Publishers%20Limited&amp;publication=0950-9232&amp;publicationDate=2013-06-17&amp;publisherName=SpringerNature&amp;orderBeanReset=true">Reprints and Permissions</a></p></div></div></section><section aria-labelledby="article-info" data-title="About this article"><div class="c-article-section" id="article-info-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="article-info">About this article</h2><div class="c-article-section__content" id="article-info-content"><div class="c-bibliographic-information"><div class="c-bibliographic-information__column"><h3 class="c-article__sub-heading" id="citeas">Cite this article</h3><p class="c-bibliographic-information__citation">Jiang, C., Croft, A., Tseng, HY. <i>et al.</i> Repression of microRNA-768-3p by MEK/ERK signalling contributes to enhanced mRNA translation in human melanoma.
                    <i>Oncogene</i> <b>33, </b>2577–2588 (2014). https://doi.org/10.1038/onc.2013.237</p><p class="c-bibliographic-information__download-citation u-hide-print"><a data-test="citation-link" data-track="click" data-track-action="download article citation" data-track-label="link" data-track-external="" href="https://citation-needed.springer.com/v2/references/10.1038/onc.2013.237?format=refman&amp;flavour=citation">Download citation<svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-download"></use></svg></a></p><ul class="c-bibliographic-information__list" data-test="publication-history"><li class="c-bibliographic-information__list-item"><p>Received<span class="u-hide">: </span><span class="c-bibliographic-information__value"><time datetime="2012-11-01">01 November 2012</time></span></p></li><li class="c-bibliographic-information__list-item"><p>Revised<span class="u-hide">: </span><span class="c-bibliographic-information__value"><time datetime="2013-04-08">08 April 2013</time></span></p></li><li class="c-bibliographic-information__list-item"><p>Accepted<span class="u-hide">: </span><span class="c-bibliographic-information__value"><time datetime="2013-04-08">08 April 2013</time></span></p></li><li class="c-bibliographic-information__list-item"><p>Published<span class="u-hide">: </span><span class="c-bibliographic-information__value"><time datetime="2013-06-17">17 June 2013</time></span></p></li><li class="c-bibliographic-information__list-item"><p>Issue Date<span class="u-hide">: </span><span class="c-bibliographic-information__value"><time datetime="2014-05-15">15 May 2014</time></span></p></li><li class="c-bibliographic-information__list-item c-bibliographic-information__list-item--doi"><p><abbr title="Digital Object Identifier">DOI</abbr><span class="u-hide">: </span><span class="c-bibliographic-information__value">https://doi.org/10.1038/onc.2013.237</span></p></li></ul><div data-component="share-box"><div class="c-article-share-box u-display-none" hidden=""><h3 class="c-article__sub-heading">Share this article</h3><p class="c-article-share-box__description">Anyone you share the following link with will be able to read this content:</p><button class="js-get-share-url c-article-share-box__button" id="get-share-url" data-track="click" data-track-label="button" data-track-external="" data-track-action="get shareable link">Get shareable link</button><div class="js-no-share-url-container u-display-none" hidden=""><p class="js-c-article-share-box__no-sharelink-info c-article-share-box__no-sharelink-info">Sorry, a shareable link is not currently available for this article.</p></div><div class="js-share-url-container u-display-none" hidden=""><p class="js-share-url c-article-share-box__only-read-input" id="share-url" data-track="click" data-track-label="button" data-track-action="select share url"></p><button class="js-copy-share-url c-article-share-box__button--link-like" id="copy-share-url" data-track="click" data-track-label="button" data-track-action="copy share url" data-track-external="">Copy to clipboard</button></div><p class="js-c-article-share-box__additional-info c-article-share-box__additional-info">
                            Provided by the Springer Nature SharedIt content-sharing initiative
                        </p></div></div><h3 class="c-article__sub-heading">Keywords</h3><ul class="c-article-subject-list"><li class="c-article-subject-list__subject"><span>miR-768-3p</span></li><li class="c-article-subject-list__subject"><span>eIF4E</span></li><li class="c-article-subject-list__subject"><span>mRNA translation</span></li><li class="c-article-subject-list__subject"><span>melanoma</span></li><li class="c-article-subject-list__subject"><span>RAF/MEK/ERK</span></li></ul><div data-component="article-info-list"></div></div></div></div></div></section>

            
        <section>
            <div class="c-article-section js-article-section" id="further-reading-section">
                <h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="further-reading">Further reading</h2>
                <div class="c-article-section__content js-collapsible-section" id="further-reading-content">
                    <ul class="c-article-further-reading__list" id="further-reading-list">
                        
                            <li class="c-article-further-reading__item js-ref-item">
                                <h3 class="c-article-further-reading__title">
                                    <a class="print-link" data-track="click" data-track-action="view further reading article"
                                       data-track-label="link:Clinical significance of serum miR-768-3p in HBV-related hepatocellular carcinoma and its potential mechanism" href="https://doi.org/10.1007/s10238-020-00646-z">
                                        Clinical significance of serum miR-768-3p in HBV-related hepatocellular carcinoma and its potential mechanism
                                    </a>
                                </h3>
                                
                                    <ul data-test="author-list" class="c-author-list c-author-list--compact u-mb-4 u-mt-auto">
                                        
                                            <li>Chunyu Cao</li>
                                        
                                            <li>Changjiang Wang</li>
                                        
                                    </ul>
                                
                                <p class="c-article-further-reading__journal-title"><i>Clinical and Experimental Medicine</i> (2020)</p>
                            </li>
                        
                            <li class="c-article-further-reading__item js-ref-item">
                                <h3 class="c-article-further-reading__title">
                                    <a class="print-link" data-track="click" data-track-action="view further reading article"
                                       data-track-label="link:Sequential decitabine and carboplatin treatment increases the DNA repair protein XPC, increases apoptosis and decreases proliferation in melanoma" href="https://doi.org/10.1186/s12885-018-4010-9">
                                        Sequential decitabine and carboplatin treatment increases the DNA repair protein XPC, increases apoptosis and decreases proliferation in melanoma
                                    </a>
                                </h3>
                                
                                    <ul data-test="author-list" class="c-author-list c-author-list--compact u-mb-4 u-mt-auto">
                                        
                                            <li>Timothy Budden</li>
                                        
                                            <li>Andre van der Westhuizen</li>
                                        
                                            <li>Nikola A. Bowden</li>
                                        
                                    </ul>
                                
                                <p class="c-article-further-reading__journal-title"><i>BMC Cancer</i> (2018)</p>
                            </li>
                        
                            <li class="c-article-further-reading__item js-ref-item">
                                <h3 class="c-article-further-reading__title">
                                    <a class="print-link" data-track="click" data-track-action="view further reading article"
                                       data-track-label="link:The landscape of BRAF transcript and protein variants in human cancer" href="https://doi.org/10.1186/s12943-017-0645-4">
                                        The landscape of BRAF transcript and protein variants in human cancer
                                    </a>
                                </h3>
                                
                                    <ul data-test="author-list" class="c-author-list c-author-list--compact c-author-list--truncated u-mb-4 u-mt-auto">
                                        
                                            <li>Andrea Marranci</li>
                                        
                                            <li>Zhijie Jiang</li>
                                        
                                            <li>Laura Poliseno</li>
                                        
                                    </ul>
                                
                                <p class="c-article-further-reading__journal-title"><i>Molecular Cancer</i> (2017)</p>
                            </li>
                        
                            <li class="c-article-further-reading__item js-ref-item">
                                <h3 class="c-article-further-reading__title">
                                    <a class="print-link" data-track="click" data-track-action="view further reading article"
                                       data-track-label="link:Selumetinib suppresses cell proliferation, migration and trigger apoptosis, G1 arrest in triple-negative breast cancer cells" href="https://doi.org/10.1186/s12885-016-2773-4">
                                        Selumetinib suppresses cell proliferation, migration and trigger apoptosis, G1 arrest in triple-negative breast cancer cells
                                    </a>
                                </h3>
                                
                                    <ul data-test="author-list" class="c-author-list c-author-list--compact c-author-list--truncated u-mb-4 u-mt-auto">
                                        
                                            <li>Yan Zhou</li>
                                        
                                            <li>Shuchen Lin</li>
                                        
                                            <li>Hai-yan Hu</li>
                                        
                                    </ul>
                                
                                <p class="c-article-further-reading__journal-title"><i>BMC Cancer</i> (2016)</p>
                            </li>
                        
                    </ul>
                </div>
            </div>
        </section>
    

            

            <span data-recommended="jobs"></span>
</div>
</article>
</main>

<aside class="c-article-extras u-hide-print" aria-label="Article navigation" data-component-reading-companion data-container-type="reading-companion" data-track-component="reading companion">
    
        
            
    
    <div class="c-pdf-download u-clear-both">
        <a href="/articles/onc2013237.pdf" class="c-pdf-download__link" data-article-pdf="true" data-readcube-pdf-url="true" data-test="download-pdf" data-draft-ignore="true" data-track="click" data-track-action="download pdf" data-track-label="link" data-track-external>
            <span>Download PDF</span>
            <svg aria-hidden="true" focusable="false" width="16" height="16" class="u-icon"><use xlink:href="#global-icon-download"/></svg>
        </a>
    </div>
    

        
    

    

    
        
    

    

    <div class="c-reading-companion">
        <div class="c-reading-companion__sticky" data-component="reading-companion-sticky" data-test="reading-companion-sticky">
            <div class="c-reading-companion__panel c-reading-companion__sections c-reading-companion__panel--active" id="tabpanel-sections">
                <div class="u-mt-16" data-component-mpu>
                    <div class="c-ad c-ad--300x250">
                        <div class="c-ad__inner">
                            <p class="c-ad__label">Advertisement</p>
                            
    <div id="div-gpt-ad-right-2"
         class="div-gpt-ad advert medium-rectangle js-ad text-center hide-print grade-c-hide"
         data-ad-type="right"
         data-pa11y-ignore
         data-gpt
         data-gpt-unitpath="/285/onc.nature.com/article"
         data-gpt-sizes="300x250"
         data-gpt-targeting="type=article;pos=right;artid=onc2013237;doi=10.1038/onc.2013.237;subjmeta=1634,1813,331,337,384,574,631,67,692,699,80,86;kwrd=Cell+signalling,Melanoma,miRNAs,Translation">
        <noscript>
            <a href="//pubads.g.doubleclick.net/gampad/jump?iu=/285/onc.nature.com/article&amp;sz=300x250&amp;c=-889080199&amp;t=pos%3Dright%26type%3Darticle%26artid%3Donc2013237%26doi%3D10.1038/onc.2013.237%26subjmeta%3D1634,1813,331,337,384,574,631,67,692,699,80,86%26kwrd%3DCell+signalling,Melanoma,miRNAs,Translation">
                <img data-test="gpt-advert-fallback-img"
                     src="//pubads.g.doubleclick.net/gampad/ad?iu=/285/onc.nature.com/article&amp;sz=300x250&amp;c=-889080199&amp;t=pos%3Dright%26type%3Darticle%26artid%3Donc2013237%26doi%3D10.1038/onc.2013.237%26subjmeta%3D1634,1813,331,337,384,574,631,67,692,699,80,86%26kwrd%3DCell+signalling,Melanoma,miRNAs,Translation"
                     alt="Advertisement"
                     width="300"
                     height="250"></a>
        </noscript>
    </div>

                        </div>
                    </div>
                </div>
            </div>
            <div class="c-reading-companion__panel c-reading-companion__figures c-reading-companion__panel--full-width" id="tabpanel-figures"></div>
            <div class="c-reading-companion__panel c-reading-companion__references c-reading-companion__panel--full-width" id="tabpanel-references"></div>
        </div>
    </div>
</aside>
</div>


    
        <nav class="u-hide-print c-header-expander" aria-labelledby="Explore-content" data-test="Explore-content" id="explore" data-track-component="nature-150-split-header">
            <div class="c-header-expander__container">
                <h2 id="Explore-content" class="c-header-expander__heading u-js-hide">Explore content</h2>
                <ul class="c-header-expander__list">
                    
                        
                            <li class="c-header-expander__item">
                                <a class="c-header-expander__link"
                                   href="/onc/research-articles"
                                   data-track="click"
                                   data-track-action="research articles"
                                   data-track-label="link"
                                   data-test="explore-nav-item">
                                    Research articles
                                </a>
                            </li>
                        
                            <li class="c-header-expander__item">
                                <a class="c-header-expander__link"
                                   href="/onc/reviews-and-analysis"
                                   data-track="click"
                                   data-track-action="reviews &amp; analysis"
                                   data-track-label="link"
                                   data-test="explore-nav-item">
                                    Reviews &amp; Analysis
                                </a>
                            </li>
                        
                            <li class="c-header-expander__item">
                                <a class="c-header-expander__link"
                                   href="/onc/news-and-comment"
                                   data-track="click"
                                   data-track-action="news &amp; comment"
                                   data-track-label="link"
                                   data-test="explore-nav-item">
                                    News &amp; Comment
                                </a>
                            </li>
                        
                            <li class="c-header-expander__item">
                                <a class="c-header-expander__link"
                                   href="/onc/current-issue"
                                   data-track="click"
                                   data-track-action="current issue"
                                   data-track-label="link"
                                   data-test="explore-nav-item">
                                    Current issue
                                </a>
                            </li>
                        
                            <li class="c-header-expander__item">
                                <a class="c-header-expander__link"
                                   href="/onc/collections"
                                   data-track="click"
                                   data-track-action="collections"
                                   data-track-label="link"
                                   data-test="explore-nav-item">
                                    Collections
                                </a>
                            </li>
                        
                    
                    
                    
                        <li class="c-header-expander__item c-header-expander__item--keyline c-header-expander__item--keyline-first-item-only">
                            <a class="c-header-expander__link"
                               href="https://twitter.com/oncogenejournal"
                               data-track="click"
                               data-track-action="twitter"
                               data-track-label="link">Follow us on Twitter
                            </a>
                        </li>
                    
                    
                    
                        <li class="c-header-expander__item c-header-expander__item--keyline c-header-expander__item--keyline-first-item-only u-hide-at-lg">
                            <a class="c-header-expander__link"
                               href="https://www.nature.com/my-account/alerts/subscribe-journal?list-id&#x3D;51"
                               rel="nofollow"
                               data-track="click"
                               data-track-action="Sign up for alerts"
                               data-track-external
                               data-track-label="link (mobile dropdown)">Sign up for alerts<svg role="img" aria-hidden="true" focusable="false" height="18" viewBox="0 0 18 18" width="18" xmlns="http://www.w3.org/2000/svg"><path d="m4 10h2.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-3.08578644l-1.12132034 1.1213203c-.18753638.1875364-.29289322.4418903-.29289322.7071068v.1715729h14v-.1715729c0-.2652165-.1053568-.5195704-.2928932-.7071068l-1.7071068-1.7071067v-3.4142136c0-2.76142375-2.2385763-5-5-5-2.76142375 0-5 2.23857625-5 5zm3 4c0 1.1045695.8954305 2 2 2s2-.8954305 2-2zm-5 0c-.55228475 0-1-.4477153-1-1v-.1715729c0-.530433.21071368-1.0391408.58578644-1.4142135l1.41421356-1.4142136v-3c0-3.3137085 2.6862915-6 6-6s6 2.6862915 6 6v3l1.4142136 1.4142136c.3750727.3750727.5857864.8837805.5857864 1.4142135v.1715729c0 .5522847-.4477153 1-1 1h-4c0 1.6568542-1.3431458 3-3 3-1.65685425 0-3-1.3431458-3-3z" fill="#fff"/></svg>
                            </a>
                        </li>
                    
                    
                        <li class="c-header-expander__item c-header-expander__item--keyline c-header-expander__item--keyline-first-item-only u-hide-at-lg">
                            <a class="c-header-expander__link"
                               href="http://feeds.nature.com/onc/rss/current"
                               data-track="click"
                               data-track-action="rss feed"
                               data-track-label="link">
                                <span>RSS feed</span>
                            </a>
                        </li>
                    
                </ul>
            </div>
        </nav>
    

    
        <nav class="u-hide-print c-header-expander" aria-labelledby="About-the-journal" id="about-the-journal" data-track-component="nature-150-split-header">
            <div class="c-header-expander__container">
                <h2 id="About-the-journal" class="c-header-expander__heading u-js-hide">About the journal</h2>
                <ul class="c-header-expander__list">
                    
                        <li class="c-header-expander__item">
                            <a class="c-header-expander__link"
                               href="/onc/journal-information"
                               data-track="click"
                               data-track-action="journal information"
                               data-track-label="link">
                                Journal Information
                            </a>
                        </li>
                    
                        <li class="c-header-expander__item">
                            <a class="c-header-expander__link"
                               href="/onc/open-access"
                               data-track="click"
                               data-track-action="open access publishing"
                               data-track-label="link">
                                Open Access Publishing
                            </a>
                        </li>
                    
                        <li class="c-header-expander__item">
                            <a class="c-header-expander__link"
                               href="/onc/editors"
                               data-track="click"
                               data-track-action="about the editors"
                               data-track-label="link">
                                About the Editors
                            </a>
                        </li>
                    
                        <li class="c-header-expander__item">
                            <a class="c-header-expander__link"
                               href="/onc/contact"
                               data-track="click"
                               data-track-action="contact"
                               data-track-label="link">
                                Contact
                            </a>
                        </li>
                    
                        <li class="c-header-expander__item">
                            <a class="c-header-expander__link"
                               href="/onc/advertising"
                               data-track="click"
                               data-track-action="for advertisers"
                               data-track-label="link">
                                For Advertisers
                            </a>
                        </li>
                    
                        <li class="c-header-expander__item">
                            <a class="c-header-expander__link"
                               href="/onc/subscribe"
                               data-track="click"
                               data-track-action="subscribe"
                               data-track-label="link">
                                Subscribe
                            </a>
                        </li>
                    
                </ul>
            </div>
        </nav>
    

    
        <nav class="u-hide-print c-header-expander" aria-labelledby="Publish-with-us-label" id="publish-with-us" data-track-component="nature-150-split-header">
            <div class="c-header-expander__container">
                <h2 id="Publish-with-us-label" class="c-header-expander__heading u-js-hide">Publish with us</h2>
                <ul class="c-header-expander__list">
                    
                        <li class="c-header-expander__item">
                            <a class="c-header-expander__link"
                               href="/onc/authors-and-referees"
                               data-track="click"
                               data-track-action="for authors &amp; referees"
                               data-track-label="link">
                                For Authors &amp; Referees
                            </a>
                        </li>
                    
                    
                        <li class="c-header-expander__item c-header-expander__item--keyline">
                            <a class="c-header-expander__link"
                               href="https://mts-onc.nature.com/cgi-bin/main.plex"
                               data-track="click"
                               data-track-action="Submit manuscript"
                               data-track-label="link"
                               data-track-external>Submit manuscript<svg role="img" aria-hidden="true" focusable="false" height="18" viewBox="0 0 18 18" width="18" xmlns="http://www.w3.org/2000/svg"><path d="m15 0c1.1045695 0 2 .8954305 2 2v5.5c0 .27614237-.2238576.5-.5.5s-.5-.22385763-.5-.5v-5.5c0-.51283584-.3860402-.93550716-.8833789-.99327227l-.1166211-.00672773h-9v3c0 1.1045695-.8954305 2-2 2h-3v10c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h7.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-7.5c-1.1045695 0-2-.8954305-2-2v-10.17157288c0-.53043297.21071368-1.0391408.58578644-1.41421356l3.82842712-3.82842712c.37507276-.37507276.88378059-.58578644 1.41421356-.58578644zm-.5442863 8.18867991 3.3545404 3.35454039c.2508994.2508994.2538696.6596433.0035959.909917-.2429543.2429542-.6561449.2462671-.9065387-.0089489l-2.2609825-2.3045251.0010427 7.2231989c0 .3569916-.2898381.6371378-.6473715.6371378-.3470771 0-.6473715-.2852563-.6473715-.6371378l-.0010428-7.2231995-2.2611222 2.3046654c-.2531661.2580415-.6562868.2592444-.9065605.0089707-.24295423-.2429542-.24865597-.6576651.0036132-.9099343l3.3546673-3.35466731c.2509089-.25090888.6612706-.25227691.9135302-.00001728zm-.9557137-3.18867991c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-6c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm-8.5-3.587-3.587 3.587h2.587c.55228475 0 1-.44771525 1-1zm8.5 1.587c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-6c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z" fill="#fff"/></svg>
                            </a>
                        </li>
                    
                </ul>
            </div>
        </nav>
    


<div id="search-menu" class="c-header-expander c-header-expander--tray u-hide-print" data-track-component="nature-150-split-header">
    <div class="c-header-expander__container">
        <h2 class="u-visually-hidden">Search</h2>
        <div data-test="inline-search">
            <div class="c-search c-search--max-width u-mb-16">
                <form action="/search"
                      method="get"
                      role="search"
                      autocomplete="off"
                      data-dynamic-track-label
                      data-track="submit" data-track-action="search" data-track-label="form">
                    <label class="c-header-expander__heading u-mb-8" for="keywords">Search articles by subject, keyword or author</label>
                    <div class="c-search__field">
                        <div class="c-search__input-container c-search__input-container--md">
                            <input type="text"
                               required
                               class="c-search__input"
                               id="keywords"
                               name="q"
                               value=""
                               data-test="search-keywords">
                        </div>

                        <div class="c-search__select-container">
                            <label for="results-from" class="u-visually-hidden">Show results from</label>
                            <select id="results-from" name="journal" class="c-search__select">
                                
                                    
                                        <option value="" selected>All journals</option>
                                        <option value="onc">This journal</option>
                                    
                                
                            </select>
                        </div>
                        <div class="c-search__button-container">
                            <button type="submit" class="u-button u-button--primary u-button--full-width" data-test="search-submit">Search</button>
                        </div>
                    </div>
                </form>
            </div>
        </div>

        <div class="c-header-expander__keyline u-mb-16">
            <p class="u-ma-0">
                <a href="/search/advanced"
                   data-track="click" data-track-action="advanced search" data-track-label="link">
                    Advanced search
                </a>
            </p>
        </div>
        <h3 class="c-header-expander__heading">Quick links</h3>
        <ul class="u-list-reset">
            <li class="u-display-inline-block u-mr-24 u-mb-16"><a href="/subjects" data-track="click" data-track-action="explore articles by subject" data-track-label="link">Explore articles by subject</a></li>
            <li class="u-display-inline-block u-mr-24 u-mb-16"><a href="/naturecareers" data-track="click" data-track-action="find a job" data-track-label="link">Find a job</a></li>
            <li class="u-display-inline-block u-mr-24 u-mb-16"><a href="/authors/index.html" data-track="click" data-track-action="guide to authors" data-track-label="link">Guide to authors</a></li>
            <li class="u-display-inline-block u-mr-24 u-mb-16"><a href="/authors/editorial_policies/" data-track="click" data-track-action="editorial policies" data-track-label="link">Editorial policies</a></li>
        </ul>
    </div>
</div>

<footer class="composite-layer" itemscope itemtype="http://schema.org/Periodical">
    <meta itemprop="publisher" content="Springer Nature">
    
    <div class="u-mt-16 u-mb-16">
    <div class="u-container">
        <div class="u-display-flex u-flex-wrap u-justify-content-space-between">
            

            <p class="c-meta u-ma-0 u-flex-shrink">
                <span class="c-meta__item">
                    Oncogene (<i>Oncogene</i>)
                </span>
                
    
    <span class="c-meta__item">
        <abbr title="International Standard Serial Number">ISSN</abbr> <span itemprop="onlineIssn">1476-5594</span> (online)
    </span>
    


                
    
    <span class="c-meta__item">
        <abbr title="International Standard Serial Number">ISSN</abbr> <span itemprop="printIssn">0950-9232</span> (print)
    </span>
    

            </p>
        </div>
    </div>
</div>


    <div>
        <div class="c-footer">
            <div class="u-container">
                <div class="u-hide-print" data-track-component="footer">
    <h2 class="u-visually-hidden">nature.com sitemap</h2>
    <div class="c-footer__header">
        <div class="c-footer__logo">
            <img alt="Nature portfolio" src="/static/images/logos/nature-portfolio-white.svg" loading="lazy" width="200" height="31">
        </div>
        <ul class="c-menu c-menu--inherit u-mr-32">
            <li class="c-menu__item"><a class="c-menu__link" href="https://www.nature.com/npg_/company_info/index.html" data-track="click" data-track-action="about us" data-track-label="link">About us</a></li>
            <li class="c-menu__item"><a class="c-menu__link" href="https://www.nature.com/npg_/press_room/press_releases.html" data-track="click" data-track-action="press releases" data-track-label="link">Press releases</a></li>
            <li class="c-menu__item"><a class="c-menu__link" href="https://press.nature.com/" data-track="click" data-track-action="press office" data-track-label="link">Press office</a></li>
            <li class="c-menu__item"><a class="c-menu__link" href="https://support.nature.com/support/home" data-track="click" data-track-action="contact us" data-track-label="link">Contact us</a></li>
        </ul>
        <ul class="c-menu c-menu--inherit">
            <li class="c-menu__item">
                <a class="c-menu__link" href="https://www.facebook.com/NaturePortfolioJournals/" aria-label="Facebook" data-track="click" data-track-action="facebook" data-track-label="link">
                    <svg class="u-icon" role="img" aria-hidden="true" focusable="false" xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 20 20"><path d="M2.5 20C1.1 20 0 18.9 0 17.5v-15C0 1.1 1.1 0 2.5 0h15C18.9 0 20 1.1 20 2.5v15c0 1.4-1.1 2.5-2.5 2.5h-3.7v-7.7h2.6l.4-3h-3v-2c0-.9.2-1.5 1.5-1.5h1.6V3.1c-.3 0-1.2-.1-2.3-.1-2.3 0-3.9 1.4-3.9 4v2.2H8.1v3h2.6V20H2.5z"/></svg>
                </a>
            </li>
            <li class="c-menu__item">
                <a class="c-menu__link" href="https://twitter.com/NaturePortfolio?lang=en" aria-label="Twitter" data-track="click" data-track-action="twitter" data-track-label="link">
                    <svg class="u-icon" role="img" aria-hidden="true" focusable="false" xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 20 20"><path d="M17.6 4.1c.8-.5 1.5-1.4 1.8-2.4-.8.5-1.7.9-2.6 1-.7-.8-1.8-1.4-3-1.4-2.3 0-4.1 1.9-4.1 4.3 0 .3 0 .7.1 1-3.4 0-6.4-1.8-8.4-4.4C1 2.9.8 3.6.8 4.4c0 1.5.7 2.8 1.8 3.6C2 8 1.4 7.8.8 7.5v.1c0 2.1 1.4 3.8 3.3 4.2-.3.1-.7.2-1.1.2-.3 0-.5 0-.8-.1.5 1.7 2 3 3.8 3-1.3 1.1-3.1 1.8-5 1.8-.3 0-.7 0-1-.1 1.8 1.2 4 1.9 6.3 1.9C13.8 18.6 18 12 18 6.3v-.6c.8-.6 1.5-1.4 2-2.2-.7.3-1.5.5-2.4.6z"/></svg>
                </a>
            </li>
            <li class="c-menu__item">
                <a class="c-menu__link" href="https://www.youtube.com/channel/UCvCLdSgYdSTpWcOgEJgi-ng" aria-label="YouTube" data-track="click" data-track-action="youtube" data-track-label="link">
                    <svg class="u-icon" role="img" aria-hidden="true" focusable="false" xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 20 20"><path d="M7.9 12.6V6.9l5.4 2.8c0 .1-5.4 2.9-5.4 2.9zM19.8 6s-.2-1.4-.8-2c-.8-.8-1.6-.8-2-.9-2.8-.2-7-.2-7-.2s-4.2 0-7 .2c-.4 0-1.2 0-2 .9-.6.6-.8 2-.8 2S0 7.6 0 9.2v1.5c0 1.7.2 3.3.2 3.3s.2 1.4.8 2c.8.8 1.8.8 2.2.9 1.6.1 6.8.2 6.8.2s4.2 0 7-.2c.4 0 1.2-.1 2-.9.6-.6.8-2 .8-2s.2-1.6.2-3.3V9.2c0-1.6-.2-3.2-.2-3.2z"/></svg>
                </a>
            </li>
        </ul>
    </div>

    <div class="c-footer__grid">
        <div class="c-footer__group">
            <h3 class="c-footer__heading">Discover content</h3>
            <ul class="c-footer__list">
                <li class="c-footer__item"><a href="https://www.nature.com/siteindex" data-track="click" data-track-action="journals a-z" data-track-label="link">Journals A-Z</a></li>
                <li class="c-footer__item"><a href="https://www.nature.com/subjects/" data-track="click" data-track-action="article by subject" data-track-label="link">Articles by subject</a></li>
                <li class="c-footer__item"><a href="https://nano.nature.com/" data-track="click" data-track-action="nano" data-track-label="link">Nano</a></li>
                <li class="c-footer__item"><a href="https://www.nature.com/protocolexchange/" data-track="click" data-track-action="protocol exchange" data-track-label="link">Protocol Exchange</a></li>
                <li class="c-footer__item"><a href="https://www.natureindex.com/" data-track="click" data-track-action="nature index" data-track-label="link">Nature Index</a></li>
            </ul>
        </div>

        <div class="c-footer__group">
            <h3 class="c-footer__heading">Publishing policies</h3>
            <ul class="c-footer__list">
                <li class="c-footer__item"><a href="https://www.nature.com/authors/editorial_policies/" data-track="click" data-track-action="Nature portfolio policies" data-track-label="link">Nature portfolio policies</a></li>
                <li class="c-footer__item"><a href="https://www.nature.com/nature-research/open-access" data-track="click" data-track-action="open access" data-track-label="link">Open access</a></li>
            </ul>
        </div>

        <div class="c-footer__group">
            <h3 class="c-footer__heading">Author &amp; Researcher services</h3>
            <ul class="c-footer__list">
                <li class="c-footer__item"><a href="https://www.nature.com/reprints/" data-track="click" data-track-action="reprints and permissions" data-track-label="link">Reprints &amp; permissions</a></li>
                <li class="c-footer__item"><a href="https://www.springernature.com/gp/authors/research-data" data-track="click" data-track-action="data research service" data-track-label="link">Research data</a></li>
                <li class="c-footer__item"><a href="https://authorservices.springernature.com/go/nr" data-track="click" data-track-action="language editing" data-track-label="link">Language editing</a></li>
                <li class="c-footer__item"><a href="https://authorservices.springernature.com/scientific-editing/" data-track="click" data-track-action="scientific editing" data-track-label="link">Scientific editing</a></li>
                <li class="c-footer__item"><a href="https://masterclasses.nature.com/" data-track="click" data-track-action="nature masterclasses" data-track-label="link">Nature Masterclasses</a></li>
                <li class="c-footer__item"><a href="https://partnerships.nature.com/product/researcher-training/" data-track="click" data-track-action="nature research academies" data-track-label="link">Nature Research Academies</a></li>
            </ul>
        </div>

        <div class="c-footer__group">
            <h3 class="c-footer__heading">Libraries &amp; institutions</h3>
            <ul class="c-footer__list">
                <li class="c-footer__item"><a href="https://www.springernature.com/gp/librarians/tools-services" data-track="click" data-track-action="librarian service and tools" data-track-label="link">Librarian service &amp; tools</a></li>
                <li class="c-footer__item"><a href="https://www.springernature.com/gp/librarians/manage-your-account/librarianportal" data-track="click" data-track-action="librarian portal" data-track-label="link">Librarian portal</a></li>
                <li class="c-footer__item"><a href="https://www.nature.com/openresearch/about-open-access/information-for-institutions/" data-track="click" data-track-action="open research" data-track-label="link">Open research</a></li>
                <li class="c-footer__item"><a href="https://www.springernature.com/gp/librarians/recommend-to-your-library" data-track="click" data-track-action="Recommend to library" data-track-label="link">Recommend to library</a></li>
            </ul>
        </div>

        <div class="c-footer__group">
            <h3 class="c-footer__heading">Advertising &amp; partnerships</h3>
            <ul class="c-footer__list">
                <li class="c-footer__item"><a href="https://partnerships.nature.com/product/digital-advertising/" data-track="click" data-track-action="advertising" data-track-label="link">Advertising</a></li>
                <li class="c-footer__item"><a href="https://partnerships.nature.com/" data-track="click" data-track-action="partnerships and services" data-track-label="link">Partnerships &amp; Services</a></li>
                <li class="c-footer__item"><a href="https://partnerships.nature.com/media-kits/" data-track="click" data-track-action="media kits" data-track-label="link">Media kits</a></li>
                <li class="c-footer__item"><a href="https://partnerships.nature.com/product/branded-content-native-advertising/" data-track-action="branded content" data-track-label="link">Branded content</a></li>
            </ul>
        </div>

        <div class="c-footer__group">
            <h3 class="c-footer__heading">Career development</h3>
            <ul class="c-footer__list">
                <li class="c-footer__item"><a href="https://www.nature.com/naturecareers" data-track="click" data-track-action="nature careers" data-track-label="link">Nature Careers</a></li>
                <li class="c-footer__item"><a href="https://conferences.nature.com" data-track="click" data-track-action="nature conferences" data-track-label="link">Nature<span class="u-visually-hidden"> </span> Conferences</a></li>
                <li class="c-footer__item"><a href="https://www.nature.com/natureevents/" data-track="click" data-track-action="nature events" data-track-label="link">Nature<span class="u-visually-hidden"> </span> events</a></li>
            </ul>
        </div>

        <div class="c-footer__group">
            <h3 class="c-footer__heading">Regional websites</h3>
            <ul class="c-footer__list">
                <li class="c-footer__item"><a href="https://www.nature.com/natafrica" data-track="click" data-track-action="nature africa" data-track-label="link">Nature Africa</a></li>
                <li class="c-footer__item"><a href="http://www.naturechina.com" data-track="click" data-track-action="nature china" data-track-label="link">Nature China</a></li>
                <li class="c-footer__item"><a href="https://www.nature.com/nindia" data-track="click" data-track-action="nature india" data-track-label="link">Nature India</a></li>
                <li class="c-footer__item"><a href="https://www.nature.com/natitaly" data-track="click" data-track-action="nature Italy" data-track-label="link">Nature Italy</a></li>
                <li class="c-footer__item"><a href="https://www.natureasia.com/ja-jp/" data-track="click" data-track-action="nature japan" data-track-label="link">Nature Japan</a></li>
                <li class="c-footer__item"><a href="https://www.natureasia.com/ko-kr/" data-track="click" data-track-action="nature korea" data-track-label="link">Nature Korea</a></li>
                <li class="c-footer__item"><a href="https://www.nature.com/nmiddleeast/" data-track="click" data-track-action="nature middle east" data-track-label="link">Nature Middle East</a></li>
            </ul>
        </div>

        <div class="c-footer__group">
            <h3 class="c-footer__heading">Legal &amp; Privacy</h3>
            <ul class="c-footer__list">
                <li class="c-footer__item"><a href="https://www.nature.com/info/privacy" data-track="click" data-track-action="privacy policy" data-track-label="link">Privacy Policy</a></li>
                <li class="c-footer__item"><a href="https://www.nature.com/info/cookies" data-track="click" data-track-action="use of cookies" data-track-label="link">Use of cookies</a></li>
                <li class="c-footer__item"><a class="optanon-toggle-display" href="javascript:;" data-cc-action="preferences" data-track="click" data-track-action="manage cookies" data-track-label="link">Manage cookies/Do not sell my data</a></li>
                <li class="c-footer__item"><a href="https://www.nature.com/info/legal-notice" data-track="click" data-track-action="legal notice" data-track-label="link">Legal notice</a></li>
                <li class="c-footer__item"><a href="https://www.nature.com/info/accessibility-statement" data-track="click" data-track-action="accessibility statement" data-track-label="link">Accessibility statement</a></li>
                <li class="c-footer__item"><a href="https://www.nature.com/info/terms-and-conditions" data-track="click" data-track-action="terms and conditions" data-track-label="link">Terms &amp; Conditions</a></li>
                <li class="c-footer__item"><a href="https://www.springernature.com/ccpa" data-track="click" data-track-action="california privacy statement" data-track-label="link">California Privacy Statement</a></li>
            </ul>
        </div>
    </div>
</div>


            </div>
        </div>
    </div>

    <div class="c-corporate-footer">
    <div class="u-container">
        <img src="/static/images/logos/sn-logo-white.svg" alt="Springer Nature" loading="lazy" width="140" height="14"/>
        <p class="c-corporate-footer__legal" data-test="copyright">&copy; 2022 Springer Nature Limited</p>
    </div>
</div>

    
    <svg class="u-hide hide">
        <symbol id="global-icon-chevron-right" viewBox="0 0 16 16">
            <path d="M7.782 7L5.3 4.518c-.393-.392-.4-1.022-.02-1.403a1.001 1.001 0 011.417 0l4.176 4.177a1.001 1.001 0 010 1.416l-4.176 4.177a.991.991 0 01-1.4.016 1 1 0 01.003-1.42L7.782 9l1.013-.998z" fill-rule="evenodd"/>
        </symbol>
        <symbol id="global-icon-download" viewBox="0 0 16 16">
            <path d="M2 14c0-.556.449-1 1.002-1h9.996a.999.999 0 110 2H3.002A1.006 1.006 0 012 14zM9 2v6.8l2.482-2.482c.392-.392 1.022-.4 1.403-.02a1.001 1.001 0 010 1.417l-4.177 4.177a1.001 1.001 0 01-1.416 0L3.115 7.715a.991.991 0 01-.016-1.4 1 1 0 011.42.003L7 8.8V2c0-.55.444-.996 1-.996.552 0 1 .445 1 .996z" fill-rule="evenodd"/>
        </symbol>
        <symbol id="global-icon-email" viewBox="0 0 18 18">
            <path d="M1.995 2h14.01A2 2 0 0118 4.006v9.988A2 2 0 0116.005 16H1.995A2 2 0 010 13.994V4.006A2 2 0 011.995 2zM1 13.994A1 1 0 001.995 15h14.01A1 1 0 0017 13.994V4.006A1 1 0 0016.005 3H1.995A1 1 0 001 4.006zM9 11L2 7V5.557l7 4 7-4V7z" fill-rule="evenodd"/>
        </symbol>
        <symbol id="global-icon-institution" viewBox="0 0 18 18">
            <path d="M14 8a1 1 0 011 1v6h1.5a.5.5 0 01.5.5v.5h.5a.5.5 0 01.5.5V18H0v-1.5a.5.5 0 01.5-.5H1v-.5a.5.5 0 01.5-.5H3V9a1 1 0 112 0v6h8V9a1 1 0 011-1zM6 8l2 1v4l-2 1zm6 0v6l-2-1V9zM9.573.401l7.036 4.925A.92.92 0 0116.081 7H1.92a.92.92 0 01-.528-1.674L8.427.401a1 1 0 011.146 0zM9 2.441L5.345 5h7.31z" fill-rule="evenodd"/>
        </symbol>
        <symbol id="global-icon-search" viewBox="0 0 22 22">
            <path fill-rule="evenodd" d="M21.697 20.261a1.028 1.028 0 01.01 1.448 1.034 1.034 0 01-1.448-.01l-4.267-4.267A9.812 9.811 0 010 9.812a9.812 9.811 0 1117.43 6.182zM9.812 18.222A8.41 8.41 0 109.81 1.403a8.41 8.41 0 000 16.82z"/>
        </symbol>
        <symbol id="icon-info" viewBox="0 0 18 18">
            <path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm0 7h-1.5l-.11662113.00672773c-.49733868.05776511-.88337887.48043643-.88337887.99327227 0 .47338693.32893365.86994729.77070917.97358929l.1126697.01968298.11662113.00672773h.5v3h-.5l-.11662113.0067277c-.42082504.0488782-.76196299.3590206-.85696816.7639815l-.01968298.1126697-.00672773.1166211.00672773.1166211c.04887817.4208251.35902055.761963.76398144.8569682l.1126697.019683.11662113.0067277h3l.1166211-.0067277c.4973387-.0577651.8833789-.4804365.8833789-.9932723 0-.4733869-.3289337-.8699473-.7707092-.9735893l-.1126697-.019683-.1166211-.0067277h-.5v-4l-.00672773-.11662113c-.04887817-.42082504-.35902055-.76196299-.76398144-.85696816l-.1126697-.01968298zm0-3.25c-.69035594 0-1.25.55964406-1.25 1.25s.55964406 1.25 1.25 1.25 1.25-.55964406 1.25-1.25-.55964406-1.25-1.25-1.25z" fill-rule="evenodd"/>
        </symbol>
        <symbol id="icon-success" viewBox="0 0 18 18">
            <path d="M9 0a9 9 0 110 18A9 9 0 019 0zm3.486 4.982l-4.718 5.506L5.14 8.465a.991.991 0 00-1.423.133 1.06 1.06 0 00.13 1.463l3.407 2.733a1 1 0 001.387-.133l5.385-6.334a1.06 1.06 0 00-.116-1.464.991.991 0 00-1.424.119z" fill-rule="evenodd"/>
        </symbol>
        <symbol id="icon-chevron-down" viewBox="0 0 16 16">
            <path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" fill-rule="evenodd" transform="matrix(0 1 -1 0 11 1)"/>
        </symbol>
        <symbol id="icon-warning" viewBox="0 0 18 18">
            <path d="m9 11.75c.69035594 0 1.25.5596441 1.25 1.25s-.55964406 1.25-1.25 1.25-1.25-.5596441-1.25-1.25.55964406-1.25 1.25-1.25zm.41320045-7.75c.55228475 0 1.00000005.44771525 1.00000005 1l-.0034543.08304548-.3333333 4c-.043191.51829212-.47645714.91695452-.99654578.91695452h-.15973424c-.52008864 0-.95335475-.3986624-.99654576-.91695452l-.33333333-4c-.04586475-.55037702.36312325-1.03372649.91350028-1.07959124l.04148683-.00259031zm-.41320045 14c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z" fill-rule="evenodd"/>
        </symbol>
        <symbol id="icon-plus" viewBox="0 0 16 16">
            <path d="m2.00087166 7h4.99912834v-4.99912834c0-.55276616.44386482-1.00087166 1-1.00087166.55228475 0 1 .44463086 1 1.00087166v4.99912834h4.9991283c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-4.9991283v4.9991283c0 .5527662-.44386482 1.0008717-1 1.0008717-.55228475 0-1-.4446309-1-1.0008717v-4.9991283h-4.99912834c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule="evenodd"/>
        </symbol>
        <symbol id="icon-minus" viewBox="0 0 16 16">
            <path d="m2.00087166 7h11.99825664c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-11.99825664c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule="evenodd"/>
        </symbol>
        <symbol id="icon-error" viewBox="0 0 18 18">
            <path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm2.8630343 4.71100931-2.8630343 2.86303426-2.86303426-2.86303426c-.39658757-.39658757-1.03281091-.39438847-1.4265779-.00062147-.39651227.39651226-.39348876 1.03246767.00062147 1.4265779l2.86303426 2.86303426-2.86303426 2.8630343c-.39658757.3965875-.39438847 1.0328109-.00062147 1.4265779.39651226.3965122 1.03246767.3934887 1.4265779-.0006215l2.86303426-2.8630343 2.8630343 2.8630343c.3965875.3965876 1.0328109.3943885 1.4265779.0006215.3965122-.3965123.3934887-1.0324677-.0006215-1.4265779l-2.8630343-2.8630343 2.8630343-2.86303426c.3965876-.39658757.3943885-1.03281091.0006215-1.4265779-.3965123-.39651227-1.0324677-.39348876-1.4265779.00062147z" fill="currentColor" fill-rule="evenodd"/>
        </symbol>
        <symbol id="icon-springer-arrow-left">
            <path d="M15 7a1 1 0 000-2H3.385l2.482-2.482a.994.994 0 00.02-1.403 1.001 1.001 0 00-1.417 0L.294 5.292a1.001 1.001 0 000 1.416l4.176 4.177a.991.991 0 001.4.016 1 1 0 00-.003-1.42L3.385 7H15z"/>
        </symbol>
        <symbol id="icon-springer-arrow-right">
            <path d="M1 7a1 1 0 010-2h11.615l-2.482-2.482a.994.994 0 01-.02-1.403 1.001 1.001 0 011.417 0l4.176 4.177a1.001 1.001 0 010 1.416l-4.176 4.177a.991.991 0 01-1.4.016 1 1 0 01.003-1.42L12.615 7H1z"/>
        </symbol>
    </svg>

</footer>






    

    <noscript>
        <img hidden src="https://verify.nature.com/verify/nature.png" width="0" height="0" style="display: none" alt="">
    </noscript>

    



<script src="//content.readcube.com/ping?doi=10.1038/onc.2013.237&amp;format=js&amp;last_modified=2014-05-15" async></script>
<img src="/platform/track/article/onc2013237" width="1" height="1" alt="" class="u-visually-hidden">
</body>
</html>
